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Molecular techniques have greatly enhanced our understanding of the 
transmission and dissemination of Mycobacterium tuberculosis (M. tb), however 
the evolution of this organism is still poorly understood. 
Molecular analysis demonstrated low levels of M. tb clustering (21%) in England 
suggesting a low rate of recent transmission. Risk factors for clustering included 
pulmonary smear negative disease and a past history of TB infection. A 
combination of Restriction Fragment Length Polymorphism (RFLP)-IS6110 and 
Variable Number Tandem Repeats-Mycobacterial Interspersed Repetitive Units 
(VNTR-MIRU) analysis provided a level of discrimination appropriate for 
clinical and public health action. 
High levels of clustering (73%) observed in Harare, Zimbabwe, suggested a high 
level of recent transmission. Although no risk factors for clustering were 
identified, the high clustering rate may reflect the high HIV positivity in this 
area. A greater diversity of spoligotype strain families were observed in London 
compared to Harare, probably reflecting the greater international diversity of the 
population in London. 
The most frequently seen M. bovis spoligotype in humans in the UK (Type 9) 
was also the most prevalent in UK cattle and could be subdivided by VNTR- 
MIRU. The majority of cases were due to reactivation of a past infection, 
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acquired prior to milk pasteurisation, because 72.3% of cases were over the age 
of 50. 
A population of M. tb and M. bovis isolates previously used to construct a 
phylogenetic tree based on silent single nucleotide polymorphisms (sSNP), were 
analysed with VNTR-MIRU. VNTR-MIRU phylogenetic codes characterised 
90.9% of isolates, defined M. tb strain families and differentiated between M. tb 
and M. bovis. A step-wise trend suggestive of bi-directional evolution was 
observed in discrepant isolates. A lineage specific panel of VNTR-MIRU could 
be used to sub-divide each lineage for epidemiological purposes. Single 
nucleotide conformation polymorphism (SSCP) followed by sequencing 
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CHAPTER 1.0 Introduction 
1.1 Tuberculosis 
Tuberculosis (TB) is one of the greatest causes of death worldwide from an 
infectious disease. Approximately 2 million deaths per year are attributed to the 
bacillus Mycobacterium tuberculosis (M. tb), the causative agent of tuberculosis. 
It is estimated that one third of the world's population is infected with M. tb from 
which 8 million new cases of TB develop annually (Corbett et al. 2003). 
The incidence of TB decreased dramatically in industrialised nations and in some 
parts of the developing world during the 20th century. Since the mid-1980s TB 
rates have increased again in the industrialised world due to increased migration 
of individuals from high incidence countries, poverty and a collapse of the public 
health infrastructure needed to control TB. In the developing world TB rates 
have increased even in countries which had initiated a successful TB control 
programme fuelled by the HIV pandemic causing the World Health Organisation 
(WHO) to declare TB a global emergency in 1993. Currently the global 
incidence of TB is increasing annually at a rate of approximately 0.4% per year, 
(www. int/ tb/publications/ llobrep) but in sub-Saharan Africa and former Soviet 
Union countries the rates are in creasing much faster. 
The incidence of TB in England and Wales was declining in line with many 
industrialised countries and dropped to a rate of between 5-6000 cases per year in 
the mid 1980s. Currently there are about 7000 new cases per annum (Figure 1.1). 
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Figure 1.1: Pulmonary and non-pulmonary tuberculosis notifications, 
England and Wales, 1982 - 2003 












Source: Statutory Notifications of Infectious Diseases (NOIDs) 
Prepared by: Communicable Disease Surveillance Centre (CDSC), Health 
Protection Agency Centre for Infections 
http: //www. hpa. org. uk/infections/topics az/tb/epidemiology/figures/figure l . htm 
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In England and Wales the incidence per 100,000 population reached 12.8 in 
2003, with the majority of cases in London where rates were much higher at 41.3 
per 100,000 (http: //www. hpa. org. uk/infections/topics az/tb/epidemiology/tablel 
5. htm). 
1.2 Mycobacterium tuberculosis infection 
M. tb is a successful obligate pathogen. Tuberculosis is usually acquired by the 
inhalation of an airborne droplet 1-2µm in size from the cough of an infected 
person, which then passes to the lower respiratory tract (Riley et al. 1995). 
Although this is the most common site of infection, tuberculosis can infect 
almost any organ of the body. Once infected a person has a 5-10% lifetime risk 
of developing the disease. Of those who develop active tuberculosis disease, 80 
percent will do so within two years of infection and nearly all within five years 
(Bloom 1994). The risk is increased in those who are HIV positive to a 10% risk 
per year with a 50% lifetime risk of developing the disease (www. who. int/health- 
services-delivery/hiv aids/English/fact-sheetl3/WHO 2000). Following 
infection, most people will not develop disease due to an effective immune 
response preventing the bacilli from proliferating leading to partial immunity to 
exogenous re-infection or endogenous reactivation of latent bacilli (Bloom 
1994). Reactivation may occur in later life, typically in the elderly when the 
immune system weakens or in those who become immunocompromised for other 
reasons, such as illness, pregnancy or drug therapy (e. g. steroids). 
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1.3 Bacteriology of Mycobacteria 
The genus Mycobacterium consists of mainly aerobic saprophytes which are 
closely related to Corynebacteria, Actinomyces and Nocardia. Several are 
clinically important including the M. tb complex species (detailed in section 1.4) 
and M. leprae whilst others cause opportunistic infections or never cause disease. 
Most mycobacteria are slow growers taking between 2 and 8 weeks to grow on 
solid media; typically the doubling time for example of M. tb is about 17 to 18 
hours (Ratledge and Stanford 1982). Mycobacteria have a lipid-rich cell wall 
which is impermeable to acidified organic compounds giving them their acid-fast 
property. Upon staining, for example with Zeihl-Neeson staining, M. tb can be 
seen under a microscope as a rod shaped bacillus which often display a 
characteristic cording pattern (Collins et al. 1997). 
1.4 Mycobacterium tuberculosis complex bacteria 
M. tb, M. bovis, the vaccine strain BCG, M. africanum, M. microti, and M. canetti 
form the Mycobacterium tuberculosis complex, with M. tb being the most 
frequently isolated species in cases of human tuberculosis. M. bovis accounts for 
I% of human cases in the UK (http: //www. hpa. org. uk/infections/topics az/tb/Mb 
ovis), while M. africanum is more often seen in patients from Africa (Niemann et 
al. 2002). M microti rarely causes disease in humans but commonly causes 
disease in other mammals (Cavanagh et al. 2002, Oevermann et al. 2004) and M. 
canetti appears to be a rare cause of disease in humans (van Soolingen et al. 
1997). The M. tb complex bacteria are differentiated on their phenotypic and 
biochemical characteristics (Table 1.1) however traditional bacteriology is time 
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consuming therefore there has been a move towards molecular techniques for the 
identification of these species. 
Table 1.1 Principle characteristics of the species within M. tb complex (Based on 
Collins et a1.1997) 
Characteristic 





M. tb S A + + P=G E 
M. africanum 
II 
S M - + P=G E 
M. africanum 
I 
S M - - P D 
M. microti S M - - P D 
M. bovis R M - - P D 
M. bovis 
BCG 
R A - +/- G E 
aR- resistant / S- sensitive. bA- aerobic growth /M- microaerophilic growth 
c Growth in the presence of TCH (thiophen-2-carboxylic acid hydrazide) 
d Nitrate reduced to nitrite e Preferred growth substrate. fP=G - Grows well on 
both types of media. 5E - Eugonic /D- Disgonic 
1.5 Molecular analysis of Mycobacterium tuberculosis complex bacteria 
Advances in molecular typing techniques over recent years have greatly 
enhanced our understanding of the transmission and dissemination of M. tb. 
Molecular tools are invaluable in outbreak investigations as they enable the rapid 
identification of clusters of related cases that may not be linked by traditional 
epidemiological methods and conversely separate cases that appear to be 
epidemiologically linked but are not (van Soolingen 2001, Drobniewski et al. 
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2003). In turn, this has increased the speed at which outbreaks are identified and 
furthermore permits a more efficient surveillance system for the control of 
tuberculosis. 
In epidemiological terms the organisms involved in an outbreak are clonally 
related. A cluster of cases according to molecular data is defined as two or more 
isolates with an indistinguishable fingerprint. A cluster in a population is thought 
to imply recent transmission whereas unique fingerprints are thought to be 
epidemiologically unrelated and so have arisen from the reactivation of a latent 
infection or the immigration of patients who have acquired infection from abroad 
(Alland et al. 1994, Maguire et al. 2002). It is essential to identify and 
differentiate between the levels of recent transmission versus reactivation in a 
population as this greatly affects the control program required. A country with 
high rates of recent transmission would need to target resources at contact tracing 
and screening which would be less important in a population with high rates of 
reactivation. 
Many molecular typing tools are available for the analysis of M. tb (van 
Soolingen 2001, Mostrom et al. 2002). Restriction fragment length 
polymorphism (RFLP), based on the insertion element IS6110, is considered to 
provide the best discrimination of M. tb isolates and is regarded as the gold 
standard for strain typing M. tb (van Embden et al. 1993, Kremer et al. 1999). 
However, the discriminatory power of RFLP-IS6110 is reduced in low copy 
number (LCN) isolates i. e. those with less than 5 copies of IS6110. Secondary 
typing techniques such as spacer oligonucleotide typing (spoligotyping) and 
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Variable Number of Tandem Repeats (VNTR) analysis can be used to 
differentiate between LCN isolates, although there are significant differences in 
their discriminatory power (Filliol et al. 2000). 
Although RFLP-IS6110 is considered the gold standard it is a slow, cumbersome 
technique which requires viable cultures. The development of rapid PCR 
techniques in an effort to replace RFLP"IS6110, until recently, have not provided 
the level of discrimination needed to accurately define clusters. Most have tended 
to link additional unrelated cases to clusters, which in terms of an outbreak 
investigation would lead to increased and potentially costly contact tracing of the 
linked cases. A promising new technique, analysis of Mycobacterial Interspersed 
Repetitive Units (MIRU) described by Supply et al. (2001), has been developed. 
MIRU is a rapid PCR-based technique, and is a form of VNTR analysis as 
originally devised by Frothingham and Meeker-O'Connell (1998) whereby 
typing is based on the number of repetitive units found at certain loci within the 
genome. Kwara et al. (2003) demonstrated that a combination of RFLP-IS6110 
with MIRU as a secondary technique provided better discrimination than the 
commonly used RFLP-IS6110 plus spoligotyping. It has been argued that MIRU 
should in fact be used as a first line technique, and then followed up with RFLP- 
IS6110 to define clusters (Savine et al. 2002). Other studies have cited MIRU as 
a possible replacement for RFLP-IS6110 and have shown similar levels of 
discrimination (Supply et al. 2001, Hawkey et al. 2003) although some studies 
have refuted this claim (Nguyen et al. 2004, Gopaul et al. unpublished data). As 
a PCR-based technique, MIRU is more rapid then RFLP, MIRU produces a 
numerical code rather then a visual banding pattern which is open to 
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interpretation that can be subjective. A numerical code has the advantage of 
being truly portable and permits straightforward analysis and comparison on a 
global scale. 
VNTR typing has been applied to many organisms including man where it is the 
basis of forensic fingerprinting and for deciphering familial relationships. These 
repetitive units or minisatellites are defined as >8bp in length and as yet their 
function is unknown. Microsatellites are smaller in length (<9bp) and allelic 
variations in these repetitive units have been linked to mental health problems, 
neurological disorders and cancer in humans (Reddy et al. 1999, Mandel and 
Biancalana 2004, Claij and to Riele 1999). In pathogenic bacteria the study of 
tandem repeats have shown they may have a gene regulatory function (Supply et 
al. 1997) or an effect on virulence (Moxon et al. 1994, van Belkum et al. 1997). 
Supply et al. (2000) identified 41 minisatellites in M. tb H37Rv which were 
named MIRU and ranged from 40 to 100bp. Of these 41 loci, 12 which displayed 
variation in copy number were used initially in the strain typing scheme as 
described above. The analysis of the complete genome sequence of the 
laboratory strain Mtb H37Rv has shown there are 79 of these repeat regions 
(http: //minisatellites U psud fr, based on a unit length of between 0 and 2000 
bases with no overlapping repeats) therefore additional hypervariable regions 
exist that have not been examined. These minisatellites were identified in Mtb 
H37Rv therefore it is conceivable that other strains of M. tb will contain 
additional variable regions that could potentially be used to improve the 
discriminatory power of MIRU. 
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1.6 Evolution of Mycobacterium tuberculosis 
The discovery of M. tuberculosis DNA in the lungs of mummies from both pre- 
Columbian America and ancient Egypt dating back to 1000-1300 AD and 1550- 
1080 BC respectively, suggests that M. tb has caused disease in humans 
worldwide for thousands of years (Salo et a1.1994, Nerlich et al. 1997). Despite 
this, relatively little is known about the evolution of this organism. Until recently 
M. tb was believed to have evolved from M. bovis following the domestication of 
cattle partly because of its small host range compared to the broad mammalian 
host range of M. bovis. However the complete genome sequence of both 
organisms (Cole et al. 1998, Gamier et al. 2003) has shown this is unlikely to be 
true. The genome of M. bovis is much smaller than that of M. tb but has more 
than 99.95% identity and contains no unique genes suggesting that M. bovis may 
have originated from M. tb. 
Molecular techniques, such as deletion typing, have allowed the classification of 
M. tb complex strains into phylogenetic lineages (Brosch et al. 2002). This 
technique is based on the presence or absence of regions of difference in the 
genome. The absence of one of these regions (region of difference 9) from M. 
bovis which is present in M. tb and M. canetti supports the evolution of M. bovis 
from M. tb. Recently additional deleted regions have been identified in M. bovis 
using an Affymetrix GeneChip system which has lead to further differentiation 
of the M. bovis lineage (Mostowy et al. 2005). 
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Numerous studies have used molecular methods to elucidate the phylogeny of 
M. tb (Fomukong et al. 1997, Fang et al. 1998, Fang et al. 1999a, Dale et al. 
2003, Brosch et al. 2002, Filliol et al. 2003, Sola et al. 2001a, Sola et al. 2001b, 
Baker et al. 2004). The insertion element IS6110, the gold standard for strain 
typing, has also been used for evolutionary studies. It has been shown that 
IS6110 types can be grouped into superfamilies (Dale et al. 2005) and that 
isolates with low copy numbers of IS6110 form families of strains which are 
unlikely to have arisen through convergent evolution by the insertion of the 
IS6110 element into preferred positions (Dale et al. 2003). The IS6110 element 
is commonly found in the direct repeat (DR) region on which spoligotyping is 
based. Strains lacking this element were also found to lack complete direct 
variable repeats (DVR) suggesting IS6110 movement, facilitated by homologous 
recombination, may remove these DVRs (Fang et al. 1998). The evolution of the 
DR locus is thought to be unidirectional, i. e. spacers are lost over time through 
both the transposition of the IS6110 element and through deletion of single or 
stretches of contiguous DVRs by homologous recombination between 
neighbouring or distant DRs (van Embden et al. 2000). 
Genotyping techniques, such as multilocus sequence typing (MLST), have been 
successfully used to characterise several bacterial populations based on neutral 
genetic variation at multiple sites in the genome (Maiden et al. 1998, Enright et 
al. 1998, Dingle et al. 2001, Gutacker et al. 2002, Baker et al. 2004). Sreevatsan 
et al. (1997) demonstrated that two non-synonymous polymorphisms, one in 
catalase-peroxidase (katG) and one in the A subunit of gyrase (gyrA), could 
divide M. tb into 3 genetic groups. Group 1 contained the M. tb ancestral strains. 
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MLST uses multiple synonymous mutations that are not subjected to 
evolutionary selection i. e. are neutral, making them valuable for studying 
evolutionary relationships. The Mtb genome is thought to be highly conserved as 
sequencing of structural genes and host immune system protein targets has 
shown limited genetic variation (Sreevatsan et al. 1997; Musser et al. 2000). A 
lack of variation could hinder MLST, however Baker et al. (2004) demonstrated 
that neutral variation could be used to index M ab into 4 lineages with M. bovis 
clearly separated on a different branch of the tree. 
Identifying mutations in the genome is commonly performed using DNA 
sequencing. DNA sequencing is a relatively expensive technique therefore other 
methods, which are more rapid and cheaper, can be used to screen for mutations. 
These include, single-stranded conformation polymorphism (SSCP), denaturing 
gradient gel electrophoresis (DGGE), heteroduplex and mix-match cleavage. The 
main disadvantage of these methods is that although a mutation can be easily 
identified it is not characterised as with DNA sequencing. 
SSCP has been successfully used to screen for mutations (Pretorius et al. 1995, 
Fang et al. 1999b, Cardoso et al. 2004) by identifying conformational changes in 
the single-stranded DNA of mutant strains. These alternations cause a change in 
mobility on polyacrylamide gels when compared to wild-type strains resulting in 
a shift of band position. Although the sensitivity of this technique varies (Telenti 
et al. 1997, Bobadilla-del-Valle et al. 2001, Cardoso et al. 2004) SSCP has been 
successfully used to identify polymorphisms that can be characterised with direct 
sequencing. 
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1.7 Aims and Objectives 
1) Examine the transmission of M. tb and M. bovis 
a. Assess the distribution and transmission rates of M. tb in a low 
incidence country, England, using a combination of molecular 
typing techniques and epidemiological information. To examine 
the occurrence of clusters and identify any risk factors for 
clustering. Determine the role of molecular typing as a tool for the 
identification of related clusters of TB for which clinical and 
public health action might be appropriate and for national 
surveillance. 
b. Investigate the pattern of TB transmission in a high incidence area 
Harare, Zimbabwe using several molecular techniques and 
epidemiological data. To examine the role of recent transmission 
versus reactivation. Identify risk factors for clustering and 
determine the impact of HIV in a country where HIV is endemic. 
c. Compare and contrast any spoligotyping families present in 
Harare, Zimbabwe (a high incidence population) to those seen in 
London, UK (a low incidence population). 
d. Examine the molecular epidemiology of M. bovis infection in 
humans in the UK using molecular typing techniques and 
compare the typing patterns observed to those seen in UK cattle. 
2) Investigate the evolution of M. tb complex strains 
a. Examine the phylogeny of M. tb complex strains by comparing 
VNTR-MIRU profiles to lineages defined by synonymous single 
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nucleotide polymorphisms (sSNP). Determine if the phylogeny of 
these organisms can be defined using VNTR-MIRU as a rapid 
tool which could aid public health planning. 
b. Expand our understanding of the phylogeny of the M. bovis by 
identifying potential sSNP which could be used to extend a 
previously published phylogenetic tree (Baker et al. 2004). 
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CHAPTER 2.0 - Materials and Methods 
2.1 Bacterial culture 
All isolates were cultured onto one slope of Lowenstein-Jensen (LJ) media 
containing pyruvate. All slopes were incubated at 37°C for 8 weeks. Stock 
cultures were stored at -70 °C in Middlebrook 7H9 media with 10% OADC in 
plastic cyrovials. 
2.2 DNA preparation 
2.2.1 DNA extraction - method 1 
A crude extraction method was used when only PCR methods were required. A 
loop of culture was removed using a1 µl loop and placed in 150 µl of sterile 
dH2O. An equal volume (150 µl) of chloroform was added. The mixture was 
vortexed for 10 s and then heat treated at 80°C for 20 mins to kill the bacteria. 
The extracted culture was frozen at -20°C for 10 mins or until needed. After, 
thawing, the mixture was spun at 8000 xg for 5 mins before use. 
2.2.2 DNA extraction - method 2 
Purified genomic DNA for RFLP-IS6110 analysis was extracted as follows: 
approximately half the bacterial growth on a LJ slope was removed with a sterile 
swab, re-suspended in 6O0µ1 of TE buffer (10mM Tris pH8,1mM EDTA) and 
heat treated at 80°C for 20 mins to kill the bacteria. Tubes were allowed to cool 
before adding 50µ1 lysozyme (10mg/ml) and vortexed. The mixture was then 
incubated overnight at 37°C. After incubation, lOµ1 proteinase K (10mg/ml) and 
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35µ1 sodium dodecyl sulfate (SDS) 20% (w/v) was added, vortexed and 
incubated at 55°C for 30 mins. 100µ1 of 5M NaCl was added and vortexed before 
adding l00µ1 of prewarmed N-cetyl-NNN-trimethyl ammonium bromide 
(CTAB) solution. The mixture was vortexed again and incubated at 65°C for 15 
mins. The mixture was allowed to cool to room temperature before adding 700µl 
chloroform: isoamyl alcohol (24: 1). The mixture was then vortexed for 10 sec and 
spun at 8000 xg for 8 mins. The supernatant was pipetted into a separate clean 
tube and 6O0µ1 of cold (-20°C) isopropanal-2-ol was added to precipitate the 
DNA. The mixture was inverted several times and then incubated for 1 hr at 
-20°C. After incubation the mixture was spun at 8000 xg at room temperature 
for 15 mins. The supernatant was decanted off being careful not to lose the DNA 
pellet from the tube. The pellet was washed with 1 ml of 70% ethanol and the 
tube was inverted to mix then spun at 8000 xg for 5 mins before removing the 
liquid with a pipette. The sample was re-spun for 1 min and any remaining 
alcohol removed before being left to air-dry. The pellet was re-suspended in 30µl 
TE and left to dissolve at 4°C overnight. 
2.3 Restriction fragment length polymorphism (RFLP) analysis 
RFLP-IS6110 analysis was performed according to the recommended 
standardised protocol described by van Emben et al. 1993. 
2.3.1 Transfer of digested genomic DNA fragments. 
For each sample, 4.5 µg genomic DNA was digested for two hours with PvuII 
and run out on a 0.8% agarose gel for approximately 16 hours at 30V. An 
external marker of 1 µg PvuII digested MT14323 DNA was run in lanes 4,13 
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and 27 on of a 30 lane gel to enable standardisation between blots. In addition 1 
µg of lambda/Hindlll was run as a size standard. Each gel was run until the 2.0kb 
lambda/HindIII fragment had migrated 7cm from the well when viewed under 
UV light. The gel was then treated with 0.25M hydrochloric acid for 20 minutes 
to depurinate the DNA fragments, rinsed in distilled water and treated twice for 
15 mins in denaturing solution (0.5M NaOH, 1.5M NaCl). Following a final 
rinse in distilled water, the gel was treated for 30 mins in neutralising solution 
(iM Tris pH 7.4,1.5M NaC1). 
Transferring the digested DNA fragments from gel to nitrocellulose membrane 
involved the use of a vacuum blotter (Hybaid, Middlesex, UK). Briefly a sheet of 
2X SSC (0.3M NaCI and 0.3M Sodium Citrate) soaked 3MM filter paper 
measuring 25 x 20 cm was placed on the base of the blotter and rolled with a 10 
ml pipette to remove any bubbles formed. A 15 x 20 cm sheet of Hybond-N 
nylon membrane (Amersham International plc, Buckingham, UK), moistened 
with 2X SSC was then layered carefully on top and again rolled to remove any 
bubbles present. A rubber mask with a central portion of 14 X 19cm missing was 
placed over the top. The gel was then aligned over the exposed membrane. The 
vacuum was applied for 90 mins to transfer the DNA to the membrane. The 
membrane was rinsed in 2X SSC and UV crosslinked with a Stratalinker 1800 
(Stratagene, La Jolla, California) using a setting of 12,000 µJ/em2 for 2 mins. 
2.3.2 Preparation and labelling of IS6110 probe 
The IS6110-probe was generated by performing DNA amplification with the 
following primers; INS1- 5' CGT GAG GGC ATC GAG GTG GC 3' and INS2 
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- 5' GCG TAG GCG TCG GTG ACA AA 3'. The reaction mix (total volume 
50µ1) contained; lx NH4 Buffer (Bioline, London, UK), 1.5mM MgC12,0.2mM 
sterile dNTPs, 0.4µM INS 1,0.4µM INS2, l Ong M. bovis BCG (Glaxo, 
Middlesex, UK) genomic DNA and lU Taq polymerase (Bioline, London, UK), 
with the remaining volume made up by dH2O. Amplification was carried out in a 
0.2µl thin-walled PCR tube (Alpha, Eastleigh, UK) in a Perkin Elmer 9600 
Thermocycler (Perkin Elmer Cetus, USA) for 5 mins at 94°C then 30 cycles of, 
30 s at 94°C, 30 s at 58°C, 30 s at 72°C and one cycle of 5 mins at 72°C. The 
resulting amplified mixture was then run and excised from a 0.8% agarose gel, 
melted and dissolved in an equal volume of sterile dH2O to give a final 
concentration of 0.2%. The probe was labelled with Biotin using ECL DirectTM 
Nucleic Acid Labelling and Detection System (Amersham International plc, 
Buckingham, UK) according to the manufacturer's instructions. 
Hybridisation and detection of the IS6110 probe was performed using the same 
ECL DirectTM Nucleic Acid Labelling and Detection System kit (Amersham 
International p1c, Buckingham, UK). 
2.4 Spoligotyping 
Spoligotyping was performed using the standardised protocol described by 
Kamerbeek et al., 1997. 
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2.4.1 PCR Analysis of the Direct Repeat (DR) region 
The reaction mix (total volume 2Oµl) contained 16mM NH4SO4 reaction buffer 
(Bioline, London, UK), 200µM dCTP, dGTP, dATP and dTTP (Pharmacia 
Biotech, UK), 5% (v/v) Dimethylsulphoxide (DMSO), IOpmol Dra primer (5'- 
GGT TTT GGG TCT GAC GAC-3' (biotinylated at the 5' end)) and DRb primer 
(5'-CCG AGA GGG GAC GGA AAC-3') (Isogen Bioscience, Maarssen, The 
Netherlands), 1U Taq polymerase (Bioline, London, UK) and 1 µl template DNA. 
Amplification was carried out in a 0.2µl thin-walled PCR tube (Alpha, Eastleigh, 
UK) in a Perkin Elmer 9600 Thermocycler (Perkin Elmer Cetus, USA) for 2 
mins at 93°C then 30 cycles of; 30 s at 93°C, 1 min at 55°C, 1 min at 72°C and 
one cycle of 10 mins at 72°C. Two positive controls (Mycobacterium 
tuberculosis H37Rv and Mycobacterium bovis BCG P3) (10 ng/µ1 of genomic 
DNA) and 2 negative controls (sterile dH2O) were included with each run. 
2.4.2 Hybridisation 
15µ1 of amplified product was added to 150µ1 of 2x saline sodium phosphate 
(SSPE) (0.2M phosphate buffer, pH 7.4 containing 2.98M NaCl and 0.02M 
EDTA) /0.1% SDS and denatured by heating at 100°C for 10 mins and 
immediately put on ice. A BiodyneC membrane (Isogen Bioscience, Maarssen, 
The Netherlands) with the 43 spacers covalently attached (Appendix 1) was 
washed in 250m1 of 2x SSPE/0.1% SDS for 5 mins at 60°C. The membrane and a 
support cushion were placed in the miniblotter MN45 (Immunetics, Cambridge, 
Mass, USA) and the residual fluid removed by aspiration. l50µ1 of each PCR 
product was loaded in a separate lane on the miniblotter and allowed to hybridise 
at 60°C for 90 min. The fluid was aspirated from each lane before the miniblotter 
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was opened. The membrane was washed twice with 250m1 of 2x SSPE/0.5% 
SDS in a hybridisation bottle for 10 mins at 60°C and allowed to cool before 
adding the enzyme to prevent inactivation. The membrane was washed with 5µl 
of 500U/ml streptavidin-peroxidase conjugate (Roche, East Sussex, UK) in 20m1 
of 2x SSPE/0.5% SDS for 60 mins at 42°C and then washed twice in 250m1 of 2x 
SSPE/0.5% SDS at 42°C for 10 mins. The membrane was rinsed twice in 2x 
SSPE for 5 mins at room temperature. 
2.4.3 Detection 
The hybridised DNA was detected using an ECL kit (Amersham International 
p1c, Buckingham, UK). The membrane was incubated in 20 ml of detection fluid 
for 1 min and then placed in a plastic bag and exposed to autoradiographic film 
for 20 min. The film was developed and fixed using standard photographic grade 
reagents (Sigma-Aldrich, Poole, UK). 
2.5 Variable Number Tandem Repeats (VNTR) 
VNTR typing was performed using various combinations of tandem repeat loci. 
The nomenclature used throughout the thesis for each combination of tandem 
repeats is described in table 2.5.1. 
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Table 2.5.1 VNTR nomenclature 
Nomenclature Loci utilised Identified by; 
VNTR-ETR ETR A to E Frothingham and Meeker- 
O'Connell 1998 
VNTR-MIRU-12 12 loci MIRU Supply et al. 2001 
VNTR-MIRU- 12 loci MIRU plus As above 
15* ETR A 
to C 
* The two remaining ETRs D and E are included within the VNTR-MIRU-12 
and correspond to MIRU 4 and 31 
2.5.1 VNTR-Exact Tandem Repeats (VNTR-ETR) 
When only the analysis of VNTR-ETR loci was required, the protocol described 
by Frothingham and Meeker-O'Connell (1998) was performed. Briefly, each 
tandem repeat was amplified in a single PCR reaction and subjected to agarose 
gel electrophoresis with 100bp and 20bp size markers. The size of each PCR 
product corresponds to the number of tandem repeats at each locus. The original 
ETR-B forward and reverse primers were extended by 3 bases at the 3' end 
(Appendix 2) to increase the annealing temperature for use with Hotstar Taq 
(Qiagen, West Sussex, UK). 
2.5.2 VNTR-Mycobacterial interspersed repetitive units (VNTR-MIRU) 
The method and primers for VNTR-MIRU-12 were as described by Kwara et al., 
(2003). VNTR-MIRU-15 was performed using the same method. (For both 
VNTR-MIRU-12 and VNTR-MIRU-15 primers see Appendix 2). 
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2.5.2.1. PCR analysis of tandem repeat regions 
Multiplex PCR reactions for VNTR-MIRU-12 were set up as follows; the 
reaction mix (total volume 10µl) contained 2.5µ1 sterile dH2O, Sµl 2x reaction 
buffer (3mM MgC12,3.2mM dNTPs, 2x NH4 buffer), 1.25µl of each primer mix 
(2µM), 0.1 µl Taq polymerase (5U/µl) (Bioline, London, UK) and 1µl template 
DNA. A primer mix comprised of forward and reverse primers for one locus. 
Forward primers were labelled with one of the three standard Beckman Coulter 
dyes (D2, D3, or D4). For each multiplex reaction two primer mixes were used 
corresponding to each of the loci analysed. The loci analysed in each multiplex 
reaction are shown in table 2.5.2. Both multiplex and simplex PCR reactions 
were set up for VNTR-MIRU-15 and are shown in Table 2.5.3. Where only one 
locus was analysed, 2.5gl of primer mix was added. 
Table 2.5.2 PCR reactions for VNTR-MIRU-12 
PCR reaction PCR 1a PCR PCR PCR PCR PCR 
2 3 4 5 6 
VNTR-MIRU loci 4 20 2 31 10 26 
analysed 
VNTR-MIRU loci 16 39 24 23 27 27 
analysed 
Dye D2 D2 D3 D3 D4 D4 
" Multiplex PCR reactions were performed containing two different primer sets 
corresponding to two different loci 
b PCR primers were labelled with standard Beckman Coulter Dyes (D2, D3 and 
D4) 
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Table 2.5.3 PCR reactions for VNTR-MIRU-15 
PCR reactions PCR PCR PCR PCR PCR PCR PCR PCR PCR 
1 2 3 4 5 6 7 8 9 
VNTR- 4 39 20 2 31 C 10 27 26 
MIRU loci 
analysed 
VNTR- 16 A 24 40 23 B 
MIRU loci 
analysed 
Dye D2 D2 D2 D3 D3 D3 D4 D4 D4 
" YCR 1,2,4,5,7 and 8 were all multiplex PCR reactions. PCR 3,6 and 9 were all 
simplex PCR reactions. b PCR primers were labelled with standard Beckman Coulter Dyes (D2, D3 and 
D4) 
Amplification was carried out in O. 2µ1 thin-walled 96 well plates (Alpha, 
Eastleigh, UK) in a Perkin Elmer 9600 Thermocycler (Perkin Elmer Cetus, USA) 
for 3min at 95°C then 30 cycles of, 30 s at 95°C, 1 min at 60°C, 1 min at 72°C, 
and 1 cycle of 5 mins at 72°C. 
2.5.2.2 Fragment Analysis 
Fragment analysis software on the CEQ8000 capillary sequencer (Beckman 
Coulter, Fullerton, California) was used to determine the size of each VNTR- 
MIRU fragment. For VNTR-MIRU-12, two pools of 6 loci were generated. Pool 
A contained the PCR products from PCR reactions 1,3 and 5 (table 2.5.2) and 
pool B contained the PCR products from PCR reactions 2,4 and 6 (table 2.5.2). 
Each pool contained 2 loci labelled with one of the three Beckman Coulter 
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standard dyes (D2, D3 and D4). Each pool was run in separate capillaries on the 
sequencer. For VNTR-MIRU-15 three pools of 5 loci were generated. Pool 
A 
contained the 1,4 and 7, pool B contained PCR products from PCR reactions 2,5 
and 8 and pool C contained the PCR products from PCR reactions 3,6 and 9. 
The Beckman Coulter dyes used to label each product are displayed in table 
2.5.3. Again each pool was run on a separate capillary. The number of repeats 
per loci corresponded to the size of the amplified fragments displayed by the 
sequencer (see allele calling table - Appendix 3). PCR products labelled with the 
same dye could be distinguished because the primers were designed in such a 
way that the size of the repeats at each loci would never fall within 8 bp of each 
other. The final results were recorded as a 12 or 15 digit code. 
2.6 Bionumerics Analysis 
Analysis of all molecular fingerprints/profiles was performed using Bionumerics 
software (version 3.0 Applied Maths, Kortrijik, Belgium). Comparison of RFLP 
fingerprints (allowing a 3% tolerance) and spoligotypes was performed using the 
Dice similarity coefficient. All RFLP-IS6110 fingerprints with an 80% similarity 
or greater were visually compared for potential clustering). VNTR-MIRU 
profiles were analysed using a categorical similarity coefficient. All dendrograms 
were displayed using UPGMA. 
2.7 Hunter-Gaston Index 
The Hunter-Gaston Index (HGI) determines the discriminatory power of a typing 
method. The HGI is based on the probability of two unrelated strains from a test 
population being placed into different typing groups. A result of 1 equals total 
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discrimination of the population, i. e. all isolates are unique (Hunter and Gaston 
1988). 
Figure 2.7.1 HGI formula 
D=l- 1 WSJ -1 nj (nj -1) 
N (N-1) 
2.8 Macroarray analysis 
N= number of strains 
S= number of different types 
nj = number of strains belonging to type j 
Analysis of four lineage-defining silent single nucleotide polymorphisms (sSNP) 
within three genes (oxyR, katG and rpoB) was performed using a DNA 
macroarray. The development of the macroarray is described in chapter 6 and the 
final protocol is described below. 
2.8.1 Amplification of target DNA 
Biotin-labelled primers were designed to flank the four regions of interest and 
were based on the sequence of M. tb H37Rv and CDC1551 (Table 2.8.1). The 
reaction mix (total volume 21.2µl) contained 5µl sterile dH2O, 10µl 2x reaction 
buffer (3mM MgC12,3.2mM dNTPs, 2x NH4 buffer), 5 t1 of primer mix (2µM 
each primer), O. 2µ1 Taq polymerase (5U/µl), (Bioline, London, UK) and 1 µl 
template DNA. Amplification was carried out in 0.2µl thin-walled 96 well plates 
(Alpha, Eastleigh, UK) in a Perkin Elmer 9600 Thermocycler (Perkin Elmer 
Cetus, USA) for 3 mins at 95°C then 30 cycles of 15 s at 95°C, 30 s at 60°C, 1 
min at 72°C and one cycle of 5 min at 72°C. 
45 
Table 2.8.1 Primer sequences for the macroarrav 
Gene Primers 5' to 3' * Product size 
oxyR Forward - atcgccgccaagaggtgcta 311 
Reverse - tcacgcactgcacgacggt 
katG Forward - tgtcccgtcgtgggtcatat 370 
Reverse - ttgtccaagctggcgttgt 
rpoB Forward - tgcgtgtgtatgtggctcagaaa 159 
Reverse - cgccgtgggtgttcaaaataat 
rpoB Forward - gtaaggcgcagttcggtgg 203 
Reverse - tttgagcagcaccttgaacga 
"' All forward primers were 5' biotin labelled 
2.8.3 Probe design 
Two probes were designed per region of interest; one with the wild type 
sequence according to M. tb H37Rv and CDC1551, the other containing the 
sSNP. Each probe was between 19 and 25 nucleotides in length. A poly-T tail of 
20bp was added to increase probe adhesion to the membrane (Table 2.8.2). 
PTI_1 -- -- -- 
1 au. C L. a. L w na-type anu mutant roh e seque nces 
Gene & nts Probe wt bp Probe mutant bp 
position 
sSNP 
oxyR-37 ccaccgcggcgaacgcgcgaag 35 gcggcgaacgcgcgaaaccc 31 
G-A 
_ ccctttttttttttttttttttt gt 
ttttttttttttttttttt 
katG-87 accccgtcgagggcggcggttttt 29 acccagtcgagggcggcggat 30 
(C-A) 
ttttttttttttttt ttttttttttttttttttt 
rpoB-2646 cggccagcttgtcaccgtcggtttt 31 cggccagcttgtccccgtcggt 31 
A-C tttttttttttttttt ttttttttttttttttttt 
rpoB-3243 ctcctgcagggtgtaggcagctttt 31 tcctgcagggtgtaggcggcat 31 
(A-G tttttttttttttttt ttttttttttttttttttt 
nt - nucleotide position within gene. ° Polymorphic site is highlighted in bold 
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2.8.4 Membrane preparation 
Each probe stock (200µM) was diluted to a working concentration of 20µM in 
purified water containing 0.001% bromophenol blue. Each probe was dotted onto 
a nylon membrane (Magnagraph 0.22µM, Osmonics, Minnetonka, USA) using a 
hand-held arraying device (VP Scientific, San Diego, USA) and allowed to dry. 
Wild type and mutant probes were orientated adjacently on the membrane (Table 
2.8.3). In addition an ink dot for orientation of the membrane and a colour 
control (2µl of oxyR primer) to check detection were added to the membrane. 
Each membrane was UV cross-linked at 12,000 µJ/cm2 for 1 min to fix the 
probes then washed twice in wash solution (0.5x SSC, 0.1% SDS) for 5 mins and 
allowed to air dry. The membranes were trimmed then placed in a 2m1 plastic 
hybridisation tube and stored at room temperature. 
Table 2.8.3 Membrane orientation 
Ink dot CDCa 
Blank Blank 
Blank Blank 
oxyR - 37 oxyR - 37mt° 
katG - 87 katG - 87mt 
Blank Blank 
Blank Blank 
rpoB - 2646 rpoB - 2646mt 
rpoB - 3243 rpoB - 3243mt 
ýoýour aevelopment control b Blanks were inserted in order to make the membrane longer for ease of handling. 
c mt = mutant type 
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2.8.5 Hybridisation 
Twelve microlitres of amplified oxyR-37 and rpoB-3243 from each sample were 
combined in a separate tube. KatG-87 and rpoB-2646 amplified products were 
first diluted 1 in 10, then 121il was added to the mixture tube. The DNA mix was 
denatured at 100°C for 10 mins then added to 50014 of hybridisation solution 
(SxSSPE, 0.5% SDS) in a hybridisation tube containing a membrane. Each tube 
was placed on a rotisserie in a hybridisation oven at 60°C for one hour. 
Membranes were washed twice in 25m1 of stringent wash buffer (0.3x SSPE, 
0.5% SDS) for 1 min at room temperature then in 10 ml of preheated stringent 
wash buffer at 60°C for 10 mins. 
2.8.6 Detection 
All washes were carried out at room temperature. The membranes were washed 
twice in 25m1 of rinse buffer (O. 1M NaCl, O. 1M Tris-HCL, pH 7.5) for 1 min 
then incubated in 5m1 rinse buffer with 0.5% blocking reagent (Roche, East 
Sussex, UK) (buffer should be stored at -20°C), before adding 20µ1 streptavidin- 
alkaline phosphatase (Roche, East Sussex, UK) and incubating for 30 mins. Each 
membrane was then washed twice in rinse buffer for 1 min and equilibrated for 1 
min in buffer 3 (O. 1M Tris, O. 1M NaCl, pH 9.5). The membranes were then 
incubated in colour development solution (l511 of p-Nitro Blue Tetrazolium 
Chloride (NBT) 75 mg/ml in 70% Dimethylformamide (DMF) and 15µl 5'- 
Bromo-4-Chloro-3-Indolyl phosphate (BCIP) 50 mg/ml in 100% DMF were 
added to 5m1 of Buffer 3) for 1 hour. The streptavidin-alkaline phosphatase binds 
to the biotin in the forward primer. The colour development solution then 
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binds to this conjugate and produces a dark spot on the membrane indicating 
hybridisation between the PCR product and probe has taken place. 
2.9 Single-stranded conformation polymorphism (SSCP) 
SSCP using polyacrylamide gel electrophoresis (PAGE) was performed to 
identify potential sSNPs in M. bovis. 
2.9.1 PCR analysis 
Primers flanking the four target regions described in 2.9.1 were amplified under 
the same conditions. To denature the amplified DNA, 3µl of each product was 
added to the same volume of denaturing solution (400nM NaOH, 20mM EDTA 
pH 8.0) and left to denature for 5 mins. From this solution 2µl was then added to 
2µl of loading buffer (Promega, Southampton, UK) and loaded onto the 
polyacrylamide gel. Two 100bp ladders and two controls were added per gel. A 
M. bovis strain previously characterised by sSNP analysis (Baker et al. 2004) 
was used as a wild-type control strain. 
2.9.2 PAGE gels 
A solution comprising of 4% glycerol (v/v) and 8% polyacrylamide (v/v) (40% 
acrylamide/bis solution, 29: 1) made up to 50m1 with 1X TBE (O. 1M Tris, 0.9M 
Boric Acid, 0.01M EDTA pH 8.4) was polymerised with 0.5% (w/v) fresh 
ammonium persulphate and 0.1% (v/v) tetramethylethylenediamine (TEMED) 
(All regents were from Bio-Rad, Hemel-Hampstead, UK). After polymerisation, 
the gel plates were loaded into a Protean II xi cell (Bio-Rad, Hemel-Hampstead, 
UK) containing 1X TBE and run at 50V for approximately 16 hrs. 
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2.9.3 Silver-staining 
Gels were fixed in a 40% (v/v) methanol for 30 mins followed by two washes in 
10% (v/v) ethanol for 15 mins each. The gel was then stained with a Bio-Rad 
silver staining kit according to the manufacturer's instructions (Bio-Rad, Hemel- 
Hampstead, UK). Briefly, the gel was incubated in 200m1 Bio-Rad oxidizing 
solution for 5 mins and rinsed twice in dH2O for 5 mins. The gel was then 
incubated in 200m1 Bio-Rad silver reagent for 20 mins and rinsed once with 
dH2O. Following this, 200m1 of Bio-Rad developing solution was added and 
incubated until bands appeared on the gel. The reaction was stopped with 5% 
(v/v) acetic acid. 
2.10 DNA sequencing 
DNA Sequencing was performed on a CEQ8000 capillary sequencer (Beckman 
Coulter, Fullerton, California). Amplified DNA from potential mutants 
previously identified in PAGE analysis was diluted 1 in 25 in sterile dH2O. 
Sequencing reaction mix (total volume 5µI) contained; 2µl Quickstart master mix 
(Beckman Coulter, Fullerton, California), 2µl diluted DNA and 1 µl of forward or 
reverse primer (primers were identical to those used for PAGE analysis). Each 
reaction underwent 30 cycles of 96°C for 20 sec, 55°C for 20 sec and 60°C for 
four mins. The labelled fragments were precipitated in a solution of 20µl sterile 
dH2O, 2.5µ13M NaOAc, 75µl ice cold ethanol and 2% (w/v) glycerol then spun 
at 1100 xg for 45 mins at 4°C. Pellets were washed twice at the same speed in 
70% ethanol for 15 mins at 4°C. A paper towel was then placed on top of the 
open tubes. The tubes were inverted, placed into a centrifuge and pulse spun to 
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10 x g. The excess liquid was absorbed by the paper towel. The pellet was then 
dried in a desiccator for 15 mins, re-dissolved in 25µ1 sample loading solution 
(Beckman Coulter, Fullerton, California) and loaded onto the analyser. 
Sequences were analysed with CEQ analysis software. 
2.11 Polyethylene glycerol (PEG) purification 
PEG purification was performed on any isolates that would not sequence. Each 
amplified product was made up to 50µ1 with sterile dH2O and incubated with 
5011 of 20% PEG (8000 average molecular weight) /2.5M NaCl for 40 mins. The 
mixture was then spun at 9400 xg for 15 mins to pellet the DNA. The 
supernatant was discarded and the pellet washed twice with 150µl of 70% 
Ethanol and spun at 9400 xg for 5 mins. The supernatant was discarded and the 
pellet re-suspended in 2Oµl of sterile dH2O. 
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CHAPTER 3.0 Molecular epidemiology of Mycobacterium tuberculosis 
infection in England, UK 
3.1 Introduction 
Rates of tuberculosis (TB) were declining in the UK, along with other 
industrialised countries, until the mid-1980s when the incidence of TB began to 
increase annually. This resurgence has been attributed to an increase in 
immigrants from high incidence countries, poverty, a failure in TB control 
procedures and improved national surveillance detecting the increased incidence 
(Hayward and Watson 1995). 
In 2003 the incidence of TB in England and Wales was 12.8 per 100,000. In 
London the rate is much greater at 41.3 per 100,000. The national TB survey of 
England and Wales, completed every five years between 1978/9 and 1998, 
highlighted that the incidence of TB has increased at a higher rate in London and 
the West Midlands compared to low incidence areas such as Anglia and Oxford. 
Rates were especially high in people born outside the UK who had recently 
arrived in the UK (Kumar et al. 1997, Ormerod et al. 1998, Rose et al. 2001). In 
1999 continuous enhanced surveillance was introduced whereby detailed clinical, 
epidemiological and microbiological information was collected on all TB cases 
in England and Wales and has confirmed the continuation of the increasing trend 
in TB incidence. 
The advent of molecular typing techniques over the last decade has dramatically 
increased our understanding of TB transmission and dissemination. The 
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identification of related cases of TB has been beneficial in terms of directing 
clinical and public health action and for national surveillance. 
The aims of this study were two fold. Firstly, to determine the molecular 
epidemiology of TB transmission in England in 1998 using a combination of 
molecular and epidemiological data, with particular regard to the level of recent 
transmission versus reactivation of disease. Secondly, to determine the role of 
molecular typing as a tool for the identification of clusters of TB that may be 
related for which clinical and public health action might be appropriate and for 
national surveillance. The results in this analysis represent a study of TB 
transmission in a city in a low incidence country. TB transmission in a city in a 
high incidence country, Harare, Zimbabwe is described in Chapter 4.0 
3.2 Transmission of M. tb in England in 1998 
3.2.1 Study population 
This work was based on a collaborative study which assessed the molecular 
epidemiology of TB in England in 1998. All culture confirmed cases of TB in 
England between the ls` January and 31st December in 1998 were eligible for 
inclusion in the study. Epidemiological information was collected from three 
sources; laboratory records on each patient, the 1998 National TB survey of 
England and Wales and Mycobnet (Mycobacterial resistance network) a 
surveillance system for drug resistant isolates in the England and Wales. In 
addition, a questionnaire requesting further epidemiological information on 
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known risk factors was sent to the clinician in charge of each clustered case and 
also to a random selection of non-clustered cases in 1998. 
3.2.2 Molecular analysis 
RFLP and spoligotyping (Material and Methods 2.3 and 2.4) were performed on 
all isolates from 1998. Clustered isolates, i. e. those with indistinguishable 
fingerprints, processed in the same hospital laboratory within 7 days were 
considered as possible laboratory cross-contamination and excluded from further 
analysis. 
3.2.3 Results 
In 1998,3698 culture confirmed cases were identified of which 15 isolates were 
excluded due to possible laboratory cross contamination. Of the remaining 
isolates, 2265 (61.2%) fingerprints by both RFLP and spoligotyping were 
produced. RFLP fingerprints were divided into those containing 5 or more copies 
of the IS6110 element i. e. high copy number (HCN) and those containing less 
than 5 copies i. e. low copy number (LCN) fingerprints. Fingerprints ranged from 
1 to 24 bands with the majority (63.0%) of isolates containing between 7 and 14 
bands (Figure 3.2.1). 
The HCN group consisted of 1808 (78.9%) isolates of which 372 (20.6%) 
formed 152 clusters. Spoligotyping was applied as a second-line method to 457 
isolates comprising the LCN group. A cluster in the LCN group was defined as 
those isolates containing indistinguishable RFLP and spoligotyping fingerprints. 
Based on this, 42 clusters containing 213 (46.6%) isolates were identified. The 
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clustering demographic (Figure 3.2.2) showed that HCN clusters ranged from 2 
to 10 isolates per cluster while LCN clusters ranged from 2 to 17 isolates. A high 
proportion of clusters in both groups (73.3% and 47.6% respectively) contained 
just two isolates. 
The study population was made up of 57.0% males and 35.6% of cases were 
between 20-34 years of age (Figure 3.2.3). The majority of cases (52.8%) were in 
people born outside the UK. Of those born in the UK (30.1%) 43% came from 
the London region. A third of cases were of Indian subcontinent ethnic origin 
(ISC) and almost the same proportion (31.0%) was of white ethnicity. A large 
percentage (16.0%) were of Black African ethnic origin (Figure 3.2.4). Drug 
resistance to one or more anti-tuberculous drugs was observed in 8.0% of cases 
and overall 1.5% were multi-drug resistant i. e. resistant to at least isoniazid and 
rifampicin. 
3.2.4 Risk factors for clustering 
The high copy number population was assessed for risk factors for clustering by 
comparing the epidemiological data of clustered cases to non-clustered cases. A 
univariate analysis found that patients of Indian sub-continent and Chinese ethnic 
origin were less likely to be clustered than white patients (p<0.05) and 
pulmonary disease was more likely to be clustered than extra-pulmonary 
(p<0.05). Patients with previous treatment compared to those without (p<0.05) 
and those patients with a drug susceptible isolate compared to those resistant to 
one or more anti-tuberculous drugs (p<0.05) were also more likely to be 
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variables that were statistically significant in the univariate analysis. Age and 
gender were added a priori. Multivariate analysis showed that cases having had 
previous treatment were more likely to be clustered than those without previous 
treatment (odds ratio (OR) 3.74,95% confidence interval (CI) 2.15 - 6.50) and 
those with pulmonary smear negative disease (OR 1.79,95% CI 1.23 - 2.61) 
were more likely to be in a cluster compared to those with extra-pulmonary 
disease. A trend towards clustering was observed in cases with pulmonary smear 
positive disease compared to those with extra-pulmonary disease (OR 1.41,95% 
CI 0.98-2.02) and those showing drug resistance to one or more anti-tuberculous 
drugs were more likely to be in a cluster than patients with a drug susceptible 
isolate (OR 1.43,95% CI 0.93-2.19) (Appendix 4). 
A case control study using all clustered cases (n = 372) and a random selection of 
control cases (n = 315) was performed. Additional information was collected 
through a questionnaire sent to the consultant in charge of each case. Bivariate 
analysis showed that homelessness and alcohol dependence were closely 
correlated therefore alcohol dependence was not included in the multivariate 
analysis. After adjusting for ethnic group and age and gender as a priori values, 
homelessness showed significance as a risk factor for clustering (OR 5.47,95% 
CI 1.24 - 24.1) (Appendix 5). 
3.2.5 Discussion 
The combination of molecular techniques and epidemiological information has 
proven to be a useful tool for the identification of related isolates that may not be 
linked by traditional contact tracing methods alone. In this study the transmission 
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of TB in England in 1998 has been described using RFLP and spoligotyping 
alongside epidemiological data. 
Clusters of identical fingerprints are thought to represent epidemiologically 
linked cases and therefore to reflect the level of recent transmission (Small et al. 
1994, Alland et a1.1994, van Deutekom et al. 1997, Maguire et al. 2002). The 
molecular analysis in this study suggests that the level of recent transmission in 
England appears to be relatively low. 
The level of clustering observed (20.6% of HCN isolates) was comparable to a 
three year study performed in London between 1995-7 which found a clustering 
rate of 22.7% (Maguire et al. 2002) but lower then that observed in other 
developed countries; 28% in France (Torrea et al. 1996), 38% in Seville, Spain 
(Safi et al. 1997), 38% in New York city, US, (Alland et al. 1994), 40% in San 
Francisco, US (Small et al. 1994) and 46% in Amsterdam, The Netherlands (van 
Deutekom et al. 1997). 
In this study cases with pulmonary TB were more likely to be clustered than 
those with extra-pulmonary disease. This is not surprising given that pulmonary 
TB represents an infectious case. However, clustering was linked to smear 
negative disease rather than smear positive disease. This maybe due to the short 
time window, linked cases including the source case may not have been detected. 
Smear negative, culture positive cases can account for a sizable amount of TB 
transmission (Behr et al. 1999) although they are less infectious they may take 
longer to diagnose leaving a longer period for transmission to occur. 
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Cases having had previous treatment were also associated with clustering. 
Reasons for this link are unclear. Perhaps this trend is due to incomplete 
treatment or reactivation of previously treated strains, which have survived in a 
dormant state but have reactivated and are then transmitted in the community. 
Previous TB treatment has been associated with cases having drug resistant TB 
(Conaty et al. 2004) but does not appear to have been previously identified as a 
risk factor for clustering in a predominantly drug sensitive population. 
There was a trend towards clustering in cases having drug resistant TB. This is a 
cause for concern and needs to be monitored to ensure that drug resistant cases 
are controlled and their spread limited. This data is in contrast to previous studies 
showing in different populations that drug resistant strains are less likely to be 
clustered then susceptible stains as these strains are assumed to be less virulent 
(van Soolingen et al. 1999, Godfrey-Faussett et al 2000). 
The case-control study showed that homelessness was linked to alcoholism and 
that homelessness was a risk factor for clustering. The health and living 
conditions associated with homelessness and alcohol dependence are well suited 
to the transmission of TB and have been previously been identified as risk factors 
for clustering (Kimerling et al. 1998). 
It is conceivable that the level of ongoing transmission in this study may have 
been underestimated as the study duration was only one year, therefore contacts 
may not have been identified. Van Soolingen et al. (1999) showed that cluster 
size increases in accordance with increasing length of study time and begins to 
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plateau after approximately 3-4 years. Based on this curve the percentage 
clustering observed in the Netherlands at one year was approximately 33%. After 
five years the level of clustering had reached 46%, hence a 13% increase in 
clustering. Although the level of clustering in different populations is dependant 
on many factors including, demographic and clinical aspects, study design and 
typing methods utilised, the level of clustering in England based on this curve 
could reach approximately 34% in a five-year study. The interpretation of the 
DNA markers used in epidemiology studies depends on the stability of the 
regions analysed. Studies have demonstrated that RFLP-IS6110 fingerprints are 
stable and have a half-life of between 3.2 and 8.7 years (de Boer et al. 1999, 
Warren et a1.2002), therefore linked cases in this study are unlikely to be sub- 
divided by RFLP-IS6110. 
A third of the culture confirmed cases in 1998 did not undergo molecular typing 
and in addition the majority of typed isolates were from the London and the 
south-east (63.9%) therefore the extent of clustering nationally may have been 
underestimated. Inevitably not identifying all epidemiologically linked cases 
would lead to an underestimate of the impact of risk factors for clustering. 
Although clustering is a good indication of the level of recent transmission 
perhaps a more accurate method would be to use the n-1 approach whereby the 
index case is presumed to be a member of each cluster (Small et aL 1994). Based 
on this the level of recent transmission in this study was 12.2%. 
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The majority of DNA fingerprints were unique. This could imply that TB disease 
in England is predominantly due to reactivation of a latent infection. A 
substantial proportion of cases will be due to reactivation of infection but 
importation of disease particularly from high incidence countries is likely to 
contribute a significant number as 52.8% of cases were born outside the UK and 
12.8% of cases had resided in England for less than two years. As clinical TB 
commonly develops within two years of infection, these cases may reflect the 
level of importation of disease seen in England. A study of the origins of M. tb in 
London found isolates could be assigned to large superfamilies based on IS6110 
patterns, which were associated with country of birth. Transmission between 
immigrant and endogenous populations was found to be limited suggesting 
transmission occurred in the country of origin prior to entry into the UK or 
through close contact in certain communities (Dale et al. 2005). 
A geographical analysis of clustering showed that clustered strains had 
disseminated throughout England demonstrating that TB transmission is not just 
a localised problem. The majority of clustered cases had not been identified 
previously through contact tracing. This supports the need for a national typing 
scheme as ongoing transmission cannot be monitored by local strain typing 
alone. 
Molecular typing is an efficient method of identifying related cases however the 
interpretation of clusters must be treated with caution as false clusters with no 
epidemiological link may occur. Although it is possible that clusters with no 
apparent link may be the result of casual contact it is also possible that no link 
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exists. Sample size, study duration, incidence of TB and the stability of DNA 
regions analysed by a typing method can all effect clustering (Glynn et al. 1999, 
van Soolingen et al. 1999). To limit the amount of false clustering a typing 
technique providing a high level of discrimination is required. The discrimination 
of various typing techniques is discussed in the next section. 
64 
3.3 Comparative study of molecular typing techniques 
3.3.1 Study population 
The isolates described in section 3.2 and those with culture confirmed cases of 
TB in England between the 1St January 1999 and 31st March in 1999 were 
combined to assess the discriminatory power of different typing techniques. 
3.3.2 Molecular Analysis 
RFLP and spoligotyping (Material and Methods 2.3 and 2.4) were performed on 
all available isolates from this 15 month period (1St January 1998 to 31St March 
1999). A geographical defined subset of this population (the London region 
comprised of 565 isolates) was selected and typed with VNTR-MIRU using 12 
loci (VNTR-MIRU-12) in addition to RFLP and spoligotyping. A sub-set of this 
population (293 isolates) was chosen in a blinded but arbitrarily manner and 
typed with VNTR-MIRU using 15 loci (VNTR-MIRU-15) (Material and 
Methods 2.5.2). A comparison of strain typing methods was performed using the 
Hunter-Gaston index (Material and Methods 2.7). 
3.3.3 Results 
A total of 4767 culture confirmed cases were recorded in Mycobnet during the 
15-month (1st Jan 1998 to 31St March 1999) study period. Overall 2688 isolates 
were successfully RFLP and spoligotyped. 
The discriminatory power of each typing method, alone and in combination was 
determined using the Hunter-Gaston Index (HGI). A typing technique providing 
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good discrimination is one with a high HGI and small number of clustered strains 
in comparison to other techniques. The HGI determined that a combination of 
RFLP and spoligotyping gave the highest discrimination of the whole population 
(0.9997) than either technique alone (Table 3.3.1). RFLP gave a higher level of 
discrimination when used alone compared to spoligotyping (0.9982 and 0.9856 
respectively). However, the discriminatory power of these two techniques 
differed considerably when analysing HCN and LCN isolates separately. 
Although RFLP was the most discriminating technique for HCN isolates, when 
used to analyse LCN isolates its discriminatory power is reduced (0.9998 to 
0.9409). Conversely, spoligotyping performed more effectively than RFLP in a 
LCN population displaying a higher discriminatory power (0.9590 and 0.9409 
respectively). 
A comparison of the clustering observed in HCN isolates according to RFLP and 
spoligotyping showed that the majority of clusters (78.4%) were concordant i. e. 
clusters defined by RFLP had indistinguishable spoligotypes. A total of 33 
clusters (containing 73 isolates) were not concordant i. e. a cluster by RFLP could 
be sub-divided by spoligotyping. Of these clusters the majority contained just 
two isolates (84.8%) and varied on average by 6 spacers, although over half 
(57.6%) varied by between 1 and 4 spacers. The high level of concordance 
observed suggests that these two techniques are not independent of each other, 
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A geographically defined population subset of TB isolates from patients residing 
in London region (n = 565) was tested using 12-loci VNTR-MIRU (VNTR- 
MIRU-12). The results are shown in Table 3.3.2. By comparing the three 
techniques when used alone, VNTR-MIRU-12 had a comparable level of 
discrimination compared to RFLP-IS6110 (0.9958 to 0.9917 respectively) based 
on the maximum number of sub-divisions produced. Interestingly, the 
discriminatory power of VNTR-MIRU-12 was higher when analysing LCN 
isolates than that of RFLP and spoligotyping (0.9894 compared to 0.9101 and 
0.9691 respectively). In the HCN population RFLP and VNTR-MIRU-12 were 
both highly discriminatory compared to spoligotyping. RFLP and VNTR-MIRU- 
12 had similar discriminatory values however the number of clustered isolates 
was far greater when the population was analysed with VNTR-MIRU-12 
compared to RFLP (196 and 42 isolates respectively, i. e. less discriminatory). 
In practice, RFLP is often used alone for isolates with a HCN in population 
studies and is then combined with a secondary typing technique in order to 
differentiate LCN isolates. In the total population a combination of RFLP and 
VNTR-MIRU-12 gave a similar level of discrimination as RFLP and 
spoligotyping according to the HGI (0.9997 and 0.9989 respectively). However 
the number of clustered isolates varied considerably in the HCN and LCN 
populations. The number of clustered isolates in the HCN population produced 
by RFLP and VNTR-MIRU-12 (n = 24) was lower than RFLP and spoligotyping 
(n =31). In the LCN number population the difference in the level of clustering 
was more pronounced between RFLP and VNTR-MIRU-12 (n = 49) and RFLP 
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high the difference in the level of clustering seen appears to suggest that a 
combination of RFLP and VNTR-MIRU-12 gives a higher level of 
discrimination. 
The greatest discrimination was achieved by using all three typing methods 
together. The discriminatory power of RFLP and VNTR-MIRU-12 was similar 
to that of all three techniques combined (0.9997 and 0.9999 respectively). 
Nevertheless, the level of clustering observed suggests three techniques were 
more discriminatory: clustering was reduced from 24 to 19 in the HCN 
population and from 49 to 26 in the LCN population by applying RFLP and 
VNTR-MIRU-12 and all three techniques respectively. 
A sub-set (293 isolates) from the 565 isolates were chosen in a blinded but 
arbitrarily manner. These isolates were further analysed with RFLP-IS6110, 
VNTR-MIRU-12 and in addition VNTR-MIRU-15. Overall, all three techniques 
were highly discriminating (Table 3.3.3). VNTR-MIRU-12 and -15 typing 
performed better in the LCN population than RFLP typing (0.9303,0.9888, and 
0.9940 respectively). In general, RFLP is poor at differentiating between LCN 
isolates. This was demonstrated by the number of clustered isolates observed in 
each group ranging from; 55 with RFLP typing to 25 with VNTR-MIRU-15 
analysis. A substantial proportion of isolates in this population were LCN 
(30.0%) therefore this will have acted to reduce the HGI of RFLP further. 
Conversely, in the HCN population the number of clustered isolates produced by 
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83 respectively) demonstrating that the discriminatory power of RFLP surpasses 
VNTR-based typing in HCN populations. 
3.3.4 Discussion 
Determining the discriminatory power of a strain typing technique permits the 
identification of the best strain-defining technique or techniques for 
understanding how TB has been transmitted within a population. The rapid 
identification of related TB cases is paramount for efficient clinical and public 
health action but is also crucial for national surveillance so that resources can be 
targeted to problem areas. 
In this study we used a population-based study to compare the discriminatory 
power of different typing techniques. A combination of RFLP and spoligotyping 
proved to be more discriminating compared to each technique alone. When both 
techniques were used alone there were variations in their discriminatory power 
depending on the composition of the population e. g. in the LCN population the 
discriminatory power of RFLP was reduced whereas spoligotyping was very 
effective at sub-dividing LCN clusters. This is consistent with previous studies 
which have shown a first and second line typing approach for LCN isolates 
provides a better level of discrimination whereby RFLP is used to analyse all 
isolates followed by spoligotyping of LCN cases to sub-divide RFLP LCN 
clusters (Goyal et al. 1997, Kamerbeek et al. 1997). However, caution should be 
taken in interpreting RFLP and spoligotyping clusters within LCN isolates to 
estimate the extent of recent transmission in epidemiological investigation as it 
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has been shown that there is congruence between these techniques which 
suggests distinct families of strains exist (Dale et al. 2003). 
An analysis of the HCN population by both RFLP and spoligotyping 
demonstrated that the clusters produced by these techniques were not always 
concordant. Although RFLP is regarded as the gold standard for typing M ab, in 
this study spoligotyping subdivided HCN clusters which could have implications 
for molecular epidemiological studies. 
RFLP IS6110 elements are believed to cause changes in the genome by 
transposition. Within the direct repeat (DR) region, on which spoligotyping is 
based, there is a copy of the IS6110 element which can alter the composition of 
this region by removing direct variant repeats (DVR) during transposition (Fang 
et al. 1998). Evolution of this region can also be IS6110-transposition 
independent by the deletion of single or contiguous stretches of DVRs through 
homologous recombination of neighbouring or distant DRs (van Embden et al. 
2000). Less than a quarter of HCN RFLP clusters in this study did not have 
indistinguishable spoligotypes. The molecular clock of RFLP is believed to be 
faster then that of spoligotyping (Niemann et al. 1999, Warren et al. 2002) 
therefore any difference in the latter may be seen as a more substantial biological 
change. However, taking this into account it is unlikely that those HCN clusters 
sub-divided by spoligotyping are false clusters and that all clusters produced by 
spoligotyping in the HCN population are the result of true transmission events. 
RFLP has proven to be a robust technique for strain typing as numerous studies 
have proven epidemiological links within RFLP HCN clusters (van Soolingen et 
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a1.1999, Maguire et al. 2002, Ruddy et al. 2004). Furthermore a previous study 
demonstrated that spoligotyping can indeed split up epidemiologically linked 
HCN RFLP clusters (Kwara et al. 2003). 
In our study the discriminatory power of spoligotyping was lower than that of 
RFLP in HCN isolates and in addition spoligotyping clusters have combined 
HCN and LCN isolates which are unlikely to be epidemiologically linked. The 
reasons behind the discrepancies between these techniques are unclear and may 
be a result of the mechanisms controlling their position and/or presence or 
absence. 
Several studies have shown that VNTR-MIRU has a discriminatory power 
similar to RFLP (Supply et al. 2001, Cowan et al. 2002, Hawkey et al. 2003) 
however Nguyen et al. (2004) found that the discrimination provided by VNTR- 
MIRU was still lower than RFLP. In this study VNTR-MIRU typing provides a 
higher level of discrimination than spoligotyping for both HCN and LCN 
isolates. Although the HGI value of VNTR-MIRU was comparable to RFLP the 
former actually clusters more isolates compared to the gold standard. The 
additional clusters produced by VNTR- MIRU in the HCN population could be 
described as false clusters. A probable reason for the similar HGI values of these 
two techniques could be due to the size of the clusters. A technique producing a 
large number of very small clusters can inflate the HGI and was observed with 
VNTR-based typing which gave the impression that its discriminatory power was 
comparable to RFLP. The value of VNTR-MIRU typing may also have been 
overestimated in the final population (n = 293), where 30% of cases were LCN, 
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because the value of RFLP will decrease with an increasing number of LCN 
isolates. VNTR based typing does perform better than RFLP in LCN 
populations, seen in this study and with other work performed in our department 
(Gopaul et al. unpublished), but in HCN populations RFLP remains the most 
discriminatory technique. 
A previous study demonstrated that the discrimination of VNTR-MIRU-12 could 
be improved by the addition of three loci from the Frothingham and Meeker 
O'Connell study; ETR-A, ETR-B, and ETR-C and that this 15 loci panel gives 
rise to discrimination that is similar to RFLP-IS6110 analysis alone (Hawkey et 
al., 2003). This suggests that a prospective typing service could be run as 
amplification techniques are more rapid and require much less DNA compared to 
RFLP which is a slow cumbersome technique requiring viable cultures. However 
the numbers employed in this study were small and analysis was based on 
selected investigations with epidemiological information. In our study there was 
an improvement in the discrimination of VNTR-MIRU with the addition of ETR- 
A to C. However there is still a large difference between the level of clustering 
produced by RFLP and VNTR-MIRU analysis. This is in accordance with further 
work performed in our department (Gopaul et al, unpublished). 
The role of molecular typing techniques for public health benefit and for national 
surveillance is undoubtedly important but the methods for achieving the best 
results are ambiguous. No single technique provides the level of discrimination 
required for confirming or disproving epidemiological investigations. Whilst 
VNTR-MIRU is a promising technique, RFLP would still be required as a 
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primary screen for isolates from the UK due to the higher level of discrimination 
produced with HCN strains which make up the majority of cases. In terms of 
LCN isolates the use of RFLP-IS6110 and VNTR-MIRU provides a better level 
of discrimination over that observed with the frequently used strategy of RFLP 
and spoligotyping. 
Note: 
This study was part of a collaboration between the HPA-Mycobacterium Reference Unit and the 
communicable disease surveillance centre (CDSC) and was funded by the Department of Health. 
Andrea Gibson performed all of the spoligotyping analysis and some of the RFLP and VNTR- 
MIRU. The RFLP analysis was mainly performed by Dr. Zack Fang (1998 isolates) and Dr. 
Krishna Gopaul (1999 isolates). The remaining VNTR-MIRU analysis was performed by Dr. 
Krishna Gopaul. Epidemiological data was analysed mainly by CDSC and in particular by Dr. 
Jane Love. Ethical approval for this study was granted by the Multi-centre Research Ethics 
Committee (ref. MREC/99/2/84) 
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CHAPTER 4.0 Molecular epidemiology of Mycobacterium tuberculosis in 
Harare, Zimbabwe. 
4.1 Introduction 
The incidence of Tuberculosis (TB) in Zimbabwe has risen dramatically over the 
last two decades from 60 per 100,000 in 1981 to 384 per 100,000 in 2001 
according to the WHO (www. stoptb. org/events/world tb day/2002/News 
Articles/ AFP 020322. htm). This resurgence, as in other parts of Africa has 
largely, been fuelled by the HIV epidemic in sub-Saharan Africa (Mwinga and 
Bernard Fourie 2004). 
The gold-standard for typing Mycobacterium tuberculosis (M. tb), restriction 
fragment length polymorphism (RFLP), is a costly, time consuming technique 
which requires viable cultures and tends to be impractical for resource poor 
settings as suitable culture facilities are not always available. PCR techniques, 
such as spoligotyping and variable number tandem repeat (VNTR) (Kamerbeek 
et al. 1997, Frothingham and Meeker-O'Connell 1998), are more suited to this 
kind of environment as PCR can be performed directly on clinical samples and 
therefore viable cultures are not necessarily required. Spoligotyping and VNTR 
do not provide the same level of discrimination as RFLP in strains with more 
than four copies of IS6110 as they can link together isolates with different RFLP 
patterns, but when applied together their discrimination of M. tb populations is 
improved (Goyal et al. 1997, Kremer et al. 1999, Filliol et al. 2000). 
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The aims of this study were to investigate the level of recent transmission versus 
reactivation of TB in Harare, Zimbabwe using two molecular typing techniques, 
spoligotyping and VNTR-exact tandem repeats (VNTR-ETR) and secondly to 
identify any spoligotyping families present in this high incidence population and 
compare them to those seen in a low incidence population in London, UK. 
4.2 Study design 
4.2.1 Patients enrolled on the study 
A total of 516 consecutive smear positive patients presenting at the Beatrice 
Road Hospital in Harare between May and October 1997 were enrolled in the 
study. The Beatrice Road TB Hospital is the main referral centre for TB and 
other infectious diseases. Each patient was given a clinical examination, chest X- 
ray and a HIV test. A total of three sputum samples were collected per patient. 
Sputa were stained using a carbol fusion based stain and smear positivity (i. e. 
most infectious) and negativity were recorded. Demographic data and medical 
history of each patient was collected using a standardised questionnaire 
administered by a trained nurse. 
4.2.2 Microbiological methods 
Sputa were all cultured on Lowenstein-Jenson media. Culturing of sputum 
samples and drug susceptibility testing was performed at the TB reference 
laboratory, Bulawayo, Zimbabwe. HIV status was also determined in Zimbabwe 
using an ELISA (enzyme-linked immuno sorbent assay) screening test (Dupont, 
Wilmington, Del. ). CD4 cell counts were measured by flow cytometry 
(FACScan Becton Dickinson, Paramus, N. J. ) 
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4.2.3 Molecular methods 
Cultures were transferred from Zimbabwe to the HPA Mycobacterium Reference 
Unit in London. A crude DNA extract (Materials and Methods 2.2.1) from each 
available culture was amplified and analysed by spoligotyping and VNTR-ETR 
(Materials and Methods 2.4 and 2.5.1). The discriminatory power of these two 
techniques was calculated using the Hunter Gaston Index (Material and Methods 
2.7) 
4.2.4 Laboratory Contamination 
Samples processed in the microbiology laboratory on the same day as a positive 
smear from another patient with the same typing pattern were considered as 
laboratory cross contamination and excluded from the study. 
4.3 Results 
4.3.1 Molecular analysis 
Of the 516 patients enrolled on the study, 502 had complete epidemiological and 
microbiological data and were included in the analysis. DNA was extracted from 
224 cultures from 502 patients (44.6%). The remaining cultures were either non- 
viable, heavily contaminated with bacteria or yeast or the glass vials containing 
the cultures were broken during transportation from Harare to London rendering 
them unusable. 
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A total of 214/224 (95.5%) isolates were spoligotyped from which 54 distinct 
spoligotypes were produced. The remaining ten isolates failed to amplify. These 
spoligotypes produced 20 clusters (180 isolates) and 34 unique types. A cluster 
was defined as two or more isolates with indistinguishable fingerprint patterns. 
Cluster size ranged form 2 to 68, with the majority of clusters (85.0%) containing 
8 or less isolates. Three clusters were disproportionately larger containing 23,25 
and 68 and accounted for 54.2% of the isolates. Examples of the two largest 
clusters are seen in figure 4.1. 
VNTR-ETR typing was successfully performed on 198/224 (88.4%) isolates and 
again the remaining isolates failed to amplify. A total of 33 VNTR-ETR profiles 
were produced containing 12 clusters (177 isolates) and 21 unique VNTR-ETR 
types. Of the clustered isolates, 140 isolates (70.7%) formed just two clusters 
containing 127 and 13 isolates while the remaining clusters contained less than 7 
isolates. 
The discriminatory value of spoligotyping (0.8708) was higher then that of 
VNTR-ETR (0.5827). By combining the two typing techniques the 
discriminatory power was increased to 0.9221. Spoligotyping as a first line 
typing technique followed by VNTR-ETR sub-divided the 20 spoligotyping 
clusters into 24 clusters containing between 2 and 48 isolates (Table 4.1). The 
largest spoligotype cluster, containing 68 isolates, was divided into 8 different 
VNTR-ETR types. Overall 25 isolates had spoligotyping data but were unable to 
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Lanes 1 and 2-M. tb H37Rv and M. bovis BCG positive controls Lanes 4 and 5- examples of the spoligotyping pattern of the largest cluster (n = 68) 
Lanes 24 to 26 - examples of the spoligotyping pattern of the second largest cluster (n = 25) 
81 
Table 4.1 Spoligotyping and VNTR used as a first and second line method 
First-line typing method Second-line typing method 
Spoligotyping VNTR 
Cluster size Fingerprint No of sub- 
clusters 
No of isolates per 
cluster 
No of unique 
isolates' 
4 000000000003771 0 0 1(3) 
2 757777777413731 0 0 11 
68 777777606060771 6 2,2,2,2,48,3 2(7) 
2 770077606060731 0 0 11 
23 777777607760771 2 2,16 2(3) 
3 477777607760771 1 2 1 
3 477777777760771 1 2 0(l) 
5 777777677760771 2 2,3 0 
8 777417606060731 1 8 0 
4 777737777760771 1 2 11 
2 677777607760771 0 0 2 
2 777777774020731 1 2 0 
3 777775606060771 1 3 0 
2 703377400001771 0 0 11 
7 777777606060731 1 7 0 
3 777777606060571 1 3 0 
25 777777777760771 3 4,2,8 7(3) 
4 777777606060631 1 4 0 
3 777777606060671 1 2 1 
7 777777606060731 1 7 0 
V NTR S oli of in 
Cluster size Fingerprint No of sub- 
clusters 
No of isolates per 
cluster 
No of unique 
isolates 
5 32333 2 2,2 1 
4 21232 2 2,2 0 
4 21233 2 2,2 0 
3 21431 3 2 1 
5 21432 1 2 3 
127 21433 13 48,16,2,3,8,2, 
3,7,3,4,4,2,7 
10(8) 
2 42435 0 0 1(1) 
13 32433 1 8 5 
2 22432 0 0 2 
6 22433 2 2,3 1 
3 23433 0 0 2(l) 
3 32332 0 0 3 
' Figures in parentheses could not be typed by the second-line typing method. 
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be VNTR-ETR typed therefore the value of VNTR-ETR may have been 
underestimated. 
Alternatively, VNTR-ETR as a first line technique followed by spoligotyping 
sub-divided the original 12 clusters into 24 clusters containing between 2 and 48 
isolates. The largest VNTR-ETR cluster, which contained 127 isolates, was sub- 
divided into 23 different spoligotypes. 
None of the clustered isolates were processed in the laboratory on the same day 
and therefore the risk of cross-contamination was reduced. 
4.3.2 Epidemiological information 
Of the 502 patients, 326 (64.9%) were male and the majority of patients were 
aged between 25-29 years with 43.6% of cases aged 25 to 34 years (Figure 4.2). 
Forty-four (8.9%) had a past history of TB and 204 (40.6%) gave a history of 
recent household contact with TB. A high proportion of patients (73.9%) were 
HIV positive and 17/458 (3.7%) of cases were resistant to one or more 
antimicrobial drugs. 
4.3.3 Risk factors for clustering 
Risk factors for clustering of patients' isolates were identified by comparing the 
epidemiological data of patients in clustered and unclustered groups using a chi- 
squared test. Univariate analysis of patients clustered by spoligotyping found 
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also observed in patients with clustered VNTR-ETR profiles. When combining 
the two techniques, gender was no longer statistically significant. Multivariate 
analysis failed to reveal any associations between clustering and any 
demographic or clinical characteristics. 
4.3.4 Geographical analysis of clustering 
There was no evidence of a higher rate of clustering in certain residential districts 
in Harare or in rural home districts. Analysis of the largest cluster (68 patients) 
according to spoligotyping found that this type accounted for more than 50% of 
patients in 5 districts. Similarly the strain responsible for the second largest 
spoligotype cluster (23 patients) was found in more than 40% of patients in three 
districts. The largest VNTR-ETR cluster (127 patients) accounted for 64.1% of 
all isolates and was found at a higher frequency (>80%) in 5 districts. None of 
these findings proved to be statistically significant except for one district in 
Harare which contained the spoligotype pattern of the largest cluster. 
4.3.5 Comparison of Spoligotypes to an international database 
The spoligotypes observed in this study were compared to an international 
database (Pasteur Institute, Guadeloupe). This database demonstrated that the 
three largest spoligotype clusters (international spoligotypes codes; 59,53 and 42 
respectively) were all well recognised and ubiquitous in Africa (Table 4.2). The 
Beijing/W strain (type 1) was represented by four strains none of which were 
geographically linked. Interestingly 35 spoligotypes in this study had not been 
observed before although strains from sub-Saharan Africa were under- 
represented in this database. 
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Table 4.2 Frequency of spoligotypes in Harare, Zimbabwe 











000000000003771 4 1 
077777606060771 1 816 
100775747413771 1 Not seen 
477777607760771 3 753 
477777777760771 3 804 
577777603760771 1 Not seen 
601777606060731 1 Not seen 
637775777763770 1 Not seen 
677777607760771 2 20 
700046677760671 1 Not seen 
700076777760771 1 92 
700777747413771 1 129 
703377400001771 2 21 
703777740003171 1 25 
737417606060731 1 805 
737777607030771 1 Not seen 
737777677670371 1 Not seen 
757777606060771 1 Not seen 
757777777413731 2 806 
770077606060731 2 807 
773777606060731 1 Not seen 
774777777760771 1 801 
777377607760771 1 81 
777417606060731 8 184 
777737777760771 4_ 1 37 
777747606060771 1 808 
777757606060731 1 82 
777774606060731 1 Not seen 
777775606060771 3 809 
777775770020771 1 Not seen 
777777414020731 1 Not seen 
777777602060771 1 810 
777777604060731 7 811 
777777606060571 3 812 
777777606060631 4 813 
777777606060671 3 814 
777777606060731 7 815 
777777606060771 68 59 
777777607760731 1 60 
777777607760771 23 42 
777777674063771 1 Not seen 
777777676060771 1 Notseen 
777777677760771 5 291 
777777757760771 1 44 
777777757763771 1 Not seen 
a Octal codes determined using 
Dale et. al (2001) protocol. 
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4.3.6 Spoligotyping families observed in Harare, Zimbabwe 
A comparison of the spoligotypes observed in this study to the published 
spoligotype clades (Filliol et al. 2002) was performed. Of the 214 isolates with a 
spoligotype only 59 (27.6%) belonged to a recognised spoligotype family. Out of 
the 36 spoligotype clades described by Filliol et al. only 9 were observed (Table 
4.3). The majority of isolates belonging to a spoligotype family (81.3%) were 
seen in just 2 families, the Ti and the (Latin American-Mediterranean) LAM 9 
families (11.8% and 10.8% respectively of the total number of isolates). The next 
largest family, the Beijing family, was seen in just 1.9% of the total isolates. 
4.3.7 Spoligotyping families observed in London, UK 
All spoligotypes from cases isolated in the London region between 1St Jan 1998 
and 31" March 1999 identified in the previous study (Chapter 3) were analysed 
to determine the demographics of spoligotype families observed in this region 
and in comparison to Harare. A total of 27 M. tb spoligotype families were 
observed in the London region (Table 4.3). From the total cases isolated during 
the study 46.0% had spoligotypes belonging to a recognised family. The most 
frequently seen spoligotype strains were Ti (18.3% of the total number of 
isolates) followed by (Central Asian family) CAS 1 (14.9%). Overall 99 
Beijing/W strains were identified which comprised 12.3% of the total. The 
Haarlem 3 strain was also prevalent and found in 9.7% of cases. The spoligotype 
signature of the M. tb laboratory strain H37Rv was observed in two cases. In 
addition, seven spoligotypes characteristic of M. africanum were observed. 
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A statistical evaluation of the prevalence of different strain families in these two 
settings was performed using a rates ratio (RR). As the majority of strain families 
were not seen in Harare the comparison was limited to 9 families of which 3 
showed a statistically significant difference. The Beijing and T1 strains were 
more prevalent in London than in Harare, RR 6.56,95% Cl (2.45-17.70) and RR 
1.57,95% CI (1.05-2.33) respectively, whereas the LAM 9 strain was less 
prevalent in London than in Harare, RR 0.30,95% CI (0.18-0.52). 
4.4 Discussion 
4.4.1 Recent transmission versus reactivation of disease 
The transmission of TB in an epidemiologically characterised population in 
Harare, Zimbabwe was assessed using two molecular techniques; spoligotyping 
and VNTR-ETR. Clusters of strains are thought to reflect recent transmission 
(Small et al. 1994, Alland et al. 1994, van Deutekom et al. 1997). Almost three- 
quarters of TB cases in Harare, Zimbabwe were clustered and so could 
potentially represent the rate of recent transmission. Reactivation of latent 
infection therefore appears to be low and accounts for very few TB cases in 
Harare. It is possible that had the collection of isolates been typed additionally 
using RFLP-IS6110, clustering rates would have been reduced. 
Nevertheless, the level of clustering seen in this study was substantially higher 
than in countries with a low prevalence of TB which have been estimated at; 
28% in France (Torrea et al. 1996), 38% in Seville, Spain (Safi et al. 1997), 38% 
in New York city, US (Alland et al. 1994), 40% in San Francisco, US (Small et 
al. 1994) and 46% in Amsterdam, The Netherlands (van Deutekom et al. 1997). 
Fewer molecular epidemiological studies have been carried out in countries 
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where rates of TB and HIV are endemic. Transmission has been estimated at 
32% in San Paulo, Brazil where about half of cases were HIV positive (Ferrazoli 
et al. 2000), 33% in Guadeloupe (Sola et al. 1997), 42% in Botswana where 69% 
of cases were HIV positive (Lockman et al. 2001), 45%-50% in South Africa 
(Godfrey- Faussett et al. 2000, Wilkinson et al. 1997) and 72% in Northern 
Malawi (Glynn et al. 2005a). A small TB study in Harare conducted in 1995 
found a clustering rate of 53.6% based on spoligotyping, (Heyderman et al. 
1998) which was lower then observed in this study, however only 28 patients 
were assessed and so this is probably not a true representation. 
The high rates of clustering seen in this study may reflect the high prevalence of 
HIV infection in this population. Almost 75% of cases were co-infected with 
HIV. HIV infection increases the susceptibility to exogenous TB infection and 
the rapid onset of TB after infection which in turn would lead to a higher 
prevalence of infectious cases over a shorter period of time. A similar rate of 
clustering was observed in Northern Malawi where clustering in older adults was 
associated with patients who were HIV positive suggesting that HIV has a 
greater impact on disease caused by recent transmission then that caused by 
reactivation (Glynn et al. 2005a). 
Overcrowding in the high-density housing in Harare may also have lead to 
increased transmission rates. The study group was also relatively young which 
has previously been identified as a risk factor for clustering (e. g. Maguire et al. 
2002). Other previously described risk factors in industrialised countries include; 
HIV infection, being a member of an ethnic minority, drug resistance, 
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homelessness, alcohol and drug abuse (Alland et al. 1994, Small et al. 1994, van 
Deutekom et al. 1997). None of these factors were found to be significant in this 
study, however it can be difficult to compare risk factors in different populations 
as definitions of certain characteristics vary. For instance the interpretation of 
`homelessness' can vary depending on the country examined. 
The short duration of the study (six months) and the fact that less than half of 
cases had molecular data may mean that links were missed. A comparison of 
patient characteristics in those with and without molecular data were similar, 
indicating that the results of this study are unlikely to be biased by availability of 
molecular data. Patients were also recruited from the main TB referral hospital 
which sees the majority of TB cases in Harare, therefore patients enrolled are 
likely to be representative of all the TB cases in the city. By only sampling smear 
positive cases a snapshot of the most efficient sources of transmission were 
identified, however smear negative, culture positive cases can still account for a 
sizable amount of TB transmission (Behr et al. 1999). Together these factors may 
have reduced the number of potential molecular epidemiological links and in turn 
contributed to an underestimation of recent transmission. 
Strains with identical fingerprints in rural areas have been attributed to the 
simultaneous reactivation of infection from a common source at some time in the 
past (Braden et al. 1997), however no clustering was observed in rural home 
districts suggesting that these cases were due to reactivation of different strains. 
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Clearly clustered cases represent TB transmission between individuals at some 
point. Thereafter, the interpretation of clustering is debatable as identical 
fingerprints are thought to represent clusters of related cases which are more 
likely to be due to recent transmission rather then simultaneous reactivation of a 
latent infection. However a study of M. tb isolates in Malaysia found that 
clustering increased with patient age and identical fingerprints were seen over a 
wide area suggesting that reactivation may have contributed to clustering (Dale 
et al. 1999). In this Zimbabwean population reactivation is unlikely to have 
contributed greatly as the majority of cases were of a young age. 
Although this study identified high rates of clustering, if the index case is 
presumed to be a member of each cluster and is therefore removed (i. e. n-1) 
(Small et al. 1994, Glynn et al. 2005a) the level of clustering is reduced from 
84.1%, 89.4%, 73.0% to 74.8%, 83.3%, 60.3% for spoligotyping, VNTR-ETR 
and combined respectively. This method is perhaps a more accurate measure of 
the level of recent transmission however it does not take into account any cases 
that are infected just before the study period and subsequently mislabelled as a 
reactivated case. 
Based on a combination of spoligotyping and VNTR-ETR just over a quarter of 
TB cases were unique and may represent reactivation of a latent infection. Due to 
the high prevalence of TB in Africa many children are likely to be exposed to 
and infected with TB before they reach adulthood, therefore reactivation of an 
infection acquired as a child could account for a large proportion of TB cases in 
Africa. A study of pulmonary TB cases in Botswana found half of all cases were 
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not linked and may have been due to reactivation of a latent infection (Lockman 
et al. 2001), however in this study recent transmission and not reactivation of 
disease appears to be the major cause of TB in Harare. 
The typing method(s) chosen for molecular epidemiological studies is important 
as the stability of markers can vary, therefore clustered cases may not always 
represent recent transmission (Glynn et al. 1999). RFLP-IS6110 is the gold 
standard for strain typing M. tb. Unfortunately RFLP-IS6110 could not be carried 
out in this study due to the high level of heavy contamination of cultures and also 
due to sparse growth. As demonstrated in chapter 3, VNTR-MIRU is more 
discriminatory than spoligotyping and appears to have a discriminatory power 
similar to that of RFLP-IS6110 analysis. The application of RFLP and VNTR- 
MIRU to strains in this study may sub-divide clusters. Unfortunately due to the 
low amounts of DNA remaining after spoligotyping and VNTR-ETR typing, 
VNTR-MIRU could not be performed. 
PCR techniques are valuable in areas where the culture of tuberculosis is difficult 
as relatively little equipment and expertise is required. Spoligotyping and VNTR- 
ETR are suited to this kind of environment as they can be applied directly to 
smear-positive sputum. However, as spoligotyping and VNTR-ETR are not as 
discriminatory as RFLP-IS6110 (Filliol et al. 2000 and Goyal et al. 1997) focus 
should be turned to PCR tools with a higher level of discrimination such as 
VNTR-MIRU. 
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4.4.2 Comparison of spoligotypes observed with an international spoligotype 
database 
A comparison with an international spoligotype database showed that the three 
most prevalent spoligotypes were all ubiquitous in Africa. Type 59, the largest 
spoligotype cluster, is found almost exclusively in Africa and had previously 
been seen in Harare (Heyderman et al. 1998). The second and third largest 
clusters are also ubiquitous but were not observed in the Heyderman et al. study, 
although this study only contained 28 cases. Spoligotypes numbered between 
804 and 815 which had not been seen before were similar to type 59 and may be 
considered evolutionary descendants. Type 62 is likely to be an emergent clone 
from type 47 which is from the Haarlem family of strains. Type 21 is found in 
East Africa and Europe, and therefore may be due to immigration from these 
countries. 
4.4.3 Spoligotyping families observed in Harare and London 
Worldwide analysis of M. tb spoligotypes has shown that the distribution of types 
can be confined to certain areas while others are widespread globally. 
Spoligotyping has been used as a phylogenetic marker to infer evolutionary 
relationships between these types or families of strains (Sola et al. 2001 a, Sola et 
al. 2001b, Filliol et al. 2002, Filliol et al. 2003). The naming of these families 
has largely been dependant on the area in which they were first recognised or 
most prevalent, for example, the Beijing type (van Soolingen et al. 1995), 
Haarlem type (Kremer et al. 1999, ) the East African-Indian and Latin American- 
Mediterranean families (Sola et al. 2001a). 
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The spoligotypes observed in two capital cities, one in a high incidence area 
Harare, Zimbabwe and the other in a relatively low incidence area London, UK 
were compared. In Harare, the majority of strains belonging to spoligotype 
clades (81.3%) were part of just two main families, the T and the LAM family 
whereas in London 13 large families were observed (those containing 20 or more 
isolates) which comprised 87.5% of isolates in a spoligotype Glade, probably 
reflecting the greater international diversity of the population in London. 
The comparison of spoligotype families observed in Harare and London found 
that the T1 strain was ubiquitous in both populations. The T family is thought to 
be a relatively old genotype (Filliol et al. 2002) and the Ti strain is found 
worldwide (Filliol et al. 2003), therefore it is not surprising that this strain was 
frequently seen in these two contrasting settings. The only member of the T 
family seen in Harare was the Ti strain, whereas in London all four T family 
strains were observed suggesting that some T strains may be more successful in 
certain regions. However it is possible that cases in Harare that could not be 
spoligotyped may have been members of the other T family strains. 
The second most frequency observed spoligotype strain in Harare (LAM 9) 
which was seen in 10.8% of cases was also observed in 3.2% of cases in London; 
the second most frequently seen strain in London (CAS 1) was not observed in 
Harare. The CAS family are newly described and are generally found in middle- 
eastern Asia (Filliol et al. 2002) whereas the LAM family is believed to have 
originated in either the Americas or in the Mediterranean region and later spread 
to the Americas through migration of infected cattle and humans (Sola et at. 
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2001a). The LAM family belongs to genetic group 2 and they are therefore 
thought to be evolutionary intermediate strains (Streevatsan et al. 1997) and are 
also thought to share a common ancestor with the Haarlem family (Sola et al. 
2001 a). The three Haarlem strains comprising the Haarlem family were all seen 
in London, particularly Haarlem 3, which was observed in 9.7% of cases. In 
Harare, however, only Haarlem 1 was observed (0.5% of strains). 
Surprisingly the (East African-Indian) EAI family, which was thought to have 
originated in Africa or Asia (Sola et al. 2001a), was not over-represented in 
Harare. In fact only one member of this family, EAI-5, was observed (0.5% of 
cases). In contrast, all members of the EAI family were seen in London isolates 
and comprised 10.9% of the total isolates. Moreover, a spoligotype with the EAI 
pattern was isolated from a 15th century skeletal sample of M. tb DNA found in a 
UK village and so spreads doubt on the hypothesised origin of this strain (Mays 
et al. 2001). 
M. africanum strains are commonly associated with TB patients in Africa 
(Nieman et al. 2002) however no spoligotype patterns from this species were 
observed in Zimbabwean isolates, conversely 7 M. Africanum strains were 
observed in London isolates, although this species has previously been seen in 
South-East of England (Grange and Yates 1989). 
The Beijing strain family was first identified in the Beijing area of China, where 
a high proportion of strains examined belonged to a genetically closely related 
group (van Soolingen et al. 1995). This strain has since disseminated globally 
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and is particularly prevalent in former Soviet Union countries (Drobniewski et al. 
2002, Bifani et al. 2002). Beijing strains are easily recognisable by their 
distinctive spoligotype pattern which only contain spacers 35 to 43 (Fig 3.3). The 
Beijing strain was observed in both settings although at a higher proportion in 
London (12.3% versus 1.9% in Harare) and demonstrates that the Beijing strain 
has continued to spread globally. The Beijing strain family are believed to be 
intrinsically more virulent then non-Beijing strains causing accelerated onset and 
more severe disease (Lopez et al. 2003). A related strain, the W strain, was the 
cause of a multi-drug resistant outbreak in New York City and has since spread 
across the USA. This strain shares the same spoligotype pattern as Beijing 
(Bifani et al. 1996, Agerton et al. 1999). None of the Beijing/W strains isolated 
in Zimbabwe were drug resistant and only 2/99 (2.0%) of strains isolated in 
London were resistant to one or more anti-tuberculous drugs. Relatively little is 
known about the effect of Beijing/W strains in Africa (Glynn et al. 2002), 
however, drug-resistant cases have been reported in Cape Town and Nairobi (van 
Rie et al. 1999, Githui et al. 2004) but a seven year study in northern Malawi 
found all Beijing strains were fully drug sensitive (Glynn et al. 2005b). 
Identifying which clades/strain families are present in various populations is not 
only important in terms of monitoring the global spread of TB but also in 
identifying which strains are successful within a population. Successful strains 
may harbour particular resistance patterns, such as the W-strain which has been 
linked to drug resistance, and therefore the spoligotypes of these strains can act 
as beacons for TB control action. In population-based studies these spoligotype 
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signatures can be used to screen isolates allowing the identification of potentially 
related cases for which public health action can be targeted. 
Note: 
This study was part of collaboration between the Department of HIV/GUM, King's College 
Hospital, UK, the HPA-Mycobacterium Reference Unit, UK, the University of Zimbabwe and 
Harare City Health Department, Zimbabwe and the Institute Pasteur, Guadeloupe. Andrea Gibson 
performed the molecular typing, except for some of the spoligotyping which was carried out by 
Dianie Lamprecht, and molecular analysis. The epidemiological analysis was performed mainly 
by Professor Philippa Easterbrook and Dr. Shahed Murad. 
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CHAPTER 5.0 Molecular epidemiology of Mycobacterium bovis disease in 
humans in the UK 
5.1 Introduction 
Mycobacterium bovis, the causative agent of bovine tuberculosis, has a wide host 
range infecting many domestic and wild animals. M. bovis infection in humans is 
relatively rare in developed countries, but it remains of public health importance 
in developing countries (Cosivi et al. 1998). Approximately 1% of 
bacteriologically proven clinical tuberculosis (TB) is attributed to M. bovis in the 
UK (http: //www. hpa. org. uk/infections/topicsaz/tb/mbovis). The resurgence of 
bovine TB in cattle in the UK has raised concerns that transmission from cattle to 
humans might be a serious public health issue. 
M. bovis was once a major source of TB in humans in the UK but was almost 
eradicated after the introduction of control measures to reduce bovine 
tuberculosis in cattle together with the pasteurisation of milk for human 
consumption. The majority of human cases of M. bovis in the 1980s and early 
1990s in the UK were due to reactivation of latent M. bovis infections which 
were acquired pre-milk pasteurisation or due to cases who were infected abroad 
and have subsequently returned or migrated to the UK (Hardie and Watson 
1992). The increase in bovine TB in cattle, particularly in the southwest of 
England, has caused concern about the subsequent transmission to humans. 
Many animals such as badgers, foxes, ferrets and deer are believed to act as 
vectors for transmission to livestock (Aranaz et al. 1996; Clifton-Hadley et al. 
1995; Delahay et al. 2001) and some have been associated with transmission to 
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humans (Dalovisio et al. 1992; Michalak et al. 1998; van Soolingen et al. 1994). 
It is therefore important to rapidly identify where rates of M. bovis in cattle are 
high and pose a potential risk of transmission to humans. 
Advances in molecular typing have enhanced our knowledge of M. bovis 
dissemination. Although RFLP-IS6110 analysis is considered the gold standard 
for typing M. tb, M. bovis isolates from cattle usually have only a single copy of 
IS6110 (Cousins et al. 1998) and therefore alternative techniques such as 
spoligotyping and variable number tandem repeats (VNTR) have been 
successfully used in discriminating between strains of M. bovis in animals 
(Aranaz et al. 1996; Cousins et al. 1998; Frothingham and Meeker-O'Connell 
1998; Haddad et al. 2001; Kamerbeek et al. 1997; Roring et al. 2002). 
5.2 Study design 
All available viable M. bovis isolates (50 isolates) from humans diagnosed in the 
UK between 1997 and 2001 were identified; 40 from the HPA Mycobacterium 
Reference Unit (MRU), London and 10 from the Scottish Mycobacteria 
Reference Laboratory (MRL), Edinburgh. A crude DNA extract (Materials and 
Methods 2.2.1) of each isolate was spoligotyped and VNTR-ETR typed 
(Materials and Methods 2.4 and 2.5.1). One strain with a spoligotype not typical 
of M. bovis was sent for deletion analysis at the Veterinary Laboratory Agency 
(VLA). The discriminatory power of each typing method was determined using 
the Hunter-Gaston index (HGI) (Material and Methods 2.7). Epidemiological 
information was obtained from laboratory records at the MRU and MRL and 
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from surveillance data held at the Health Protection Agency (HPA) 
Communicable Disease Surveillance Centre (CDSC). 
5.3 Results 
Spoligotyping of the 50 human M. bovis isolates produced 25 distinct 
spoligotypes with a HGI of 0.892. Thirty-two isolates were divided into 7 
clusters A to G (Table 5.1). The spoligotypes were compared with M. bovis 
spoligotypes from a bank of over 15,000 cattle isolates collected from all over 
the UK held at the Veterinary Laboratory Agency (VLA) dating between 1987- 
2002. The largest cluster of human M. bovis isolates (15 isolates, 30%) had been 
seen in cattle before and was sequentially numbered type 9 (international type 
SB140 - http: //www. Mbovis. org) at the VLA. Type 9 is the most frequently seen 
spoligotype of M. bovis (over 30 % of all isolates have this spoligotype) isolated 
from cattle and has a wide geographical range in the UK (Durr et al. 2000). 
Human type 9 isolates were seen across the UK, suggesting that transmission 
between cattle and humans might occur. Interestingly, 15 of the human M. bovis 
spoligotypes had not been seen at the VLA in cattle isolates. When compared to 
the international spoligotype database, only 2 of the 15 types were recognised. 
The first was isolated in Argentina and the second in Australia, the remaining 13 
spoligotypes were all unique to the UK. In the majority of these cases it is likely 
that disease was due to reactivation of a past infection that had been acquired 
prior to milk pasteurisation, rather then primary infection, because 11/13 (84.6%) 
cases were over the age of 50. The two cases under the age of 50 were part of an 
epidemiologically conformed case of transmission described on page 103. 
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Excluding these two cases the age range was 51 to 96 years with a median age of 
67. Therefore, these 11 unique spoligotypes may reflect M. bovis strains 
circulating in the UK 50 years ago. 
VNTR-ETR typing alone produced 18 different profiles and had a HGI of 0.844. 
Combining spoligotyping with VNTR-ETR vastly improved the level of 
discrimination producing 34 different types with a high HGI of 0.958. 
Furthermore VNTR-ETR was very useful in subdividing type 9 spoligotypes, 
separating the group into 6 subtypes (Table 5.2). 
Table 5.2 Sub-division of spoligotyping clusters using VNTR-ETR 
Spoligo cluster* 
(n of isolates) 
n of VNTR-ETR 
subtypes 
VNTR-ETR profiles 
A (2) 2 55543 75543 
B (2) 2 55543 75543 
C (2) 1 75553 
D (3) 2 63543 75543 
E (15) 6 56543 63543 65542 
65543 75543 75553 
F (6) 2 65543 66543 
G (2) 2 54544 55343 
-. I u&Lianry iaoeiieu clusters 
Epidemiological data showed that the study population was widely distributed 
across the UK, had an average age of 58.7 years with the majority of cases 
(72.3%) over the age of 50 and approximately equal proportions of males and 
females (21: 17). Where ethnicity was known (n = 15), 14 cases were white and 1 
104 
was of Black-African origin who was originally from Nigeria but had lived in the 
UK since 1996. This person had a unique spoligotype therefore it is possible that 
she was infected in Nigeria before arriving in the UK. Of interest, 59% (13/22) of 
cases had some contact with a farm, ranging from a part-time job milking cows, 
living on a dairy farm as a child, to being a farmer (now retired). One 
spoligotype cluster represents an outbreak on a farm in Gloucester which was 
established by this work. Two siblings, (a 20 year old male and a 17 year female) 
living on their parents' farm became infected with M. bovis. The brother 
occasionally helped his father on the farm by restraining the cattle and would 
often be sprayed with nasal mucus. Cattle infected with M. bovis of the same 
spoligotype had been detected on the farm in previous years. Transmission from 
cattle to human is thought to have occurred by inhaling infected aerosols from 
cattle. The brother is thought to have subsequently infected his sister, as she had 
no contact with the cattle but was also diabetic and pregnant i. e. immuno- 
compromised. This is thought to be the first documented case of animal to human 
transmission since the resurgence of bovine TB in the UK (Smith et al. 2004). 
M. bovis spoligotypes do not usually contain spacers 39-43, however, one 
spoligotype from the panel contained spacers 40 to 43, which are more 
commonly seen in M. tuberculosis. Phenotypic and biochemical tests 
demonstrated that this isolate had typical M. bovis characteristics; it was 
microaerophilic, TCH (thiophen-2-carboxylic acid hydrazide) negative, 
pyrazinamide resistant and grew better on pyruvate than glycerol Lowenstein- 
Jensen slopes. 
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Deletion analysis was performed (at the VLA) to ascertain the identity of this 
strain. The strain contained RD 4,12, and 13 but lacked RD 7,8,9 and 10 
(Brosch et al. 2002) indicating that this strain was actually M. africanum and not 
M. bovis. 
5.3.1 VNTR-MIRU compared to VNTR-ETR and spoligotyping in an M. 
bovis population 
Based on the analytical strategy described in chapter 3 each of the M. bovis 
isolates in this panel were VNTR-MIRU typed using 15-loci. Of the 49 M. bovis 
isolates (excluding the isolate confirmed as M. africanum), 45 VNTR-MIRU 
types were observed which included 4 clusters each containing 2 isolates. This 
dramatic decrease in the number of clusters indicates VNTR-MIRU is more 
discriminatory than either spoligotyping or VNTR-ETR alone or in combination 
(Table 5.3). 
Table 5.3 Comparison of the discriminatory power of each typing technique 
Technique n of 
clusters 
Total n of 
types 
n of clustered 
isolates (%) 
n of unique 
types 
HGI 
Spoligotyping 7 24 32 17 0.892 
VNTR-ETR 7 17 39 10 0.844 
VNTR-MIRU- 12 8 29 28 21 0.952 
VNTR-MIRU- 15 4 45 8 41 0.997 
Spoligotyping + 
VNTR-ETR 
5 33 20 29 0.958 
Spoligotyping + 
VNTR-MIRU-12 
4 45 8 41 0.997 
Spoligotyping + 
VNTR-MIRU-15 
2 47 4 45 0.999 
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VNTR-MIRU-15 gave the best discrimination of this bovine population followed 
by VNTR-MIRU-12, spoligotyping and VNTR-ETR (0.997.0.952,0.892,0.844 
respectively). When combined, spoligotyping and VNTR-MIRU-15 had the best 
discriminatory power (0.999). VNTR-MIRU-15 alone had a discriminatory 
power almost equal to that of both techniques combined however it produced 
more clustered isolates. VNTR-MIRU-15 was useful in sub-dividing type 9 
spoligotypes: 15 isolates were sub-divided into 14 different subtypes suggesting 
VNTR-MIRU-15 would be more useful for epidemiological studies than 
spoligotyping or VNTR-ETR. 
Apart from one exception, there was no epidemiological evidence to support the 
four clusters linked by VNTR-MIRU-15. The epidemiologically linked cluster 
contained two siblings involved in the farm outbreak of M. bovis (described on 
page 103). Of the three remaining VNTR-MIRU-15 clusters, only one contained 
isolates with the same spoligotype (type 9). The remaining two clusters were, in 
each case, composed of one isolate with a known pattern and one with a pattern 
not previously seen in the UK. 
5.4 Discussion 
Although the number of bacteriological conformed cases of TB caused by M. 
bovis remains small in the UK, it is important to continue to monitor bovine TB 
in humans. This is particular important in those who are at high risk of primary 
infection such as agricultural and abattoir workers. The increasing popularity of 
holidays in parts of the world where M. bovis disease in animals is common 
(transmission can occur through the consumption of unpasteurised milk and 
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cheese) provides another source of infection. Within the UK, high rates of bovine 
TB in cattle could potentially increase the risk of transmission to humans, 
therefore a strict test and slaughter policy, systematic inspection of meat 
carcasses and the monitoring of cattle movement are essential. In addition the 
adequate pasteurisation of milk for human consumption remains a corner stone 
of public health control. 
A combination of spoligotyping and VNTR-ETR is an efficient discriminatory 
tool for the molecular surveillance of M. bovis and also addresses the problem of 
analysing isolates with single copies of IS6110. The most frequently observed 
spoligotype in humans in the UK was type 9 which is also the most frequently 
seen in cattle. This spoligotype was sub-divided by VNTR-ETR into 6 different 
types. The geographical distribution of VNTR-ETRs in M. bovis isolates with the 
most frequently observed spoligotype patterns (type 9 and type 17) in Great 
Britain, suggests that M. bovis has undergone a series of clonal expansions 
(Smith et al. 2003). Only one type 17 spoligotype was seen in this study, whereas 
type 9 spoligotypes were observed in 30% of isolates. The type 9 strains included 
VNTR-ETR patterns 6554 and 7554 (ETR A to D) of which the former is the 
most frequently seen in isolates with type 9 spoligotypes and latter is thought to 
be the ancestral type due to its wide distribution (Smith et al. 2003). 
The application of VNTR-MIRU has shown a high level of discrimination in this 
M. bovis population and was able to sub-divide the most prevalent spoligotype - 
type 9. However two VNTR-MIRU clusters were sub-divided by spoligotyping. 
As both techniques analyse different parts of the genome it is difficult to 
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decipher which is the more accurate. Spoligotyping (as seen with the type 9 
isolates) tends to group isolates together which may not be linked. Conversely it 
is possible that the discriminatory power of VNTR-MIRU may be too high 
resulting in the break up of clusters that are linked. Evidence in this population, 
however, shows this is unlikely as the epidemiologically confirmed cluster was 
not sub-divided. Indeed in a study of M. tb isolates all RFLP-IS6110 and 
epidemiologically linked isolates were clustered by VNTR-MIRU (Kwara et al. 
2003). VNTR-MIRU also has the advantage of analysing multiple loci situated 
around the genome and therefore each locus is unlikely to be subjected to the 
same selection pressures i. e. VNTR-MIRU may reflect a fairer picture compared 
to spoligotyping which only analyses one locus. 
VNTR-MIRU has proven to be a good technique for the analysis of M. bovis 
isolates. As a PCR-based technique, VNTR-MIRU is rapid and requires only 
small amounts of DNA. Furthermore, VNTR-MIRU-15 has a higher 
discriminatory power then many of the other commonly used PCR techniques 
therefore VNTR-MIRU-15 alone or in combination with spoligotyping should be 
the method of choice for studying M. bovis in human isolates. It is also highly 
likely that the VNTR-MIRU-15 technique would be far superior to the currently 
used spoligotyping or VNTR-ETR strategies employed for investigating animal 
or veterinary transmission. 
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CHAPTER 6.0 Phylogenetic analysis of Mycobacterium tuberculosis complex 
6.1 Introduction 
The advent of molecular techniques has dramatically increased our 
understanding of the transmission and dissemination of M. tb but despite these 
advances the evolution of this organism is still poorly understood. 
Genotyping techniques based on neutral genetic variation such as multilocus 
sequence typing (MLST) have been successfully used to characterise bacterial 
populations (Maiden et al. 1998, Enright et al. 1998, Dingle et al. 2001, 
Gutacker et al. 2002, Baker et al. 2004). Although the M. tb genome is thought to 
be highly conserved (Sreevatsan et al. 1997 and Musser et al. 2000), sufficient 
neutral variation in the form of silent single nucleotide polymorphisms (sSNPs) 
was found in M. tb complex isolates from which a robust phylogenetic tree was 
constructed (Baker et al. 2004). The tree demonstrated that M. tb is clonal and can 
be sub-divided into 4 distinct lineages while M. bovis is closely related but found 
on a separate branch. The tree also accommodated other phylogenetic groupings 
including genetic groups 1 to 3 (Sreevatsan et al. 1997) and the M. tb specific 
deletion (TBD1) (Brosch et al. 2002). IS6110 and spoligotyping families such as 
Beijing, Haarlem, Central Asian (CAS), Delhi and East African-Indian (EAI) 
families all appeared exclusively on different branches of the tree. 
Variable Number Tandem Repeat - Mycobacterial Interspersed Repetitive Units 
(VNTR-MIRU) is a high-throughput technique which analyses the number of 
tandem repeats at loci distributed around the M. tb genome (Supply et al. 2001). 
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Studies have explored VNTR-MIRU as a tool for discriminating between strains 
and in comparison with other molecular techniques (Cowan et al. 2002, Hawkey 
et al. 2003, Kwara et al. 2003, Roring et al. 2004 and Supply et al. 2001) but 
there is less published data using VNTR-MIRU to study the evolution of the Mtb 
complex. VNTR using 5-loci and 12-loci MIRU have been used in combination 
with other techniques such as spoligotyping to investigate the evolution of M. tb 
complex (Ferdinand et al. 2004, Kam et al. 2005 and Sola et al. 2001 a), but none 
have utilised 15-loci VNTR-MIRU to define evolutionary pathways 
characterised by sSNP analysis. 
Based on the sSNP-defined phylogenetic tree (Baker et al. 2004) this study 
aimed to evaluate the use of VNTR-MIRU, commonly used in epidemiological 
investigations, as a rapid tool for the phylogenetic classification of M. tb and M. 
bovis. Validation of the VNTR-MIRU phylogenetic classification was achieved 
by characterising an additional panel of M. tb and M. bovis strains with a sSNP 
macroarray tool (the development of which is described in section 6.2.2) and 
examining the concordance with VNTR-MIRU. 
6.2 Study design 
6.2.1 Mycobacterial strains 
A panel (panel 1- test population) of 312 Mtb clinical isolates collected in 
England and Wales between Vt January and 31" December 1998 included all 
isolates resistant to one or both of the first-line antituberculous drugs (isoniazid 
and rifampicin), 100 randomly chosen fully susceptible isolates and in addition 
four M. bovis isolates (Baker et al. 2004). These isolates were typed initially with 
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VNTR-MIRU-12 then supplemented with ETR A, B and C (VNTR-MIRU-15) 
(Materials and Methods 2.5.2). All members of this panel had previously been 
classified into one of five lineages according to the presence of characteristic 
sSNPs (Baker et al. 2004). The laboratory reference strain Mtb H37Rv (which 
had been characterised by sSNP analysis) was also VNTR-MIRU typed. 
A second panel (panel 2) of 205 isolates which included 80 Mtb isolates 
identified in England and Wales in 1998 but not previously analysed by Baker et 
al. and 80 M. tb isolates identified in England and Wales in 2004 were analysed 
with VNTR-MIRU-15. Two different time windows, 1998 and 2004 were chosen 
to ensure that the results seen were reproducible and not unique to 1998, the year 
from which panel 1 strains were isolated. The M. tb isolates were all randomly 
chosen from 1998 and 2004. An additional 45 M. bovis isolates from a panel 
previously described in chapter 5 and by Gibson et al. (2004) were also analysed 
(the original four M. bovis from Baker et al. (2004) were drawn from this panel). 
Panel 2 was characterised with a macroarray developed in this study (see section 
6.2.2) to define sSNPs seen in each of the five lineages. Sequencing these 
additional isolates to obtain sSNP data would have been very resource-intensive 
so a macroarray was developed for the rapid classification of these isolates into 
one of the five lineages. 
Validation was performed blinded. Results were only compared once a lineage 
based on each technique had been determined. The macroarray was validated on 
a sub-panel of 46 previously genotyped isolates from panel 1. 
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6.2.2 Development of a macroarray to identify sSNPs 
A combination of four sSNPs within three genes; oxyR-37, katG-87, rpoB-2464 
and -3243 were able to define all five lineages (Baker et al. 2004). 
Primers flanking each of the four sSNPs and probes targeting each sSNP site 
were designed. Both primers and probes were based on the DNA sequences of 
M. tb H37Rv and CDC1551 and checked for homology to other DNA sequences 
in the M. tb / M. bovis genome using BLAST (www. ncbi. nlm. nih. ogv). 
Wild-type (wt) (M. tb H37Rv sequence) and mutant-type (mt) (corresponding to 
the sSNPs defining each of the lineages described by Baker et al. 2004) probes of 
between 18 and 25 bases long were initially designed with the target sSNP, if 
possible, in a central position. If no hybridisation signal was observed the sSNP 
was moved to either end of the probe, but never within three bases of the end, 
until a hybridisation signal was observed. To optimise probe performance a poly- 
T tail of 10 bp was added. 
The final macroarray method is described in Materials and Methods 2.8 and each 
of the probes tested in the following experiments is listed in Appendix 6. A series 
of experiments were performed to optimise the method for detecting the target 
sSNPs in this study and are described below. 
Each probe was tested separately by blotting three dots onto a membrane using a 
pipette tip. Wild-type probes were tested using M. tb H37Rv (a lineage II isolate) 
and mt probes were tested with one clinical isolate corresponding to each of the 
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four remaining lineages. The four regions containing the sSNPs of interest 
(described in Material and Methods 2.8.1) were amplified in one isolate from 
each of the five lineages. After amplification 12 µl of each PCR product 
corresponding to one isolate from each of the five lineages was denatured using 
an equal amount of denaturing solution (400mM NaOH, 20mM EDTA) for 5 
mins. The denatured solutions were incubated in separate tubes containing a 
membrane and hybridisation solution (5x SSPE, 0.5% SDS) for 1 hr at 60°C. 
Details of the hybridisation and detection protocol are detailed in Material and 
Methods 2.8.5 and 2.8.6 (N. B. Material and Methods 2.8.5 gives a final method. 
In the preliminary experiments 0.4X SSPE was used in the stringent wash 
buffer). Once a hybridisation signal was observed for each wt and mt probe the 
PCR products (i. e. four for each isolate) were combined to ascertain whether they 
would perform well together. To test this, a membrane containing all eight 
probes (4 wt and 4 mt) was designed (Material and Methods 2.8.3). 
The four regions containing the sSNPs of interest (described in Material and 
Methods 2.8.1) were amplified in one isolate from each of the five lineages. 
After amplification 12 µl of each of the four PCR products corresponding to one 
isolate from each lineage was combined and incubated with a membrane 
containing all wt and mt probes. The hybridisation and detection procedure 
remained the same. No hybridisation signals were observed after completion of 
the experiment (results not shown). The concentration of NaOH was possibly too 
high for hybridisation to occur compared to the conditions when the probes were 
analysed separately (48 pl of NaOH versus 12 µl respectively). Solutions to this 
problem included using less DNA (hence reducing the amount of NaOH added) 
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or to denature the DNA using heat rather than chemicals. The experiment was 
repeated under three different conditions: 1) 2 µl of each PCR product plus 8 µl 
of denaturing solution, 2) 2 pl of each PCR product. Denature DNA at 100°C for 
10 mins and 3) 12 pl of each PCR product. Denature DNA at 100°C for 10 mins. 
This time only M ab H37Rv was tested as the aim was to determine which 
denaturising condition produced the best results. All three conditions gave 
hybridisation signals (Figure 6.1). Condition 3 gave the strongest hybridisation 
signal while chemical denaturation gave the weakest signal. Heat denaturation of 
12 pl of each of the four regions of interest (containing the sSNPs) was used in 
all future experiments. 
Using this method hybridisation of M. tb H37Rv DNA was observed at both the 
wt and mt probes at all sSNP sites. As M. tb H37Rv is a wt strain, hybridisation 
should only be observed at wt probes. The stringency of the washing conditions, 
e. g. by changing the temperature or the salt concentration at the 
hybridisation/washing phase, was altered to improve specificity. 
A titration of salt concentrations was set up from 1X to 0.4X SSPE at 0.2X 
intervals then from 0.4X to O. 1X SSPE at 0.1X intervals as salt concentration 
could be controlled more accurately than temperature (the temperature of 
hybridisations ovens can vary). For this experiment clinical isolates from each of 
the four lineages (I, III, IV and M. bovis) were analysed in additional to M. tb 
H37Rv (a lineage II strain) in order to determine the optimum washing 
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development -o 40 
control 
DNA amplification of the four gene regions (used to differentiate between the 5 
lineages) was performed using M. tb H37Rv (i. e. the wild-type strain). The PCR 
products were combined and incubated with I of 3 membranes corresponding to 
1 of the 3 different denaturing conditions (detailed below). 
a Condition 1-2 µl of each PCR product plus 8 gl of denaturing solution. 
Condition 2-2 µl of each PCR product. Denature DNA at 100°C for 10 mins. 
Condition 3 -12 gl of each PCR product. Denature DNA at 100°C for 10 mins. 
The single spot in the first row corresponds to the colour development control 
followed by four rows of wt (left hand side) and mt probes (right hand side) for 
each gene; oxyR-37, katG-87, rpoB-2646 and rpoB-3243 respectively. NB. The 
wt and mt probes for rpoB - 3243 were reversed in this experiment only. 
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conditions. In this experiment the expected hybridisation patterns for each 
lineage are described in table 6.1. 
Table 6.1 Hybridisation patterns corresponding to the sSNPs defining each 
lineage 
Lineage Probes 
OxyR-37 OxyR- KatG-87 KatG- RpoB- RpoB- RpoB- RpoB- 
37°" 87" 2646 2646" 3243 3243" 
I x VO x VO xxV 
II x '0 
1 
x Vxx 
III WO x VO 
Ix 
xxV 
IV x VO V x xx 
40 x x %0 %0 xx M. 
bovis 
m` - mutant type 
/x - positive/negative hybridisation signal 
The results showed that 1X to 0.6X SSPE gave strong hybridisation signals but 
no differentiation between wt and mt probes (results not shown). A concentration 
of 0.4X and 0.3X SSPE gave strong hybridisation signals but variable 
discrimination between wt and mt probes whereas 0.2X and O. 1X SSPE gave 
better discrimination between wt and mt probes but fainter hybridisation signals 
(results not shown). 
As some probes worked well at one salt concentration but not another further 
changes would have been counter-productive as increasing stringency to increase 
specificity would result in those probes with weaker hybridisation signals 
disappearing. For this reason all probes were re-designed. The probes were kept 
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as short as possible to try and increase specificity by making them less stable 
during washing and a longer poly-T tail (20bp) was added to increase adhesion. 
Several batches of new probes were designed and tested at 0.1X, 0.2X, 0.3X and 
0.4X SSPE. Figure 6.2 shows the results for 0.2X, 0.3X and 0.4X SSPE. 
Figure 6.2 Stringency titration using 0.2X, 0.3X and 0.4X SSPE 
0.2 x 0.3 X 
a Corresponds to M. tb lineage Ito IV. B=M. bovis 
I II III IV Ba 
0.4 X 
DNA amplification of the four gene regions was performed using an isolate from 
each of the 5 lineages. For each lineage the appropriate PCR products were 
combined and incubated with a membrane. 
The single spot in the first row corresponds to the colour development control 
followed by four rows of wt (left hand side) and mt probes (right hand side) for 
each gene; oxyR-37, katG-87, rpoB-2646 and rpoB-3243 respectively. The 
expected hybridisation patterns are shown in table 6.1. 
I II III IV Ba 





I II III IV Ba 
Salt concentrations of 0.3X and 0.4X SSPE gave good discrimination between wt 
and mt probes and the strongest intensity of hybridisation signal. In future 
experiments 0.3X SSPE was used. 
At this stage an isolate belonging to any of the five lineages could be 
differentiated on the basis of the hybridisation signals observed, however, 
isolates belonging to lineage IV and III (which have mutations at oxyR-37 and 
rpoB-2646 respectively) hybridised to both the mt and wt probes accordingly. 
Isolates belonging to lineage I, II and M. bovis all have wt sequences at these 
positions and only hybridised to the wt probe. Although mutant strains of oxyR- 
37 and rpoB"2646 hybridised to both mt and wt probes differentiation could still 
be achieved. However, the aim of the macroarray was for each strain tested to 
hybridise to either the wt or mt target. To improve the specificity a mismatch was 
added to the wt probe of these two targets in order to destabilise the DNA duplex. 
Any partial hybridisation of a mt strain should be unstable (as the wt probe would 
contain two mismatches) and easily removed during washing. A G-T mismatch 
was used as this base combination has the weakest bond therefore a wt strain 
should still hybridise to the wt probe. This approach was successful with 
hybridisation occurring at either the wt or mt probe at each target (Figure 6.3). 
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Figure 6.3 Hybridisation patterns corresponding to the sSNPs defining each 
lineage 
Lineage I II III IV M. bovis 
AMMONIUM& 





0".. 0 0 
Orientation of probes from left to right and top to bottom: ink spot; colour 
development control; 4 blanks; oxyR-37 wild type (wt); oxyR-37 mutant type 
(mt); katG-87wt; katG-87mt; 4 blanks; rpoB-2646wt; rpoB-2646mt; rpoB-3243wt 
and rpoB-3243mt. NB. Blank spaces were included to extend the length of the 
macroarray for ease of handling. (A table showing orientation of probes can be 
found in Material and Methods 2.8.3). 
Isolates from each of the five lineages were amplified to demonstrate the 
hybridisation pattern for each lineage. M. tb H37Rv is a lineage II isolate, hence 
hybridisation at all four wt probes. The expected hybridisation patterns are shown 
in table 6.1. 
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6.3 Results 
6.3.1 VNTR-MIRU analysis of panel 1 
The panel of 312 M. tb isolates (panel 1) which had been characterised by sSNP 
analysis into four lineages plus M. bovis (Baker et al. 2004) was VNTR-MIRU- 
12 typed. Figure 6.4 displays the five main lineages and sub-lineages based on 
225 isolates with complete sequencing data. The remaining 87 isolates could be 
assigned to one of the 5 main lineages, but not a sub-lineage, using partial 
sequencing data. VNTR-MIRU profiles were obtained from 309/312 (99.0%) of 
M. tb isolates and 4/4 (100%) of M. bovis isolates. These isolates were examined 
to identify if any single VNTR-MIRU polymorphism or combination of 
polymorphisms were common to each lineage and could potentially be used to 
define each lineage. 
Figure 6.4 Phylogenetic tree based on sSNPs in 225 isolates with completed 




























N. B. The synonymous sequence 
types are marked 1-34. 










Analysis of VNTR-MIRU profiles showed that the allelic diversity at certain loci 
was conserved while others varied considerably (Table 6.2). This was observed 
both within a lineage and between each lineage. 
Table 6.2 Range of repeat numbers observed at loci within each lineage 
Locus Range of repeat no No of repeats observed within each lineage 
I II III IV 
2 1-5 2 1-4 1-4 1-5 
4 1-9 2 1-8 1-2 2-9 
10 2-7 3-6 2-7 2-7 2-7 
16 0-5 1-4 1-5 2-5 0-4 
20 1-3 1-2 1-3 1-2 1-2 
23 1-11 5-6 1-6 3-5 2-11 
24 1-2 1 1-2 1 2 
26 1-12 5-8 1-9 1-12 1-2 
27 1-7 1-7 1-4 1-3 1-6 
31 1-7 4-6 1-5 4-6 3-7 
39 1-4 2-4 1-3 1-4 1-4 
40 0-7 1-4 1-7 1-6 0-5 
A 1-11 3-4 1-11 1-9 1-10 
B 1-10 2 1-3 1-5 1-10 
C 1-5 4 1-5 2 1-5 
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No single polymorphism was able to define each lineage; instead a combination 
of polymorphisms were used to classify each phylogenetic branch (Table 6.3). 
For example, in lineage I the majority of isolates (90%) contained three copies of 
MIRU-10, five or seven copies of MIRU-26 (90%) and three copies of MIRU-39 
(90%). None of these markers could be used to define lineage I alone as these 
repeat numbers were observed in other lineages. By combining these 
polymorphisms a VNTR-MIRU phylogenetic code was created which could 
define 80% of lineage I isolates. The same analysis was carried out on the other 
three lineages and M. bovis isolates. 
Lineage IV was highly conserved and 92% of isolates contained the VNTR- 
MIRU phylogenetic code defining their group i. e. two copies of both MIRU-24 
and -26. The high allelic diversity in lineage II and III resulted in a low number 
of isolates containing the lineage-defining polymorphisms, 70% and 52% 
respectively. M. tb H37Rv, which belongs to lineage II, also displayed a lineage II 
code. M. bovis isolates were highly conserved. All isolates contained the three 
polymorphisms defining this group, however, only 4 isolates were examined 
therefore analysis of a larger panel of isolates would be needed to validate this 
VNTR-MIRU code (see section 6.3.2). 
Interestingly, the polymorphic codes were almost exclusive. The codes defining 
lineage II and IV were not observed in any isolates from other lineages. The 
code for lineage I was seen in one isolate in lineage III and the code for lineage 
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Table 6.3 VNTR-MIRU loci and repeats common to each of the 4 M. tb and M. 
bovis lineages based on VNTR-MIRU-12 
Lineage VNTR- No of No of isolates Total no of isolates 
(Total MIRU repeats containing with all 
No) locusa observedb polymorphisms° polymorphismsd 
Lineage 10 3 18/20 (90%) 16/20 (80%) 
I 26 5,7 18/20 (90%) 
(20) 39 3 19/20(95%) 
Lineage 26 1,4,5 146/166 (88%) 115/165 (70%) 
II 31 3 145/163 (89%) 
(168) 39 2 162/165 (98.1%) 
Lineage 16 4 48/62 (77%) 32/61 (52%) 
III 39 3 54/62 (87%) 
(62) 40 3 45/61 (74%) 
Lineage 24 2 59/61 (97%) 57/62 (92%) 
IV 26 2 58/62(94%) 
(62) 
M. 4 3 4/4 (100%) 4/4 (100%) 
bovis 10 2 4/4 (100%) 
(4) 40 2 4/4(100%) 
a VNTR-MIRU loci containing little or no variation in each lineage. b Most 
common repeat number observed at these loci and ° the percentage of isolates 
containing the repeat number. 
d The percentage of isolates containing the combination of polymorphisms 
(described in a, b and °) used to classify each phylogenetic branch. 
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III was seen in one isolate from lineage I and in three isolates in lineage IV. The 
M. bovis code was unique to M. bovis and was not observed in any M. tb isolates. 
6.3.2 Addition of exact tandem repeat (ETR) loci 
To try and improve the VNTR-MIRU phylogenetic codes, three additional 
repeat loci were analysed; exact tandem repeat (ETR) A, B and C from the 
original 5 loci VNTR method (Frothingham and Meeker-O'Connell 1998) 
giving 15 loci (VNTR-MIRU-15). The two remaining ETRs D and E were 
already included in the initial panel of 12-MIRU (ETR-D is MIRU 4 and ETR-E 
is MIRU 31). Improving the phylogenetic code relies on loci containing little 
variation within a lineage but enough variation between each lineage to separate 
them from each other. The main aim of this investigation was to produce a code 
that was able to define the majority of isolates in each lineage with the least 
number of markers. 
The addition of the three ETRs increased the proportion of definable isolates in 
all lineages except lineage IV. In lineage I the majority of isolates (95%) 
contained four copies of ETR-A and all isolates contained 4 copies of ETR-C 
(Table 6.4). Unfortunately these two markers alone could not be used to define 
lineage I as this combination was observed in isolates from other lineage, 
therefore these markers were combined with the original code to determine the 
best combination of polymorphisms which would define the most isolates. 
Supplemented with MIRU-39 from the original VNTR-MIRU code, 90% of the 
isolates in lineage I contained all three polymorphisms. This was a 10% 
125 
improvement on the original coding. The same principle was performed for the 
other lineages. 
In lineage II the ETR loci were highly polymorphic. Identifying a single 
defining allele was difficult; instead a combination of 1 or 2 copies of ETR-B 
was used and this was able to define 98.1% of the lineage. When this marker 
was added to the original code only the addition of MIRU-39 was able to 
improve the percentage of definable isolates; however, these 2 markers were 
observed in several isolates from other lineages indicating that another marker 
was required. The addition of MIRU-26 and -31 actually reduced the number of 
isolates the code could define therefore a new marker was sought. MIRU-16 
showed the most potential as 98.2% of isolates contained one, two or three 
copies of this MIRU. When combined with ETR-B and MIRU-39,92.7% of 
isolates were definable which was a 22.7% increase on the original coding. 
Two copies of ETR-C were observed in 100% of isolates in lineage III, however, 
none of the original markers when added to ETR-C improved the phylogenetic 
code. Instead, five copies of MIRU-23 combined with one copy of ETR-C were 
able to define 98.4% of isolates. This was a remarkable improvement on the 
original code which only defined 52% of isolates. 
In lineage IV all of the ETRs were very polymorphic and so of little additional 
value; the original code was therefore retained. 
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Table 6.4 VNTR-MIRU loci and repeats common to each of the 4 Mtb and M. 
bovis lineages based on VNTR-MIRU-15 
Lineage VNTR-MIRU loci (n of isolates with Observed in other lineages? 
correct repeat no) 
1(20) 39 -3 (19/20 =95%) 2 isolates in lineage IV. 
A-4(19/20=95%) 
C-4 (20/20 = 100%) 
39-3+A-4+C-4=(18/20=90%)a 
11 (168) 16 - 1,2,3 (164/167 = 98.2%) 2 isolates in lineage IV 
39-2(160/167=95.8%) 
B-1,2 (162/165 = 98.1) 
16 -1,2,3 + 39 -2+B -1,2 = (153/166 
= 92.7%) 
111 (62) 23 -5 (61/62 = 98.4%) 1 isolate in lineage IV and 
C-2 (62/62 =100%) 1 isolate in lineage II. 
23-5+C-2=(61/62=98.4%) 
IV (62) 24 -2 (61/61 =100%) Not seen in any other 
26 -2 (60/62 = 98.8%) lineage 
24-2+26-2=(59/61 =96.7%) 
M. 10-2 (4/4 = 100%) Not seen in any other 
bovis 40-2 (4/4 = 100%) lineage 
(4) C-5 (4/4 =100%) 
10-2+40-2+C-5 = (4/4 = 100%) 
a Combined polymorphism can be used to define each lineage 
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In M. bovis only ETR-C was conserved with 100% of isolates containing five 
copies which was the same level of discrimination as that given with MIRU-4. 
ETR-C is used to define other lineages whereas MIRU-4 is not therefore it 
would be beneficial to use ETR-C rather than MIRU-4 in order to keep the total 
panel of lineage-defining VNTR-MIRU as small as possible to ensure costs and 
analysis time are kept to a minimum. However this code needs to be applied to 
the additional M. bovis isolates (panel 2) to determine if it is robust as only 4 
isolates were tested. 
Six isolates possessed VNTR-MIRU polymorphisms associated with more than 
one lineage. In all cases the isolates possessed the characterising VNTR-MIRU 
phylogenetic code consistent with the sSNP defined lineage plus polymorphisms 
associated with another lineage (Table 6.4). 
6.3.3 Macroarray analysis 
The macroarray (for development see section 6.2.2, for final method see Material 
and Methods 2.8) was validated using a subset of 46 strains belonging to panel 1. 
The macroarray and original sSNP results were concordant, i. e. the macroarray 
correctly identified the lineage of each isolate based on the detection of probe- 
defined sSNPs. 
6.3.4 VNTR-MIRU analysis of panel 2 
In order to validate the VNTR-MIRU codes defined in the test population, panel 
2 (205 isolates) was VNTR-MIRU-15 typed and analysed for sSNPs with the 
macroarray. Overall there was 88.9% concordance between the lineage of 
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isolates defined by the macroarray and VNTR-MIRU. Within the M. tb lineages 
the level of concordance varied from 81.3% to 100% (Table 6.5). 
The code for M. bovis (2 copies of MIRU-10 and MIRU-40 and 5 copies of ETR- 
C) was based on only 4 isolates. The analysis was extended to an additional 45 
isolates (panel 2) from the human M. bovis isolates described in chapter 5 and in 
Gibson et al. 2004. (The original 4 isolates in the Baker et al. (2004) panel plus 
these additional 45 isolates comprised the 49 isolates described in Chapter 5). 
The applicability of the code was reduced from 100% to 88.9% when the 
additional 45 isolates were added, indicating that the code was not as robust as it 
first appeared but still gave a good level of discrimination. 
Table 6.5 The number of isolates in panel 2 belonging to each lineage according 
to the macroarray and its concordance with the VNTR-MIRU phylogenetic codes 







I 16 13/16 (81.3) 3(18.8) 
II 79 68/79 (86.1) 11 (13.9) 
III 38 38/38 (100) 0(0.0) 
IV 27 23/27 (85.2) 4(14.8) 
M. bovis 45 40/45 (88.9) 5 (11.1) 
Total 205 182 (88.8) 23 (11.2) 
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6.3.5 Total panel analysed by VNTR-MIRU 
Combining panel 1 and 2 gave 518 isolates (465 M. tb and 49 M. bovis) analysed 
with both VNTR-MIRU and sSNPs (DNA sequencing or the macroarray). 
Overall, there was 90.9% concordance between lineage-defined VNTR-MIRU 
phylogenetic codes and sSNP-defined lineages. The number of definable isolates 
varied from 86.1 to 99.0% in M ab and was 89.8% in M. bovis isolates (Table 
6.6). 
Table 6.6 The number of isolates belonging to each lineage according to sSNP 
analysis and its concordance with VNTR-MIRU for all M. tb and M. bovis 
isolates tested 




I 36 31 (86.1) 
II 245 220 (89.8) 
III 100 99 (99.0) 
IV 88 77 (87.5) 
M. bovis 49 44 (89.8) 
Total 518 471 (90.9) 
a Total number of isolates tested (excludes 3 isolates from panel 1 that did not 
amplify) 
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6.3.6 Discrepant results 
As sSNPs display neutral variation they are unlikely to be under any selection 
pressures. The sSNPs discussed here are concordant with other genetic and 
phenotypic groupings (including genetic groups 1 to 3, M. tb specific deletion, 
spoligotyping and IS6110 families) (Baker et al. 2004) and therefore they are 
likely to be definitive. Any disagreement with the sSNP-defined lineages was 
considered as discrepant. Overall, 47 (9.1%) discrepant results were observed i. e. 
the VNTR-MIRU code did not match the lineage defined by sSNP analysis 
(Table 6.7). Of these, 42 were M ab isolates and the remaining 5 were M. bovis 
isolates. Of the M. tb isolates, 27/42 (64.3%) did not match any of the defined 
VNTR-MIRU codes. These isolates differed in repeat number at one or two loci 
to one of the VNTR-MIRU phylogenetic codes. In each case this matched the 
lineage defined by sSNP analysis. For example, five isolates grouped as lineage 
II discrepancy `b' had a similar VNTR code to lineage II except that MIRU-39 
possessed one copy instead of two copies. Three isolates grouped as lineage II 
discrepancy `g' contained five copies of MIRU-16 and three copies of ETR-B as 
opposed to the predicted one, two or three copies of MIRU-16 and one or two 
copies of ETR-B. The allelic diversity at the discrepant loci in all lineages 
displayed a stepwise trend. For example, discrepant isolates `b' to `e' in lineage 
II contained either 1 or 3 copies of MIRU-39 instead of 2 copies and discrepant 
isolates `g' and `i' contained three copies of ETR-B instead of 1 or 2 copies. 
These discrepancies support the presence of sub-lineages within lineage II. 
Twelve M. tb isolates had VNTR-MIRU codes for two lineages. Three isolates 
defined as lineage II by sSNP analysis had the VNTR-MIRU code for both 
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Table 6.7 Discrepancies observed in each lineage (total population of 518 
isolates) 
Lineage Defined MIRU- 
VNTR loci & 
repeat no 
Discrepancy Discrepant MIRU-VNTR 
code(s)a 
No. of times 
observed 
I 39-3 a 39-2, A-3, C-4 + code for II 1 
A-4 b 39-2, A-4, C-4 + code for II 2 
C-4 c 39-3, A-3, C-4 1 
e 39-4, A-4, C-4 1 
II 16 -1,2,3, 
39 - 2, 
a Codes for lineage II and III 
present 
3 
B -1,2 b 16-3,39-1, B-2 5 
c 16-3,39-1, B-1 2 
d 16-1,39-3, B-1 1 
e 16-3,39-3, B-2 4 
f 16-4,39-2, B-2 4 
g 16-5,39-2, B-3 3 
h 16-1,39-2, B-3 2 
i 16-3,39-2, B-3 1 
III 23 - 5, C-2 a 23-3, C-2 1 
IV 24-2 
26-2 
a Codes for lineage I and IV 
present 
6 
b Codes for lineage II and IV 
present 
2 
c Codes for lineage III and 
IV present 
1 
d 24-2,26-1 2 
M. 10-2 a 10-2,40-2, C-2 1 
bovis 40-2 b 10-2,40-2, C-3 1 
C-5 c 10-2,40-2, C-4 1 
d 10-6,40-2, C-4 1 
e 10-2,40-3, C-5 1 
a Discrepant loci are highlighted in bold 
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lineage II and III and nine isolates defined as lineage IV had the code for this 
lineage plus another M. tb lineage code. The phylogenetic code for lineage IV 
was exclusive and not observed in any other lineage therefore it seems that any 
discrepant isolate containing the VNTR-MIRU code for lineage IV should be 
designated a lineage IV strain. However the VNTR-MIRU code for lineage II 
was not exclusive making it difficult to distinguish which lineage these isolates 
belong to. Only 3/245 (1.2%) isolates in lineage II had two codes therefore the 
chances of this occurring are probably low. Interestingly, if the code for lineage 
II is modified by only counting two copies of ETR-B instead of one and two 
copies, then the code becomes highly conserved and is not observed in any other 
lineage. However, the increase in specificity is outweighed by the loss in 
sensitivity reducing the proportion of isolates defined from 92.7% to 76.3%. 
The remaining three M. tb discrepant strains were defined as lineage I according 
to sSNP analysis but all had the lineage II code and a partial code for lineage I. 
All three had a Beijing spoligotype, i. e. spacers 1-34 absent, 35-43 present, and 
may represent evolutionary intermediates. 
Of the discrepant M. bovis isolates all five had different codes. Again a step-wise 
trend was seen in the discrepant isolates. For example, two, three, four and five 
copies of ETR-C were observed. 
Panel 2 was comprised of 80 M. tb isolates from 1998 and 80 from 2004 in order 
to confirm the phylogenetic analysis was reproducible and not unique to 1998. 
The number of discrepant isolates in 2004 in each lineage was less in most cases 
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than the number seen in 1998 (Table 6.8) suggesting that the phylogenetic codes 
are robust and reproducible through time. 
Table 6.8 Number of discrepant isolates in 1998 and 2004 
Lineage No of discrepant 
isolates in 1998 
(n = 389) 
No of discrepant 
isolates in 2004 
(n = 80) 
Rates Ratio (95% 
confidence interval) 
I 2 3 0.13 (0.02 - 0.81) 
II 21 3 1.44 (0.44 -4.71) 
III 1 0 - 
IV 9 2 0.93 (0.20 - 4.20) 
The difference in the number of discrepant isolates was not significant in any 
lineage except lineage I. Discrepant isolates were 0.13 times less likely in this 
lineage in 1998 than in 2004. 
6.3.7 Indeterminate isolates 
Four isolates not assigned a lineage in the Baker et al., panel because of 
incomplete MLST data were analysed by VNTR-MIRU to determine whether 
they could be classified using these codes. Three isolates had the VNTR-MIRU 
code for lineage II but none of the other codes. The remaining isolate had three 
copies of MIRU-39 and four copies of ETR-C but five copies of ETR-A rather 
then four which is seen in the code for lineage 1. This isolate did not have a 
VNTR-MIRU profile matching any of the other phylogenetic codes. sSNP 
macroarray analysis confirmed that three of the isolates were indeed from lineage 
II and the remaining isolate was from lineage I. 
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6.3.8 Clustering of M. tb for molecular epidemiological analysis 
6.3.8.1 VNTR-MIRU-12 
VNTR-MIRU profiles from the 518 M tb and M. bovis isolates (panel 1 and 2) 
were compared using a categorical similarity coefficient and displayed using an 
UPGMA dendrogram. The reason for this analysis was to determine if the 
VNTR-MIRU phylogenetic codes would be useful for molecular epidemiological 
investigations i. e. if clusters were confined to one lineage. Cluster analysis based 
on 12-loci produced 76 clusters containing between 2 and 17 isolates (Figure 
6.5). The majority of clusters (56.6%) contained just 2 isolates. Each cluster 
contained isolates from only one lineage, with 3 exceptions: one cluster of ten 
isolates contained one isolate from lineage III and the remaining nine isolates 
from lineage I. One cluster of eleven isolates contained one isolate from lineage 
IV and the remaining ten isolates from lineage II and finally one cluster of 
seventeen isolates contained one isolate from lineage I and the remaining sixteen 
isolates from lineage III. 
6.3.8.1 VNTR-MIRU-15 
In comparison to the discriminatory power of VNTR-MIRU-12, VNTR-MIRU- 
15 reduced the number of clusters from 76 to 65. Clusters contained between 2 
and 10 isolates and all but one belonged to the same lineage, therefore VNTR- 
MIRU-15 appears to be more discriminatory than VNTR-MIRU-12. This cluster 
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six isolates belonged to lineage II. This cluster was part of an original cluster of 
eleven isolates produced by VNTR-MIRU-12 analysis but was sub-divided into 
two clusters when ETR-A, -B and -C were added. The addition of the three ETRs 
either sub-divided clusters, demonstrated by the smaller cluster sizes compared 
to VNTR-MIRU-12, or removed them altogether by generating unique VNTR- 
MIRU profiles. For example the number of clusters containing two isolates 
reduced from 43 to 37 clusters with the addition of the three ETRs. This analysis 
shows VNTR-MIRU-15 is more discriminatory then VNTR-MIRU-12 and that 
the VNTR-MIRU phylogenetic codes identified are indeed useful for 
epidemiological studies as clusters appear to be contained within separate 
lineages. 
6.3.9 VNTR-MIRU discrimination 
Once a population of strains have been assigned to a lineage, it would be useful 
for epidemiological studies to be able to sub-divide lineages into 
epidemiologically linked and unique isolates. The discriminatory power of each 
VNTR-MIRU locus was examined and a specific set of VNTR-MIRU capable of 
sub-dividing each lineage was determined (Table 6.9). A combination of six loci 
(MIRU-16, -26, -27, -31, -20 and ETR-A) when applied to lineage I isolates were 
able to generate the same degree of discrimination as VNTR-MIRU-15. The 
number of VNTR-MIRU loci could not be reduced for lineage II without 
reducing the discrimination. In lineage III, nine loci (MIRU-10, -16, -20, -26, - 
27, -31, -39 -40, and ETR-B) and in lineage IV, eight loci (MIRU-4, -10, -31, - 
39, -40, -23, ETR-A and ETR-B) differentiated all isolates. Total discrimination 
of the M. bovis lineage was achieved with eight loci (MIRU-23, -24, -26, -27, 
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ETR-A, ETR-B and a combination of two VNTR-MIRU drawn from the 
following; MIRU-4, -31, or -39). 
However, if a lower level of discrimination is acceptable then an even smaller 
number of VNTR-MIRU could be applied which may be of value in resource 
constrained laboratories. For example by allowing 4 or less discrepancies per 
lineage (i. e. those isolates that are clustered when using a smaller panel of 
VNTR-MIRU compared to clustering seen with all 15 VNTR-MIRU); 4,12,7,7 
and 6 VNTR-MIRUs would be sufficient to produce the same level of intra- 
lineage discrimination as the whole panel when applied to lineage I, II, III, IV 
and M. bovis respectively (Table 6.9). 
6.3.10 Mycobacterium africanum 
In Chapter 5 one isolate believed to be an M. bovis isolate due to its phenotypic 
biochemical characteristics but displaying an unusual spoligotypes pattern i. e. 
contained spacers 40 to 43, was found to be an M. africanum strain after deletion 
typing. This isolate was analysed with the macroarray and found to have a 
lineage I hybridisation pattern. 
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Table 6.9 VNTR-MIRU loci used to sub-divide each lineage into true clustered 
and true unique isolates 
Lineage No. of No. of No. of VNTR-MIRU Additional VNTR- 
(n) clusters clustered unique (discrepancies MIRU for total 
(range) isolates isolates =/<4)a discrimination 
(discrepancies)b 
1(36) 6(2-9) 27 9 16,26,27,31 +A (1) 
(4) +A + 20 (0) 
11(245) 30 120 125 4,10,16,20, +B (2) 
(2-13) 23,26,27,31, +B+2 (1) 
39,40, A, C (4) +B+2+24(0) 
111 (100) 15 63 37 10,16,26,31, +20(l) 
(2-13) 39,40, B (2) +20+27(0) 
IV (88) 7(2-4) 19 69 4,10,31,39, A, +23 (0) 
B, 40(2) 
M. bovis 5 10 39 23,24,26,27, A combination of 
(49) (2 only) A, B (3) two MIRU from; 4, 
31 or 39(0) 
a Isolates could initially be screened with a smaller panel of VNTR-MIRU in a 
resource constrained laboratory wishing to produce a reasonable level of intra- 
lineage discrimination for epidemiological purposes at lower cost. This column 
shows the maximum number of VNTR-MIRU loci required to produce 4 or less 
discrepancies i. e. isolates which are clustered when using a smaller panel of 
VNTR-MIRUs compared to clustering with VNTR-MIRU-15 
b List of additional VNTR-MIRU loci that would need to be added to the smaller 
panel to give the same level of intra-lineage discrimination of clustered isolates 
as VNTR-MIRU-15 typing. 
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6.4 Discussion 
The identification of key phylogenetic markers within populations of isolates is 
important in order to aid our understanding of M. tb complex evolution and 
pathogenesis. A series of such markers in M. tb and M. bovis have been 
previously described by Baker et al., (2004) which defined 5 distinct lineages. 
VNTR-MIRU is a rapid, high throughput-typing tool which provides useful 
epidemiological markers for use in TB outbreaks and control programs. If the 
numeric codes by which VNTR-MIRU types are expressed can also define 
phylogenetic lineage, very large populations of M. tb complex isolates can be 
studied from an evolutionary perspective as this typing system is beginning to be 
used routinely in some centres both in the UK and globally. 
In this study VNTR-MIRU was successfully applied to a test population to 
determine phylogenetic codes capable of defining each of the lineages described 
previously. These VNTR-MIRU codes were then applied to an additional panel 
using a newly developed portable sSNPs-based macroarray. Developing a 
macroarray to identify known sSNPs in a population allowed the rapid speciation 
and identification of key lineages incorporating important TB strain families 
including, Beijing, CAS/Delhi and EAI and eliminating the need for time 
consuming more-costly sequencing. The macroarray also proved to be useful in 
defining the lineage of isolates that cannot be confirmed by sequencing or 
VNTR-MIRU as shown by the indeterminate isolates which were resolved by the 
macroarray. The macroarray therefore, would be a useful preliminary screening 
tool for M. tb and M. bovis populations. 
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Overall, the VNTR-MIRU phylogenetic codes were able to define 90.9% of 
sSNP-characterised M. tb and M. bovis isolates using a combination of ten loci of 
the 15 loci examined. 
Lineage I accommodates the Beijing family strains. In this study, 86.1% of the 
Beijing isolates were defined using the VNTR-MIRU lineage I code. It should be 
noted that even family groups such as Beijing which have been shown to be 
genetically homogenous can exhibit evolutionary divergence. Although the 
VNTR-MIRU codes were not as definitive as spoligotyping, dnaA-dnaN (Filliol 
et al. 2002, Drobniewski et al. 2002, Kurepina et al. 1998) and sSNP analysis, 
the data shown here demonstrates the potential of VNTR-MIRU as a good 
screening marker for Beijing-type strains. Ferdinand et al., (2004) genotyped 
spoligotype-defined families using the VNTR-MIRU-12 system. They found that 
all Beijing isolates could be characterised using a maximum of six MIRUs; as 
their focus was to characterise all isolates the loci and repeat numbers used were 
not the same for all Beijing isolates. A single code for the identification of 
Beijing isolates may therefore be more useful before or in parallel to, 
discriminating between these isolates. 
In terms of allelic diversity the Beijing phylogenetic code loci, MIRU-39 and 
ETR-A and -C, were very stable (0.05,0.05 and 0.00 respectively according to 
the HGI). This low diversity makes them useful markers for phylogenetic 
purposes (as opposed to a molecular epidemiology tool where high diversity is 
required) to indicate links between isolates. A study of Russian Beijing isolates 
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found a similar level of allelic diversity in MIRU 39, ETR-A and ETR-C (0.02, 
0.05,0.02) (V. Nikolayvsky, Personal communication/submitted for publication) 
suggesting that these markers could be used to define Beijing isolates globally. 
Unfortunately most Beijing strains characterised by VNTR-MIRU for strain 
differentiation and/or phylogenetic analysis have used VNTR-MIRU-12 only 
(Ferdinand et al. 2004, Mokrousov et al. 2004, Kam et al. 2005), therefore, 
comparison of their populations with our VNTR-MIRU code was not possible. 
Lineage III contained the CAS/Delhi family of strains (Filliol et al. 2002, Bhanu 
et al. 2002). The VNTR-MIRU code for this family, five copies of MIRU-23 
and two copies of ETR-C, defined 99% of isolates, making the differentiation of 
CAS/Delhi strains within a population simple and specific. 
Locus MIRU-24 has previously been used to classify M. tb strains into two 
groups for evolutionary analysis; those containing 1 copy and those containing 2 
or 3 copies (Ferdinand et al., 2004). Our VNTR-MIRU code is in agreement with 
Ferdinand et al., (2004) who found 97.8% East African-Indian (EAI) strains 
contained 2 copies of MIRU-24. The EAI strains in this study were found in 
lineage IV however, other strains including M. bovis contained 2 copies of 
MIRU-24 therefore this locus could not be used to define lineage IV alone. The 
addition of MIRU-26 resulted in this code becoming exclusive and so provided a 
simple code to define this family. 
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An important observation was that the M. bovis phylogenetic code was unique 
and not observed in any M. tb isolates. Therefore this phylogenetic code is an 
excellent marker for differentiating between these two species. 
The step-wise trend seen in discrepant isolates suggests that evolution is bi- 
directional in that repeat numbers either increase or decrease over time at all the 
loci utilised in one of the five phylogenetic codes except for MIRU locus 24. 
Indeed, certain loci show more allelic diversity than others which may be due 
different selection pressures acting at different loci. The molecular clocks of 
some loci may be faster than others and some loci may tolerate more 
polymorphisms than others. The exact function of MIRUs is unknown; different 
MIRUs may have distinct functions. One suggestion is that they may perform a 
regulatory function. Their high variability may be a way for the bacteria to adapt 
to a new environment. Changes in the copy number of tandem repeats may affect 
gene regulation (Supply et al. 1997), and have been shown to affect the 
expression of genes involved in adaptive responses (Moxon et al. 1994). 
Variation in copy number may also have an affect on virulence as seen in 
Haemophilus influenzae where changes in tetranucleotide repeat number in genes 
involved in the biosynthesis of cell wall lipopolysaccharide had an effect on 
virulence (Moxon et al. 1994, van Belkum et al. 1997). MIRU have been 
identified in the intergenic region of senX3-regX3, a gene deletion of this two- 
component system had an effect on the virulence of M. tb (Parish et al. 2003). 
Strains of M. tb complex other than M. bovis BCG were found to have varying 
numbers of a 77bp MIRU plus a 53bp repeat within the senX3-regX3 intergenic 
region, whist M. bovis BCG strains only contained copies of the 77bp repeat 
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(Magdalena et al. 1998). The virulence of Al. bovis BCG is attenuated and is 
generally regarded as non-pathogenic (although BCG strains can sometimes 
cause disease), therefore, theoretically there could be a link between the 
presencelabsence of repeat units and virulence although there is no direct 
evidence to support this. 
VNTR-MIRU can simultaneously differentiate strains and define phylogeny as 
demonstrated in this study. A lineage specific panel of VNTR-MIRU was used to 
sub-divide each lineage into clustered and unique strains, therefore eliminating 
the need to analyse all VNTR-MIRU-15 for every isolate. Using a smaller panel 
of VNTR-MIRU is advantageous in terms of reduced costs and analysis time. In 
molecular epidemiological studies the greatest discrimination would normally be 
required therefore isolates could be screened initially with a smaller VNTR- 
MIRU panel followed by the analysis of clustered isolates with additional 
VNTR-MIRU for total discrimination. 
VNTR-MIRU can characterise a population of di tb and M. bovis isolates for 
phylogenetic/evolutionary purposes. It is also suggested that VNTR-MIRU is 
able to provide information on sub-lineages and molecular clocks. VNTR-MIRU 
analysis is a high-throughput, reproducible method, which produces digital 
results that are readily portable between laboratories and so is suited to 
phylogenetic studies as well as having a high discriminatory value for molecular 
epidemiological investigations. Conversely, although genotyping by indexing 
genetically neutral variation provides a robust phylogeny for M. tb and 
identification of key strain families its value is limited for definitive 
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epidemiological typing. This study has demonstrated that VNTR-MIRU profiling 
can be used for rapid classification of M. tb and M. bovis isolates, and can be used 
to subdivide M. tb isolates into 4 major phylogenetic lineages. This technique 
could potentially be extended to identify the other members of the M. tb complex; 
M. africanum, M. microti and M. canetti, and should be investigated. 
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CHAPTER 7.0 Extending the Mycobacterium bovis phylogenetic tree using 
SNP analysis 
7.1 Introduction 
Mutations in the base sequence of DNA can occur spontaneously, through errors 
in DNA replication or recombination events, and through the damaging effects of 
physical or chemical agents on DNA. When considering phylogeny, two types of 
single nucleotide polymorphisms (SNP) occur within genes: silent or 
synonymous (sSNP) and non-synonymous (nsSNP). Synonymous SNPs cause no 
change in phenotype and variation is genetically neutral whereas nsSNP cause a 
change in the amino acid of a protein and so this type of variation can be selected 
for or against. Comparisons of this type of variation in nucleotide sequences 
provides robust and portable data which is useful for phylogenetic studies (Baker 
et al. 2004, Gutacker et al. 2002). 
Many methods exist for the identification of DNA mutations but by far the most 
comprehensive is DNA sequencing. Other methods, such as single stranded 
conformation polymorphism (SSCP), tend to be used as screening techniques 
because they do not characterise the mutation observed. SSCP is a low cost and 
simple method. The genomic or cDNA region of interest is amplified, denatured 
and the single strands separated by electrophoresis. Mutations cause a change in 
the tertiary structure of the single stranded DNA through intramolecular 
interactions. Folding of the molecule affects the mobility of the strand resulting 
in a banding pattern that differs to the wild-type strain. 
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SSCP has been successful utilised for detecting mutations causing or attributing 
to a variety of diseases or disorders in humans such as; hypercholesterolemia 
(Humphries et al. 1997, Pongrapeeporn et al. 2001), cancer (Park et al. 2005) 
and cystic fibrosis (Quint et al. 2005). This technique has also been used for the 
identification of mutations in M. tb, particularly in the genes associated with drug 
resistance (Telenti et al. 1993, Pretorius et al. 1995, Telenti et al. 1997, Fang et 
al. 1999b Cardoso et al. 2004). Studies using this method for detecting isoniazid 
and rifampicin resistance found the sensitivity ranged from 87-96% (Telenti et 
al. 1997, Cardoso et al. 2004). However, another study which analysed 
rifampicin resistant and sensitive isolates found that although the specificity was 
100% the sensitivity was much lower at 31.4% (Bobadilla-del-Valle et al. 2001). 
The aim of this study was to expand our understanding of the phylogeny of M. 
bovis using a combination of SSCP and sequencing to identify potential SNPs, in 
loci analysed in a previous study, which could be used to extend a previously 
published phylogenetic tree (Baker et al. 2004). 
7.2 Methods 
All available human isolates of M. bovis were collected from the HPA- 
Mycobacterium Reference Unit between 1986 and 2004, and included the 45 M. 
bovis isolates described in chapters 5 and 6 (excluding the 4 M. bovis previously 
sequenced by Baker et al. 2004). M. bovis isolates collected between 1987-97 
had all been kept as cultures on LJ slopes at room temperature while those 
isolated between 2001-4 were taken from the frozen archives, which were not 
available at the time of the study detailed in chapter 5. The DNA was extracted 
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(Material and Methods 2.2.1) and amplification of three regions analysed by the 
macroarray (excludes the region surrounding the sSNP at nucleotide position 
3243 in rpoB) was performed (Materials and Methods 2.8.1). These genes, oxyR, 
katG and rpoB, were targeted as sSNPs had previously been identified in these 
genes in M. tb and M. bovis. SSCP was performed on all isolates (Materials and 
Methods 2.9). One of the four previously sequenced M. bovis isolates (Baker et 
al. 2004) which had no mutations in either oxyR or rpoB but contained the M. 
bovis specific mutation in katG87 was used as a control. Any isolate displaying a 
shift in banding pattern compared to the control was subjected to DNA 
sequencing (Materials and Methods 2.10) using the same primers as described 
above (Materials and Methods 2.8.1). 
Each M. bovis isolate was also VNTR-MIRU-15 typed (Materials and Methods 
2.5.2) to establish if they contained the M. bovis specific VNTR-MIRU 
phylogenetic code and to determine if any mutant isolates comprised VNTR- 
MIRU sub-lineages. 
7.3 Results 
7.3.1 SSCP and DNA sequencing results 
A total of 137/185 (74.1%) M. bovis isolates were successfully amplified and 
subjected to SSCP. Of these, 129 (94.2%) isolates had complete SSCP data on all 
three genes (oxyR, katG and rpoB) (Table 7.1). Overall 28 shifts in band position 
were identified on polyacrylamide gels in 16 isolates: 12 band changes in oxyR, 
15 in katG and one in rpoB. An example of a band shift observed in katG is 
shown in figure 7.1. 
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Table 7.1 Number of isolates with SSCP data and the number of isolates 
containing potential mutations in each gene. 
Gene (nt region) No of isolates with 
SSCP data 
No of isolates with 
band shifts 
oxyR (1-311) 135 12 
katG (58-428) 132 15 
rpoB (2588-2746) 133 1 
Total no isolates 
containing a band shifta 
129 16 
a Some isolates contained a band shift in more then one gene rep-ion 
Of the 12 isolates with band shifts in oxyR, seven isolates could not be sequenced 
and the remaining five displayed one of the following mutations: four had a 
nsSNP at nucleotide position 37 and one had a nsSNP at position 159 (Table 
7.2). In rpoB, one isolate had a sSNP at nucleotide 2628. In katG, one isolate had 
the M. bovis specific sSNP at katG87 identified by Baker et al. (2004), while 12 
isolates did not contain this sSNP i. e. were M. tb-like, and two isolates could not 
be sequenced. 
Isolates that could not be sequenced were run on a 1.5% agarose gel to check for 
amplification and that the product was the correct size. In all cases a product of 
the correct size was observed. The PCR products of these isolates were then 
purified to remove any substances that may have inhibited the sequencing 
reaction. Two purification methods were used; standard PEG purification 
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Figure 7.1 Examples of band shifts on a SSCP gel in katG 
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Table 7.2 SNPs identified in each gene observed after sequencing 




Base change Amino Acid 
change 
oxyR 73873 159 G to C Arg > Ser 
20064 37 C to T Asn > His 
10243 37 C to T Asn > His 
70082 37 C to T Asn > His 
10111 37 C to T Asn > His 
63524 Fa - - 
01/10080 F - - 
03/11343 F - - 
04/00870 F - - 
04/08065 F - - 
32154 F - - 
42764 F - - 
katG 73873 87 C to A Pro -º Pro 
10111 87 No change° Pro --º Pro 
10243 87 No change Pro -º Pro 
20064 87 No change Pro --º Pro 
42680 87 No change Pro -º Pro 
41963 87 No change Pro -º Pro 
63524 87 No change Pro -* Pro 
60936 87 No change Pro --º Pro 
70082 87 No change Pro -º Pro 
00/00970 87 No change Pro -º Pro 
04/00870 87 No change Pro --º Pro 
01/10080 87 No change Pro -º Pro 
04/08065 87 No change Pro --ý Pro 
42764 F - - 
31254 F - - 
rpoB 73873 2628 T to G Gly > Gly 
-r =sequencing tailed. ° katci - -' " M. aovis specific sbivr iaenttttea by naxer er ai. zvu' .- No 
change in base compared to M. tb H37Rv, i. e. katG C 87 A M. bovis specific sSNP not observed. 
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(Material and Methods 2.11) and a QlAquick PCR purification kit (Qiagen, West 
Sussex, UK) which was performed according to the manufacturer's instructions. 
After purification each sample was sequenced but no result was seen. Next, the 
PCR products were diluted down 1 in 1000µ1 to dilute away any possible 
inhibitors. The PCR reaction was then repeated with the diluted DNA solution. 
Again no sequencing results were observed suggesting that possibly inhibitors 
were not the source of the problem. This suggested that the denaturation stage of 
20sec may not have been long enough to separate the DNA strands due to 
increased secondary structure in these samples. To compensate, the denaturation 
step was increased to 1 min at 96°C, however no sequencing result was obtained. 
Ten isolates (two isolates from oxyR and eight isolates from rpoB) appeared to 
display slight band aberrations which may possibly have been caused by a 
mutation or a distortion in the gel. These isolates were sequenced to ascertain if 
they did contain a mutation. In all cases no mutations were found which suggests 
the DNA fragments may have been distorted for technical reasons such as the 
temperature of the gel during electrophoresis becoming too hot or an air bubble 
in the gel. 
Overall four different mutations were identified; two in oxyR, one in katG and 
one in rpoB. Of these mutations, two were nsSNP i. e. caused a change in amino 
acid while the remaining two mutations were sSNP i. e. did not cause a change in 
amino acid. 
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Interestingly one isolate (lab no 73873) which contained the katG87 mutation also 
had a mutation in the oxyR and rpoB genes. Although a sSNP was found at 
katG87, this mutation could not have accounted for the band shift seen on the 
SSCP gel as the M. bovis control strain also contained this sSNP, therefore 
another mutation must exist. A mutation may have been present near the primers 
as the sequencing data obtained did not cover these regions. 
The mutation at oxyR37 (C to T) had previously been seen in M. tb isolates (Baker 
et al. 2004) suggesting that either, M. bovis can also contain this sSNP or that 
these isolates were not M. bovis. To check that the isolates containing oxyR37 and 
those isolates not containing the katG87 mutation were actually M. bovis, 
spoligotyping and Genotype MTBC typing (HAIN Lifesciences, Nehren, 
Germany) were performed (Table 7.3). Genotype MTBC typing, which is based 
on polymorphisms in the gyrB gene, was performed according to the 
manufacturer's instructions. Three of the four isolates containing oxyR37 had 
M. tb spoligotypes and the remaining isolate had a spoligotype which looked 
similar to an M. bovis spoligotype, but contained spacer 39 which is normally 
missing. This spoligotyping pattern also had similarities to the other three 
isolates containing the oxyR37 sSNP therefore it may not be M. bovis but actually 
an M. tb isolate. Genotype MTBC typing identified these isolates were all M. tb 
although this technique cannot differentiate between M. tb, M. africanum II and 
M. canetti (personal communication, M. Yates). Interestingly all these isolates 
contained the VNTR-MIRU code for M. tb lineage IV. 
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Of the 12 isolates that did not contain the katG87 sSNP, four also had the oxyR37 
sSNP (their spoligotypes and Genotype MTBC results are described above), four 
isolates had spoligotyping patterns and Genotype MTBC results suggestive of 
M. tb and four isolates were identified as M. africanum I by Genotype MTBC 
typing. Of these latter four, one had an M. bovis spoligotype, two had 
spoligotypes resembling M africanum and one had no spoligotype. Interestingly, 
the four isolates with M. tb spoligotypes all had lineage II VNTR-MIRU profiles. 
The four isolates labelled as M. africanum I by Genotype MTBC typing did not 
have a M. tb or M. bovis phylogenetic code. The two remaining SNPs identified, 
oxyR G 159 c and rpOBT 2628 c, were both found in one isolate (lab no 73873). This 
isolate had a M. tb spoligotype but no Genotype MTBC typing result was 
available. 
Overall the spoligotyping and Genotype MTBC data suggests that 13 out of 16 
isolates displaying band shifts were not actually M. bovis isolates, the remaining 
three isolates had no sequencing data for oxyR or katG and also had no 
spoligotyping or Genotype MTBC result. These isolates were collected from the 
M. bovis archives at the MRU however on closer inspection their phenotypic and 
biochemical characteristics were not always typical for M. bovis; three isolates 
were sensitive to pyrazinamide (two of which had an M. tb spoligotype and one 
had no spoligotype) and three isolates were TCH (thiophen-2-carboxylic acid 
hydrazide) + or +/- (two of which had an M. tb spoligotype and one had no 
spoligotype). The phenotypic and biochemical characteristics of a sample of 20 
isolates with no band shift were examined to determine if these isolates all 
contained typical M. bovis features: all 20 isolates had typical M. bovis 
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characteristics i. e. microaerophilic, TCH negative, pyrazinamide resistant and 
grew better on pyruvate than glycerol Lowenstein-Jensen slopes. 
7.3.2 VNTR-MIRU analysis 
Each isolate was VNTR-MIRU-15 typed to determine if the VNTR-MIRU 
phylogenetic code for M. bovis identified in chapter 6 was present in all strains. 
A total of 131/138 (94.9%) isolates had complete VNTR-MIRU data (N. B. one 
isolate that would not amplify for SSCP analysis was included in the VNTR- 
MIRU analysis as it was one of the 45 original M. bovis isolates hence a total of 
138). The M. bovis code; 2 copies of MIRU-10,2 copies of MIRU-40 and 5 
copies of ETR-C were found in 97/131 isolates (74.0%). None of the 16 isolates 
which contained a shift of band position contained the M. bovis phylogenetic 
code which is not surprising as according to the combined data from, SNP 
analysis, spoligotyping and Genotype MTBC typing, 13 of these isolates did not 
appear to be M. bovis. If these isolates were removed from the analysis 97/118 
(82.2%) isolates contained the M. bovis phylogenetic code. 
7.4 Discussion 
Genes with sSNP previously identified in M. tb and M. bovis as having lineage 
defining genotypes were targeted as possible `hot spots' for the identification of 
further mutations in M. bovis. SSCP analysis was successfully utilised as a 
screening method for the detection of mutations in these isolates which were 
subsequently characterised by direct DNA sequencing. 
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Of the 137 isolates analysed, 16 isolates had band shifts compared to the wild- 
type control using SSCP analysis. From the 13 isolates with complete sequencing 
data, four different SNPs were found in the three genes examined of which two 
were non- synonymous and two were synonymous mutations. The two sSNP at 
oxyR37 and katG87 had been identified before in M. tb and M. bovis respectively 
(Baker et al. 2004). The two nsSNP at oxyR159 and rpoB2628, where found in an 
isolate with typical phenotypic and biochemical characteristics of M. bovis and 
the sSNP at katG87 suggestive of M. bovis but a spoligotype pattern characteristic 
of M. tb. This isolate may have been an M. bovis strain but could also represent an 
intermediate between M. tb and M. bovis. These nsSNPs could therefore not be 
added to the Baker et al. (2004) tree. 
It is also unclear from this data which of the mutations at oxyR1S9 and rpoB2628 
came first in the evolutionary pathway as no intermediate containing just one of 
these mutations were observed. To determine the order of acquisition of these 
SNPs additional isolates need to be examined. 
There are however limitations to adding these non-synonymous SNPs to the 
phylogenetic tree. Baker et al. (2004) constructed their tree using synonymous 
SNPs which are neutral variation and therefore unlikely be selected for and 
against, creating an unambiguous tree, whereas the opposite may be true for 
nsSNP. 
In summary, from the 13 isolates with SNP data, eight appeared to be M. tb 
according to the combined data from SNP analysis, spoligotyping, VNTR-MIRU 
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analysis and Genotype MTBC typing. The remaining five isolates did not have 
concordant results between the four typing methods and so may represent 
intermediates within the M. tb complex. To ascertain the identity of these isolates 
further work is required for example by deletion typing which separates the M. tb 
complex based on the presence or absence of regions of difference in the genome 
(Brosch et al. 2002, Mostowy et al. 2005). 
The sensitivity of the M. bovis VNTR-MIRU phylogenetic code decreased with 
the addition of more M. bovis isolates from 88.9% (45 isolates from chapter 6) to 
74.0% (total 131 isolates); however the 13 of the 16 isolates with mobility shifts 
did not appear to be M. bovis. Removing these isolates from the analysis 
increased the number of definable isolates to 82.2%. 
A total of nine isolates with band shifts in oxyR and katG could not be 
sequenced. Various purification techniques were used but no interpretable 
sequencing results were obtained. Other reasons that could explain the poor 
sequencing results include, for example, the fact that PCR is exponential whereas 
sequencing is not. Inefficient primers can still work for PCR whereas they will 
affect the efficiency of a sequencing reaction. Primers can also anneal to a 
mismatched priming site. The mutation could have been located in the primer 
sequence and so affected the binding of the primers in the sequencing reaction. 
These primers were successfully used for VNTR-MIRU typing, however during 
PCR if a primer manages to anneal once to a mismatch region then the extension 
product will then be a perfect match for subsequent cycles. This is not the case in 
sequencing reactions and so a mismatch is likely to affect the result. 
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Overall 48 extracted isolates would not amplify using the original macroarray 
primers. Almost all of these isolates were kept on LJ slopes at room temperature 
for, in most cases, over a decade. This suggests that although PCR can be 
performed on non-viable isolates it is likely the quality of DNA will deteriorate 
over time if the culture is not kept under suitable conditions i. e. frozen at -70°C 
which is now standard practice. 
Many factors can affect the results of SSCP such as the running temperature of 
the gel, length of the polyacrylamide gel, running time and speed, and length of 
the PCR fragments (Humphries et al. 1997). In this study a magnetic stir was 
used during electrophoresis to prevent the occurrence of hot spots in the gel. The 
gel was also run overnight at a low voltage to minimise overheating. Large gels 
(20cm) were used, maximising running time to allow adequate band separation. 
An optimal length of fragments analysed by SSCP of between 150 and 200 
nucleotides has been suggested (Humphries et al. 1997). In this study only one of 
the regions analysed was between these boundaries (rpoB length = 159bp) 
therefore mutations may have been missed in the other two genes affecting the 
sensitivity of the technique. It is believed that changes in conformation will not 
be picked up as easily the longer the fragment is. The sensitivity of SSCP is this 
study was not known as only isolates with band shifts were sequenced. The 
specificity of the technique was 100% although it is worth noting that the 
mutation detected in one isolate with a band shift could not be found upon 
sequencing; however this isolate had incomplete sequencing data. This suggests 
that this isolate was not a false positive result but rather the mutation was in a 
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region with no sequencing data. Further investigation with additional primers 
would be required to confirm this. 
This study found that SSCP is a cost effective, rapid, method for screening M. 
bovis isolates for mutations. The gene regions in this study were targeted because 
mutations in M. tb and M. bovis had previously been identified in these areas 
(Baker et al. 2004). Although the SNPs identified appeared not to be in M. bovis 
isolates the approach was successful as all genes analysed contained mutations. 
Therefore the other genes analysed by Baker et al. (2004) should be examined 
for additional mutations which may further expand the M. bovis phylogenetic 
tree. 
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CHAPTER 8.0 Conclusions and future work 
8.1 Transmission of M. tb and M. bovis 
Molecular typing is a useful tool for the identification of related cases that may 
not be linked through traditional epidemiological or contact tracing methods. 
Identical fingerprints, when using methods with a high degree of discrimination 
such as RFLP-IS6110, are thought to represent recently infected cases and can be 
targeted for epidemiological investigation. Unique fingerprints are not thought to 
be epidemiologically related and may have arisen either from the reactivation of 
a latent infection or the immigration of patients who have acquired infection 
from abroad (Alland et al. 1994, Maguire et al. 2002). 
The data obtained from the molecular epidemiological study of TB in England 
found low levels of clustering (21%), this was comparable to a study of TB in 
London between 1995-1997 which found 23% of cases were clustered (Maguire 
et al. 2002). The low number of potentially linked cases suggests low levels of 
recent transmission in England. The majority of TB cases may reflect 
reactivation and importation of disease through recent immigrants from high 
incidence countries. Risk factors for clustering were identified and included 
cases with previous treatment and pulmonary smear negative disease. A case 
control study demonstrated that homelessness associated with alcohol 
dependence was also a risk factor for clustering. 
High levels of clustering (73%) were observed in Harare, Zimbabwe suggesting 
high rates of recent transmission, however, some caution is needed in this 
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interpretation as RFLP-IS6110 fingerprinting could not be performed on these 
strains. It is likely that a degree of false clustering was present as the 
discriminatory value of spoligotyping and VNTR-ETR is lower then that of 
RFLP-IS6110. Surprisingly, no risk factors for clustering were observed even 
with a substantially high level of HIV co-infection (74%). Again this may have 
been due to the lower discriminatory power of spoligotyping and VNTR-ETR, 
merging epidemiologically linked and unlinked cases and affecting the 
identification of risk factors. The two transmission studies of England and Harare 
could not be compared directly as slightly different molecular techniques were 
used. However, a high rate of clustering was observed in Harare where TB and 
HIV are endemic, whereas relatively low rates of clustering were observed in 
England where the incidence of both TB and HIV infection are low. HIV 
infection increases the susceptibility to exogenous TB infection and the rapid 
onset of disease after infection. High levels of HIV in a population could lead to 
a higher prevalence of infectious TB cases over a shorter period of time therefore 
this may have contributed to the high levels of clustering observed in Harare. 
A comparison of spoligotyping families observed in the two contrasting settings, 
London (a low incidence population) and Harare (a high incidence population) 
found a greater diversity of spoligotype strain families in London. Just two main 
families, the T and the LAM family were observed in Harare, whereas in London 
13 large families were present (those containing 20 or more isolates); a probable 
reflection on the greater international diversity of the population in London. 
Of all the strain types present in these two contrasting settings it was found that 
the Ti strain was ubiquitous. This is not surprising as the T family is thought to 
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be a relatively old genotype (Filliol et al. 2002) and the Ti strain is found 
worldwide (Filliol et al. 2003). M. Africanum strains are commonly associated 
with TB patients in Africa (Niemann et al. 2002) however no spoligotype 
patterns from this species were observed in Zimbabwean isolates. Conversely 7 
M. Africanum strains were observed in London isolates although this species has 
previously been seen in South-East of England (Grange and Yates 1989). To 
conclude spoligotype signatures can be used to screen populations allowing the 
identification of clades/strain families which may be useful for both public health 
action and monitoring the global spread of TB. 
A comparison of typing techniques using M. tb isolates from England between 1s` 
January 1998 and 31S` March 1999 demonstrated that VNTR-MIRU analysis 
displayed high levels of discrimination. However, in a HCN population (isolates 
with five or more bands) the gold standard RFLP-IS6110 still provided the 
greatest level of discrimination. A combination of RFLP-IS6110 and VNTR- 
MIRU were more discriminatory than the commonly used combination of RFLP- 
IS6110 and spoligotyping suggesting the former are most useful for public health 
and contact tracing purposes. Further investigation is required to determine if 
VNTR-MIRU can replace RFLP-IS6110, as this would allow a prospective 
typing service which currently is not possible due to the slow turnover time of 
RFLP. A total of 79 variable regions have been identified within the M. tb H37Rv 
genome (http: //minisatellites. U. psud. fr) many of which have not been assessed 
for their variability in repeat number between strains. Furthermore other variable 
regions may exist in clinical strains of M. tb which may provide the additional 
level of discrimination required. 
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Unfortunately RFLP-IS6110 and VNTR-MIRU could not be performed on the 
Zimbabwean isolates due to contaminated cultures and the low yields of DNA 
obtained. However from the evidence presented in the comparative study of 
typing techniques it is likely that the level of clustering would have been reduced 
with the application of RFLP-IS6110 and VNTR-MIRU. Relatively few 
molecular epidemiological studies using VNTR-MIRU have been carried out in 
high incidence areas particularly in Africa. As VNTR-MIRU is a PCR-based 
technique it overcomes the problems of requiring viable cultures, therefore this 
should be addressed in future to determine how discriminatory VNTR-MIRU 
typing is in areas where TB and HIV are endemic. 
The majority of M. bovis infections in humans in the UK were most likely due to 
reactivation of a latent infection acquired pre-milk pasteurisation rather than 
primary infection as almost three-quarters of cases were over the age of 50. 
Spoligotyping demonstrated the most prevalent strain in humans (Type 9) was 
also the most prevalent in cattle populations. Thirteen spoligotypes were unique 
to humans and had not previously been observed in UK cattle. Due to the high 
levels of reactivation, these isolates may represent strains circulating in UK cattle 
over 50 years ago. 
VNTR-MIRU using 15 loci provided the highest discriminatory power when 
using a single technique for analysing human M. bovis isolates in the UK. 
Furthermore it also proved to be the best technique for discriminating between 
M. bovis isolates belonging to spoligotype 9. In future VNTR-MIRU-15 should 
164 
be considered alone or in combination with spoligotyping for epidemiological 
studies of human M. bovis. It is also possible that this technique will be of value 
in determining transmission dynamics in M. bovis in cattle and other mammals. 
8.2 Phylogeny of M. tb complex 
VNTR-MIRU provided a rapid, robust tool for the phylogenetic analysis of M. tb 
and M. bovis. Over 90% of M. tb and M. bovis isolates were characterised by 
defined VNTR-MIRU phylogenetic codes, which could also differentiate 
between M. tb and M. bovis strains. VNTR-MIRU was not only useful for 
phylogenetic studies but could simultaneously strain type isolates and was 
therefore beneficial for epidemiological purposes. Future work should 
concentrate on improving the phylogenetic codes by analysing additional 
variable regions both to improve existing codes. This is particularly important in 
Beijing strains (lineage I) where the phylogenetic code defined the least number 
of isolates compared to the other M. tb lineages. Furthermore, improving on these 
codes will enable further study of sub-lineages within the four lineages of M. tb 
and M. bovis. This technique should also be extended to the other members of the 
M. tb complex including; M. africanum, M. microti and M. canetti to determine 
whether a phylogenetic code for these species could be identified. 
The step-wise trend seen in discrepant isolates suggests that the evolution of 
VNTR-MIRU may be bi-directional in that the number of repeats at each locus 
can increase or decrease over time. This should be investigated further by 
analysing serial isolates from patients. Any changes identified may determine if 
repeat number can increase, decrease or change in both directions over time. 
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Little variation in VNTR-MIRUs was observed in serial isolates from patients in 
South Africa (Savine et al. 2002) i. e. only one change at one locus was observed 
in 56 patients in up to a six year period. However, this is a relatively small 
sample and so further analysis of serial isolates from both high and low incidence 
settings should be analysed to elucidate this theory. 
Single stranded conformation polymorphism (SSCP) was successfully used as a 
screening technique to identify mutations. Band shifts were identified in 16 
isolates recorded as M. bovis. Overall, four mutations were identified by direct 
sequencing, of which two, oxyR37 and katG87, had been previously identified. 
One isolate contained the remaining two mutations at oxyR1S9 and rpoB2629 
however it is unclear from this data which of the mutations appeared first in the 
evolutionary pathway and indeed how these SNPs would fit into the Baker et al. 
(2004) phylogenetic tree as the identity of this isolate was unclear. Typing data 
suggested it could be an intermediate between M. bovis and Mtb. 
Indeed of the 13 isolates with band shifts and complete sequencing data, none 
appeared to be M. bovis isolates. The identities of eight isolates were concordant 
by all typing methods (SNP analysis, spoligotyping, VNTR-MIRU analysis and 
Genotype MTBC typing) and appeared to be M. tb isolates. The remaining four 
isolates were not concordant between these typing techniques and could 
represent intermediates within the M. tb complex. Future work would therefore 
involve defining these isolates. Deletion typing has been used to differentiate 
between members of the M. tb complex (Brosch et al. 2002). This technique is 
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based on presence or absence of regions of difference in the genome. Recently 
additional deleted regions have been identified in M. bovis and M. bovis-like 
isolates using an Affymetrix GeneChip system (Mostowy et al. 2005). This 
approach has further differentiated the M. bovis lineage and could be used to 
analyse these discrepant isolates to determine if they are indeed sub-species 
within M. bovis. 
In future the three genes partially analysed in this study; oxyR, katG, and rpoB 
should be targeted in full to determine if SNPs can be identified in the isolates 
confirmed as M. bovis. In addition the remaining four genes; ahpC, pncA, rpsL 
and gyrA analysed by Baker et al. (2004), which were found to contain sSNPs in 
M. tb, could contain sSNPs for the construction of a M. bovis phylogenetic tree 
and so should be investigated. 
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. 5'-CGCCATCTGTGCCTCATACAGGTCC- 3' 
. 5'-GGAGCTTTCCGGCTTCTATCAGGTA- 3' 5'-ATGGTGGGACATGGACGAGCGCGAC- 3' 
. 5'-CGCAGAATCGCACCGGGTGCGGGAG- 3' 
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APPENDIX 2 
VNTR-ETR primers sequence 
ETR A 5'- AAA TCG GTC CCA TCT CCT TCT TAT-3' 
5'- CGA AGC CTG GGG TGC CCG CGA TTT -3' 
ETR B 5'- GCG AAC ACC AGG ACA GCA TCA TGG GTT -3' 
5'- GGC ATG CCG GTG ATC GAG TGG CTA TA -3' 
ETR C 5'- GTG AGT CGC TGC AGA ACC TGC AG -3' 
5'- GGC GTC TTG ACC TAA TCG AGT G -3' 
ETR D 5'- CAG GTC ACA ACG AGA GGA AGA GC -3' 
5'- GCG GAT CGG CCA GCG ACT CCT C -3' 
ETR E 5'- CTT CGG CGT CGA AGA GAG CCT C -3' 
5'- CGG AAC GCT GGT CAC CAC CTA AG -3' 
VNTR-MIRU-12 primers 
MIRU 2 5'-CAG GTG CCC TAT CTG CTG ACG -3' 
5'- GTT GCG TCC GGC ATA CCA AC - 3' MIRU 4 5'- GTC AAA CAG GTC ACA ACG AGA GGA A -3' 
5'- CCT CCA CAA TCA ACA CAC ACT GGT CAT -3' 
MIRU 10 5'- ACC GTC TTA TCG GAC TGC ACT ATC AA-3' 
5'- CAC CTT GGT GAT CAG CTA CCT GAC CTA - 3' MIRU 16 5' - CGG GTC CAG TCC AAC TAC CTC AAT-3' 
5'- GAT CCT CCT GAT TGC CCT GAC CTA-3' 
MIRU 20 5'- CCC CTT CGA GTT AGT ATC GTC GGT T -3' 
5'- CCA TCA CCG TTA CAT CGA CGT CAT C -3' MIRU 23 5'- CGA ATT CTT CGG TGG TCT CGA GT -3' 
5'- ACC GTC TGA CTC ATG GTG TCC AA -3' 
MIRU 24 5'- GAA GGC TAT CCG TCG ATC GGT T -3' 
5'- GGG CGA GTT GAG CTC ACA GAA C -3' 
MIRU 26 5'-GCG GAT AGG TCT ACC GTC GAA ATC -3' 
5'- TCC GGG TCT TAC AGC ATG ATC A- 3' 
MIRU 27 5'- TCT GCT TGC CAG TAA GAG CCA -3' 
5'- GTG ATG GTG ACT TCG GTG CCT T -3 
MIRU 31 5'- CGT CGA AGA GAG CCT CAT CAA TCA T -3' 
5'- AAC CTG ACC GAT GGC AAT ATC -3' 
MIRU 39 5'- CGG TCA AGT TCA GCA CCT TCT ACA TC -3' 
5'- GCG TCC GTA CTT CCG GTT CAG -3' 
MIRU 40 5'- GAT TCC AAC AAG ACG CAG ATA AAG A -3' 
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We examined the pattern of tuberculosis (TB) transmission (i. e., reactivation versus recent transmission) 
and the impact of human immunodeficiency virus (HIV) Infection in Harare, Zimbabwe. Consecutive adult 
smear-positive pulmonary TB patients presenting to an urban hospital in Harare were enrolled. A detailed 
epidemiological questionnaire was completed, and tests for HIV type 1 and CD4 cell counts were performed for 
each patient. Molecular fingerprinting of the genomic DNA recovered from cultures of sputum was performed 
by two molecular typing methods: spacer oligonucleotide typing (spoligotyping) and analysis of variable 
number of tandem DNA repeats (VNTRs). A cluster was defined as Isolates from two or more patients that 
shared the same spoligotype pattern or the same VNTR pattern, or both. DNA suitable for typing was recovered 
from 224 patients. The prevalence of HIV infection was 79%. Of 187 patient isolates (78.6%) typed by both 
spoligotyping and analysis of VNTRs, 147 were Identified as part of a cluster by both methods. By spoligotyping 
alone, 84.1% of patient Isolates were grouped into 20 clusters. The cluster size was generally <8 patient 
Isolates, although three large clusters comprised 68,25, and 23 patient isolates. A total of 89.4% of the patient 
isolates grouped into 12 clusters defined by analysis of VNTRs, with 2 large clusters consisting of 127 and 13 
patient isolates, respectively. Thirty-six percent of patient isolates with a shared spoligotype and 17% with a 
shared VNTR pattern were geographically linked within Harare, but they were not linked on the basis of the 
patient's home district. In a multivariate analysis, there were no independent predictors of clustering, includ- 
ing HIV Infection status. Comparison with the International Spoligotype database (Pasteur Institute, Pointe A 
Pitre, Guadeloupe) demonstrated that our three largest spoligotype clusters are well recognized and ubiquitous 
in Africa. In this epidemiologically well characterized urban population with a high prevalence of IIIV 
infection, we identified a very high level of strain clustering, Indicating substantial ongoing recent TB trans- 
mission. Geographic linkage could be detected In a proportion of these clusters. A small group of actively 
circulating strains accounted for most of the cases of TB transmission. 
Tuberculosis (TB) has reemerged as an important public 
health problem in Zimbabwe. Following a stabilization of the 
TB rates in the early 1980s at approximately 50 per 100,000 
population, since 1987 there has been a dramatic increase to 
250 per 100,000 population, which is largely attributable to the human immunodeficiency virus (HIV) epidemic in sub-Sa- 
haran Africa (9,28). 
Strain-specific markers for the differentiation of Mycobacte- 
rium tuberculosis complex strains are reliable tools for the 
identification of specific strains and are useful for epidemio- logical studies of TB. The most extensively used differentiation 
method is restriction fragment length polymorphism (RFLP) 
typing, which uses the insertion sequence IS6110 to differen- 
tiate clinical isolates (39). However, this technique is techni- 
Corresponding author. Mailing address: Department of HIV/GU Medicine, The Guy's, King's and St. Thomas's School of Medicine, Weston Education Centre, Cutcombe Rd., King's College Hospital, 
Denmark Hill Campus, London SE5 9RT, United Kingdom. Phone: 
020 7848 5770. Fax: 020 7848 5769. E-mail: philippa. easterbrook @kcl. ac. uk. 
cally demanding and expensive and requires viable bacterial 
growth, and so it may not be optimal for large epidemiological 
studies in resource-poor settings. New PCR-based typing 
methods such as spacer oligonucleotide typing (spoligotyping), 
based on polymorphisms in the direct repeat locus, require less 
DNA and have been increasingly used for the rapid typing of 
isolates. However, spoligotyping used alone is less discrimina- 
tory than RFLP typing and tends to overestimate the number 
of epidemiological links, so the use of a second method for 
confirmation of the results is recommended (22). Fingerprint- 
ing based on the variable number of tandem DNA repeats 
(VNTRs) is a further highly reproducible rapid typing method 
(15) that yields a high level of cluster discrimination compara- 
ble to that of RFLP analysis when it is used as a second-line 
test with spoligotyping (13,26). 
Use of conventional epidemiological data in combination 
with these DNA techniques can help answer important ques- 
tions about the epidemiology of TB in large populations by 
distinguishing between newly acquired and reactivated disease 
(1,4,6,7,16,23,32,37). Patients whose isolates have identical 
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patterns (i. e., a cluster) are likely to have been infected re- 
cently and can be targeted for epidemiological investigation to 
identify a chain of transmission, whereas patients whose iso- 
lates demonstrate unique patterns are likely to have reactiva- 
tion of a latent infection. Most previous studies that have used 
these DNA fingerprinting techniques have focused on the trac- 
ing of TB outbreaks within a hospital or other high-risk envi- 
ronments and the dissemination of multidrug-resistant strains, 
in which isolates from epidemiologically related patients are 
usually identical (8,10,11,14). Although it was previously 
thought that 90% of TB cases in the developed world resulted 
from the endogenous reactivation of latent infection, popula- 
tion-based RFLP studies conducted in the United States and 
Western Europe, areas with a relatively low incidence of TB, 
show that recent infection accounts for up to half of the cases 
among both HIV-infected and HIV-negative patients in urban 
areas (1,4,6,7,16,23,32,37). These studies also showed that 
only a fraction of the main TB transmission routes are dis- 
closed by classical contact-tracing practices. 
In Africa, where TB is endemic, it has generally been con- 
sidered that most cases of TB in HIV-infected and HIV-neg- 
ative patients result from reactivation (9). However, there are 
few data to support this, as few detailed molecular epidemio- 
logical studies have been undertaken in countries with high 
rates of both TB and HIV infection. It has been shown that 
despite the more limited strain diversity in sub-Saharan Africa, 
there is still adequate strain variability among M. tuberculosis 
isolates from patients living in developing countries to permit 
the application of molecular approaches to the tracking of TB 
transmission (24,25). Our objectives were, first, to examine the 
pattern of TB transmission (i. e., the relative frequency of re- 
activation versus that of recent infection) and the role of HIV 
infection using two molecular typing methods, spoligotyping 
and analysis of VNTRs, in tandem with epidemiological data 
and, second, to identify the risk factors for recent transmission 
in a well-characterized cohort of smear-positive TB patients in 
Harare, Zimbabwe. 
(This study was presented in part at the 9th Conference on 
Retroviruses and Opportunistic Infections, Seattle, Wash., 24 
to 28 February 2002 [P. Easterbrook, A. Gibson, S. Murad, A. 
Ferguson, P. Mason, A. Ndudza, L. Mbengeranwa, and F. 
Drobniewski, Abstr. 9th Conf. Retrovir. Opportunistic Infect., 
abstract 621 W, 2002]. ) 
MATERIALS AND METHODS 
A total of 516 consecutive adult smear-positive pulmonary TB patients pre- 
senting to the Beatrice Road TB Hospital in Harare, Zimbabwe, between May 
and October 1997 were enrolled in the study. The Beatrice Road TB Hospital is 
the main referral center for TB and other infectious diseases in Harare and 
captures the majority of TB cases in the city, which has a population of about 1.25 
million. Data for each patient were collected by using a standardized question- 
naire and pro forma by a trained research nurse and included demographic data 
(age, gender, occupation, marital status, number of children, rural home district, 
present address and all previous residence addresses over the last year in Harare, household size, number of rooms and household crowding level [i. e., number of dwellers per number of rooms], medical history [past history of TB and treat- 
ment, M. bov4 BCG vaccination, and history of other medical conditions, e. g., diabetes], the history of TB in the household within the last S years, and smoking 
and alcohol consumption). A chest X ray was obtained for each patient, and a 
comprehensive physical examination focused on the detection of clinical features 
suggestive of HIV disease. Informed consent to perform HIV testing was ob- 
tained from all patients, and the study was approved by the Medical Research 
Council Ethics Committee of Zimbabwe. 
Laboratory methods. HIV infection status was determined by an enzyme- 
linked immunosorbent assay (Dupont, Wilmington, Dcl. ). CD4 cell counts were 
measured by flow cytometry (FACScan; Becton Dickinson, Paramus, N. J. ). 
Three smear-positive sputum samples from each patient were sent to the TB 
reference laboratory in Bulawayo, Zimbabwe, by the usual transport system and 
were cultured on Lowenstein-Jensen medium. Cultures and drug susceptibility 
testing were performed for all 502 patients with microbiologically confirmed 
cases of TB. Isolates were categorized into drug-sensitive and single-drug- or 
multidrug-resistant strains. 
Molecular typing was performed at the National Mycobacterial Reference 
Unit, Health Protection Agency, London, United Kingdom, after transport of 
the cultures by overnight courier from Zimbabwe. Spoligotyping was performed 
with genomic DNA extracted from cultures of sputum by a standard phenol- 
chloroform method (43). The spacers between the direct repeats in the target 
region were amplified by using two 18-nucleotide primers (primer 5'-CCAAGA 
GGGGACGGAAAC-3' and biotinylated primer 5'-GGTTTI'GGGTCTGACG 
AC-3'). The PCR products were then hybridized to a Biodyne C membrane 
(Isogen Bioscience, Maarsen, The Netherlands). This membrane contains im- 
mobilized synthetic oligomeric spacer sequences derived from the direct-repeat 
region of M. tuberculosis H37Rv and M. bovis BCG. Hybridized DNA was 
detected by using an enhanced chemiluminesence kit (Amcrsham International 
plc, Little Chalfont, United Kingdom), with exposure to X-ray film producing a 
pattern or profile reminiscent of a bar code. 
Analysis of VNTRs was performed as described previously (15), but with the 
following modifications: DNA was extracted from the cultures as described 
above. PCR was performed in a total volume of 20 µl containing 11 µl of 
HotStarTaq DNA polymcrasc (Oiagen, Chichester, United Kingdom) and 10 to 
100 ng of DNA sample. An initial denaturation at 94°C for 15 min was followed 
by 30 cycles of denaturation at 94°C for 30 a, annealing at 60°C for 1 min, and 
extension at 72°C for 2 min, followed by a final extension at 72°C for 10 min. An 
aliquot (10 µ1) from each reaction tube was run on a 2% Nusicve GTG Agarose 
gel (Flowgcn, Leicestershire, United Kingdom). Molecular weight standards 
(100-bp ladder [Promega, Southampton, United Kingdom) and a 20-bp ladder 
[Sigma-Aldrich, Dorset, United Kingdom]) were loaded every eight lanes. The 
gel was stained with ethidium bromide and visualized under UV light. Once the 
size of the PCR product was determined, the number of copies for each exact 
tandem repeats (ETR) (A to E) was determined by a previously described 
method (15) and a five-digit number representing the allele profiles was created. 
Statistical analysis. Patient isolates were categorized into one of two groups 
according to whether the spoligotype or VNTR pattern was unique or was 
identical to that for another sample (i. e., a cluster). A cluster was defined as a 
group of two or more patient isolates that shared the same spoligotype or VNTR 
pattern. Clusters were considered false positive if the sample was processed in 
the microbiology laboratory on the same day that a specimen with a positive 
smear from another patient with the same typing pattern was processed. We also 
reanalyzed the data by assuming that each cluster of n patients comprised one 
source case and that all the other cases in the clusters (i. e., n- 1) were due to 
recently acquired disease through active transmission (32). Therefore, a mini- 
mum estimate of the proportion of cases of TB caused by recent transmission was 
calculated as (number of clustered patients - number of clusters)/total number 
of patients. Patient isolates contained within clusters and those with unique 
patterns were compared by chi-square tests or Fisher's exact test and by Mann- 
Whitney U tests for categorical and continuous variables, respectively. Risk 
factors for clustering identified by univariatc analysis (P < 0.2) were then in- 
cluded in a multivariate logistic regression model to identify independent risk 
factors for clustering, with clustered and nonclustered being the dependent 
outcomes and with a cluster defined as two or more patient isolates that shared 
the same (i) spoligotype and VNTR patterns, (ii) the same spoligotype pattern, 
and (iii) the same VNTR pattern. Since the overall rate of clustering may not 
always be informative, we also examined whether certain Harare districts and 
rural home districts were associated with a higher frequency of overall clustering 
and with particular clusters identified by spoligotyping or analysis of VNTRs 
using a binomial probability test and one-sided P values after exclusion of those 
districts in which only one study patient was recorded and exclusion of those 
patients within a district who were part of a cluster but from another district. For 
each patient within a cluster, the location of the patient's home was recorded by 
using the Harare Street Atlas. Individuals living within 0.5 km of a patient who 
was part of the same cluster were considered part of a geographically based 
cluster. Data were analyzed by using STATA software (version 7.0; STATA 
Corporation, College Station, Tcx. ). Taxatron software (Institut Pasteur, Paris. 
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FIG. 1. Prevalence of HIV-1 infection among TB patients by age 
group. 
France) was used to calculate the molecular weights of the hybridizing bands and 
to compare the isolates with those in the International Spoligotype database. 
RESULTS 
Study population. A total of 516 patients with smear-positive 
TB who presented to the Beatrice Road TB Hospital from May 
to October 1997 were enrolled in the study. Complete data 
were available for 502 patients, and these patients were in- 
cluded in the analysis. Of the 502 patients, 371 (74%) were 
HIV positive and 65% were male. The median age at presen- 
tation was 31 years (interquartile range [IQR], 27 to 40 years). 
Among the 502 patients, 204 (41%) gave a history of recent 
household contact with TB and 44 (9%) had a past history of 
TB. There was a striking difference in the prevalence of HIV 
infection by age (Fig. 1). For the HIV-positive patients, the 
median CD4 cell count at the time of presentation was 150 X 
106/liter (IQR, 64 to 291/liter). Drug resistance was identified 
in isolates from only 17 (4%) of 458 patients. 
Spoligotyping and VNTR patterns. Useable DNA was re- 
covered from 224 of the 228 individual cultures available for 
502 (44.6%) patients. A significant number of the remaining 
cultures were extensively contaminated with bacteria or yeasts, 
which led to degradation of the medium. Spoligotyping was 
performed on 214 samples (after the exclusion of 10 contam- inated samples), and analysis of VNTRs was performed on 198 
samples (after the exclusion of 3 contaminated samples). There were no statistically significant differences in the char- 
acteristics of the 187 patients from whom DNA was available for typing compared to those of the 317 patients from whom DNA was not available. Of the 187 patients with available 
spoligotype and VNTR typing data, 147 (78.6%) were identi- fied as part of a cluster on the basis of both methods, with an 
additional 20 identified as part of a cluster on the basis of 
analysis of VNTRs alone and 12 identified as a cluster on the basis of spoligotyping alone. 
By using spoligotyping alone, 54 distinct spoligotypes were identified and a total of 180 patient isolates (84.1%) were 
grouped into 20 clusters (or 15 clusters on the basis of the n- 1 approach, as 10 patient isolates were in clusters with only 2 isolates). The cluster size was generally less than 8 isolates (Table 1); however, three large clusters comprised 68,25, and 23 patient isolates, respectively, and these accounted for 50% 
of the isolates. In comparison, there were 33 distinct strains by 
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TABLE 1. Clustering results obtained by analysis of VNTRs as a 
first-line test followed by subclustering by spoligotyping and 
obtained by spoligotyping as a first-line test followed by 
subclustering by analysis of VNfRs 









No. of subclusters by: 
Spoligotyping Analysis of VN. IRs" 
Analysis of VNTRs 
5 3233'3 3 
4 2123'2 2 
4 2123.3 2 
3 2143'1 2 
5 2143'2 4 
127 2143'3 23 
2 4243'5 
13 3243'3 6 
2 2243'2 2 
6 2243'3 3 
3 2343'3 2 
3 3233'2 3 
Spoligotyping 
4 b( _ 3) 
2 -(NT-1) 
68 8 (NT-7) 
2 - (NT=4) 





4 2 (NT=1) 
2 2 
2 - 






' Expressions in parentheses represent numbers of samples not tested (NT) 
because a strain type was not available by analysis of VNTRs for some isolates 
analyzed by spoligotyping. 
b -, no subclustcrs identified. 
analysis of VNTRs, and 177 patient isolates (89.4%) grouped 
in 12 clusters defined by analysis of VNTRs (or 10 clusters on 
the basis of the n-1 approach, as 4 patient isolates were in 
clusters with only 2 isolates), with 2 large clusters comprising 
127 isolates (which accounted for 64.1% of the isolates in the 
study) and 13 patients. The minimum estimate for the propor- 
tion of TB cases due to recent transmission was 74.8% [(180 - 
20)/214, i. e., (number of clustered patients - number of clus- 
ters)/total number of patients] for spoligotyping and 83.3% 
[(177 - 12)/198] for analysis of VNTRs. 
Analysis of VNTRs was less discriminatory as a first-line 
fingerprinting method (Table 1). Eleven of the 12 (91.7%) 
clusters identified by analysis of VNTRs could be further sub- 
divided by spoligotyping into distinct subtypes, with each clus- 
ter containing from 2 to 23 subtypes. Conversely, only 8 of 20 
(40%) clusters obtained by spoligotyping were further subdi- 
vided by analysis of VNTRs. Within the three largest clusters 
obtained by spoligotyping, analysis of VNTRs identified 8,11, 
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TABLE 2. Characteristics of clustered and nonclustered patients determined by spoligotyping° 
Characteristic 
Value for group 
Cluster of z2 isolates (n = 180) Noncluster (n = 34) 
P value 
Median age (yr [IQR]) 30 (26-38.7) 31(26.7-37.2) 0.71 
No. male (%) 110 (61.1) 28 (82.3) 0.02 
No. (%) HIV-1 seropositive 138 (77.1) 30 (88.2) 0.17 
No. (%) resistant with isolates to one or 4 (2.2) 3 (9.1) 0.08 
more anti-TB drug 
No. (%) with household crowding level oft' 0.30 
<1 19 (10.8) 4(12.1) 
1-2 29 (16.5) 9(27.3) 
>2 128 (72.7) 20 (60.6) 
No. (%) who ever smoked 59 (32.8) 20 (58.8) 0.004 
No. (%) with: 
BCG scar 161(89.9) 32 (94.1) 0.75 
TB in household in last 5 year 65 (36.7) 12 (35.3) 0.89 
Past history of TB 11(6.1) 5(14.7) 0.08 
Symptoms of HIV infection` 0.70 
1 symptom 53 (29.6) 12 (35.3) 
z2 symptoms 44 (24.6) 9(26.5) 
Harare districts" 0.47 
Median CD4 count (106/liter [IQR]) 232.5 (87443) 262.5 (125-396) 0.83 
Comparison of clusters defined by two or more isolates by analysis of VNTRs (n - 177) and noncluster (n - 21) and those defined as a cluster by both spoligotyping 
and analysis of VNTRs (n - 147) versus noncluster (n - 8) yielded similar results, except that gender was no longer statistically significant. b Calculated from number of dwellers/number of rooms in household. `Chronic diarrhea for >1 month, recurrent pneumonia, wasting syndrome, herpes zoster rash, and persistent genital ulcers. d Eleven districts: Budiriro, Chitungwiza, Dzivaresckwa, Glen Norah, Glen View, Higficld, Kambuzuma, Mbara, Mufakose, Mabunku, and Kuwadzana. 
and 4 additional unique strains, respectively. However, a cor- 
responding fingerprint obtained by analysis of VNTRs was not 
available for five distinct spoligotypes, so the discriminatory 
power of analysis of VNTRs may have been underestimated. 
Risk factors for clustering. To identify risk factors for recent 
infection with M. tuberculosis, the 180 patients whose isolates 
were in spoligotype-defined clusters were compared with the 
34 patients whose isolates were not in clusters. Univariate 
analysis (Table 2) showed that patients whose isolates were in 
clusters were less likely to be male (P = 0.02), less likely to harbor a drug-resistant isolate (P = 0.08), and less likely to have a history of TB (P = 0.08) but were more likely to have 
never smoked (P = 0.004) than patients whose isolates had 
unique DNA patterns. Factors not associated with clustering 
were age, HIV infection status, household crowding level, his- 
tory of TB in the household in the last 5 years, number of 
symptoms suggestive of HIV (i. e., chronic diarrhea of >1 
month, recurrent pneumonia, wasting syndrome, herpes zoster 
rash, and persistent genital ulcers), presence of a BCG scar, 
and CD4 cell count. We found similar results when we com- 
pared the 177 patients whose isolates were in clusters identified by analysis of VNTRs and the 21 patients whose isolates were 
not clustered and when we compared the 147 patients whose isolates were defined as part of a cluster on the basis of both 
spoligotyping and analysis of VNTRs and 8 patients whose isolates were not clustered, except that gender was no longer 
statistically significant in these analyses. In a multivariate anal- 
ysis, we found no independent predictors of clustering. We also 
performed a similar analysis to establish risk factors for mem- 
bership in a large cluster (z6, a12, and Z20 patients with a 
shared strain). We found that a history of TB in the household 
within the last 5 years was significantly less common among 
those within a cluster comprising six or more patient isolates 
with a shared spoligotype and VNTR pattern (30.2%) than in 
patients whose isolates comprised a cluster with less than six 
isolates (60.7%; P=0.003), and the CD4 cell count was sig- 
nificantly higher in the former group than in the latter group 
(320 x 106 and 240 x 106 cells/liter, respectively; P=0.02). In 
a multivariate analysis, a history of TB in the household in the 
last 5 years (odd ratio = 0.24; 95% confidence interval = 0.09 
to 0.68; P=0.007) and infection with a drug-resistant isolate 
(odds ratio = 0.05; 95% confidence interval = 0.003 to 0.95; P 
= 0.05) were inversely associated with the presence of cluster- 
ing. 
Geographic mapping of clusters identified by spoligotyping 
and analysis of VNTRs. Overall, we found no evidence for a 
significantly higher frequency of clustering within certain 
Harare districts of residence or on the basis of the patients' 
rural home districts in Zimbabwe. However, when we repeated 
the analysis according to the individual clusters identified by 
spoligotyping and analysis of VNTRs, 7 of 20 (35%) strains 
that clustered by spoligotyping and 2 of 12 (16.7%) strains that 
clustered by analysis of VNTRs had a higher frequency in 
certain Harare districts (but not the rural home districts) com- 
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TABLE 3. Geographic clusters within Harare districts for 7 of 20 clusters identified by spoligotyping and 2 of 12 clusters identified by analysis 
of VNTRs 
Typing method and No. of patients Frequency (%) in overall 
No. of study patients in cluster Fregsolat (n 
strict 
cluster p value Harare district in district/no. of study patients cluster code in cluster study population isolate in district in district 
Spoligotyping 
777777606060771 68 37.8 Glen View 10/19 52.6 0.14 
Highfield 13/23 56.5 0.06 
Kuwadzana 4/7 57.1 0.25 
Mbare 12/26 46.1 0.25 
Waterfalls 2/2 100 0.14 
777777607760771 23 12.8 Chitungwiza 215 40 0.13 
Dzivaresekwa 2/5 40 0.13 
Kambuzuma 2/3 66.7 0.05 
777777677760771 5 2.8 Glen View 2/19 10.5 0.11 
777777604060731 7 3.9 Mufukose 3/13 23.1 0.01 
777777777760731 25 13.9 Mufakose 4/13 30.8 0.09 
777777606060631 4 2.2 Highfield 2/23 9.0 0.09 
777777606060731 7 3.9 Braeside 2111 18.2 0.07 
Analysis of VNTRs 
2123*2 4 2.0 Highfield 2/26 7.7 0.10 
Glen View 2122 9.1 0.07 
2143*3 127 64.1 Arcadia 212 100 0.41 
Budiriro 8/9 88.9 0.11 
Glen View 16/22 72.7 0.26 
Harare 2/2 100 0.41 
Kambuzuma 3/4 75 0.54 
Mabvuku 6/7 85.7 0.22 
Southerton 3/3 100 0.26 
pared to the frequency of the strain cluster in the overall study 
population, although the differences did not generally attain 
statistical significance (Table 3). Isolates in one large cluster 
identified by spoligotyping (n = 68), which accounted for 
37.8% of all isolates, were found at a higher frequency (>50%) 
in five districts, while a further cluster of 23 isolates (12.8% of 
the study population) was found among >40% of patients in 
three districts. Five other smaller clusters identified by spoli- 
gotyping were also disproportionately represented in certain 
Harare districts. A similar picture emerged with 2 of the 12 
clusters identified by analysis of VNTRs. The largest cluster 
identified by analysis of VNTRs (n = 127), which accounted 
for 64.1% of all isolates, was found at a higher frequency 
(>80%) in five districts, although this did not attain statistical 
significance. A further small cluster of four patients identified 
by analysis of VNTRs was found among patients from only two 
districts. When we mapped the locations of the patients' homes 
on a map of Harare, we found that the vast majority of the 
patients in patient clusters within a particular district resided 
within 0.5 km of each other. 
Relationships between isolates identified by spoligotyping 
(Table 4). Linkage with the International Spoligotype database 
(Pasteur Institute, Pointe A Pitre, Guadeloupe) demonstrated 
that our three largest spoligotype cluster types (International 
Spoligotype Database code numbers 59,53, and 42) are all well 
recognized and ubiquitous in Africa. All clusters between types 
804 and 815 have not yet been described elsewhere and could 
be considered a result of the specific evolution of type 59. Type 
1 is the Beijing/W strain, which was represented by the isolates 
from four patients in the study population, none of whom were 
geographically linked, although two of the patients originated 
from the same rural home district in Chinhoyi, which is just 
north of Harare. Two of the patients infected with the Be- 
jingfW strain also gave a history of a household contact with 
TB within the last 10 years, but none harbored a drug-resistant 
isolate. 
DISCUSSION 
We have used spoligotyping and VNTR typing of an epide- 
miologically well characterized patient population to describe 
the current pattern of TB transmission in Harare, Zimbabwe, 
a country in which HIV and TB are endemic. On the basis of 
shared spoligotype and VNTR patterns, more than three-quar- 
ters of the strains were potentially linked, suggesting a high 
level of recent TB transmission in Harare. This is substantially 
higher than the estimates of recent transmission reported from 
other studies. The proportions of new cases due to recent 
infection have been estimated in cities and countries where the 
rates of endemic TB are low and have been found to be 38 to 
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TABLE 4. Frequency of spoligotypes in Harare, Zimbabwe 
Octal code° 
No. of isolates 




No. of isolates 
observed in Harare 
International Spolijotype 
database code 
000000000003771 4 1 777737774020771 1 218 
077777606060771 1 816 777737777760731 1 73 
100775747413771 1 Not seen 777737777760771 4 37 
457347607760671 1 Not seen 777747606060771 2 808 
477777607760771 4 753 777757606060731 2 82 
477777777760771 3 804 777757777760671 1 83 
517347606060661 1 79 777773604060731 1 84 
557163777760671 1 Not seen 777774606060731 1 Not seen 
557757606060771 1 85 777775606060771 3 809 
577347606060631 1 Not seen 777775770020771 1 
Not seen 
577717606060731 1 Not seen 777776777760771 1 119 
577756777760601 1 Not seen 777777414020731 1 Not seen 
577757604040731 1 Not seen 777777602060771 1 810 
577757606060731 1 Not seen 777777604000171 1 Not seen 
577757606060771 1 87 777777604060731 8 811 
577777603760771 1 Not seen 777777606060571 3 812 
601777606060731 1 Not seen 777777606060631 5 813 
601777606060771 1 Not seen 777777606060631 1 
Not seen 
637775777763770 1 Not seen 777777606060671 4 814 
677777607760771 2 20 777777606060731 9 815 
700046677760671 1 Not seen 777777606060771 68 
59 
700076777760771 1 92 777777607760731 1 60 
700775747473771 1 Not seen 777777607760771 23 
42 
700777747413771 2 129 777777674063771 1 Not seen 
703377400001771 3 21 777777676060771 1 Not seen 
730377600003771 1 Not seen 777777677760771 6 
291 
737417606060731 2 805 777777747473771 1 Not seen 
737777607030771 1 Not seen 777777757760771 1 
44 
737777677670371 1 Not seen 777777757763771 1 
Not seen 
757757606060771 1 Not seen 777777773413731 1 Not seen 
757777606060771 1 Not seen 777777774020731 2 62 
757777777413731 2 806 777777774020771 1 47 
770077606060731 3 807 777777774060771 1 Not seen 
773777606060731 1 Not seen 777777777413771 1 236 
774017606060731 1 Not seen 777777777420731 1 817 
774777777760771 1 801 777777777473771 1 Not seen 
777357606060731 1 Not seen 777777777600771 1 780 
777357607760631 1 Not seen 777777777760671 1 245 
777377607760771 1 81 777777777760771 25 53 
777417606060731 9 184 
Octal codes were determined by the protocol of Dale et at. (7a). b Obtained from the Pasteur Institute, Pointe a Pitre, Guadeloupe. 
41% in New York City (1,14); 32% in Baltimore, Md. (6); 40% 
in San Francisco, Calif. (32); 28% in Berne, Switzerland (16); 
46% in Amsterdam, The Netherlands (37); 28% in France 
(36); and 38% in Seville, Spain (31). Fewer molecular epide- 
miological studies of TB transmission have been undertaken in 
countries where HIV and TB are endemic; and estimates range 
from 25% of 84 TB patients in Honduras (30); 32% of 239 
patients in San Paulo, Brazil, of whom approximately half were 
HIV infected (12); 33% of 51 patients in Guadeloupe (33); 
41% in a study of 41 HIV-positive TB patients from Nairobi, 
Kenya (17); 42% of 301 acid-fast bacillus smear-positive pa- 
tients from Botswana (69% were HIV seropositive) (27); 45% 
of 38 patients in Havana, Cuba (29); 45% of 246 patients (20) 
and 50% of 371 patients (42) in South Africa; 62% of patients 
in Tunisia (24); and 53.6% of 28 TB patients in a small study 
conducted in Harare in 1995 (25). Our high rate of clustering 
suggesting recent transmission probably reflects the high prev- 
alence of HIV infection (74%) in our urban population and the 
relatively young age (median age, 31 years) of our urban pop- 
ulation living in generally overcrowded, high-density housing. 
HIV infection increases susceptibility to exogenous TB infec- 
tion (3), and in turn, primary TB is more likely to develop in 
the first 12 months following acquisition (3). Among HIV- 
infected patients living in New York City and San Francisco, 
more than 60% of new TB cases were the result of recent 
transmission (1,32). These studies also found that the fre- 
quency of strains with clustered patterns was significantly 
higher among seropositive patients (1,32), although this has 
not been a consistent finding (20,27,38). 
The significance of clustering in population-based studies is 
controversial (18). While epidemiological data from urban ar- 
eas strongly suggest that clustering indicates recent transmis- 
sion of TB, in geographically stable rural populations, cluster- 
ing may result from the simultaneous reactivation of infection 
acquired from the same source in the distant past (7) or from 
the predominance of certain well-conserved ancestral strains in 
the population, which would result in an overestimate of recent 
transmission. For example, in a study from Malawi and Kenya, 
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strains from a widespread area were found to have identical 
DNA fingerprints, but no apparent epidemiological links could 
be identified (21). We found that approximately half of our M. 
tuberculosis isolates that clustered by spoligotyping and that 
70% of our M. tuberculosis isolates that clustered by analysis of 
VNTRs belonged to just a few major families of clustered 
patterns. A recent study of strains from countries with a high 
prevalence of M. tuberculosis infection has also suggested that 
the majority of circulating strains in a particular locality belong 
to a limited number of families (24), although Warren et al. 
(41) found a high degree of strain diversity in Cape Town, 
South Africa, where the incidence of TB is high. However, 
despite this, there was still substantial diversity in our typing 
patterns, with 54 different strains detected among our study 
population by spoligotyping and 33 different strains detected 
by analysis of VNTRs, suggesting that the chance occurrence 
of identical patterns among unrelated cases would be unusual. 
Furthermore, with 8 (35%) of 20 clusters identified by spoli- 
gotyping and 2 (17%) of the 12 clusters identified by analysis of 
VNTRs, there was a trend toward a higher rate of clustering 
within certain Harare districts, but statistical confirmation was 
limited by the small sample size. Although we did not under- 
take formal contact tracing to establish the presence of specific 
epidemiological links between these geographically based clus- 
ters, we found that almost all patients within these clusters 
lived within 0.5 km of each other. Importantly, we did not 
identify any clustering according to rural home district, which 
argues against the possibility that these clustered strains reflect 
reactivation of strains acquired from a common source in the 
past. Overall, these observations suggest that cases of TB 
caused by strains with identical spoligotype or VNTR patterns 
in our study are due to recently transmitted disease but that the 
incidence of TB in Harare is strongly influenced by a relatively 
small subset of actively circulating strains. 
Various studies have identified multiple factors associated 
with TB due to recent infection, including young age (1,30, 
32); HIV infection status (1,32); drug resistance (1,12); and 
membership in ethnic minority populations, drug and alcohol 
use, and homelessness (1,14,16,32,37). The only risk factor 
for clustering in a recent molecular epidemiological study from 
Botswana comparable to our study was prior imprisonment (27). In our multivariate analysis, infection with an isolate with 
a pattern found to be part of a cluster was not associated with 
any particular demographic or clinical characteristics, includ- ing HIV infection. However, in the analysis of risk factors for 
membership in a large cluster (six or more strains), unique or 
nonclustered strains were significantly associated with a history 
of TB in the household in the last 5 years, and there was a borderline association with drug resistance. The lack of an 
association between HIV seropositivity and clustering has been 
reported in other studies (20,27,38,42), and in our study it 
most likely reflects the very high HIV type 1 (HIV-1) sero- 
prevalence in the population. Our explanation of the associa- tion between a household history of TB and infection with a 
nonclustered strain rather than a clustered strain is that resi- dence within the various high-density districts of Harare is likely to be the more dominant factor in recent exposure and transmission and that reactivation of TB acquired from a household contact, often years previously, would result in a 
unique strain rather than a clustered strain. Finally, since we 
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enrolled patients with new pulmonary cases of TB only over a 
6-month period, it is unlikely that we would have been able to 
identify a link with a case from many years earlier. 
Comparison with the International Spoligotype database 
demonstrated that our three largest spoligotype clusters are 
well recognized and ubiquitous in Africa. Type 59 is found 
almost exclusively in Africa and was described in a previous 
study in Harare (25). Types 53 and 42 are ubiquitous, with a 
trend for type 42 to be overrepresented in Latin America and 
Mediterranean countries, but probably also in Africa. We iden- 
tified the presence of the Beijing/W genotype strain in four 
patients, none of whom were geographically or epidemiologi- 
cally linked. Strains of the Beijing/W genotype family have had 
a strong impact on the TB epidemics in Asia, Vietnam, and the 
former republics of the USSR (40) and increasingly in other 
geographic regions (19). They have also been associated with 
large outbreaks, some involving multidrug resistance (19). The 
occurrence of the Beijing/W strain in Vietnam has been cor- 
related with young age, suggesting recent transmission (2), and 
its presence in four patients in our study population is likely to 
represent imported transmission. 
The spoligotyping and analysis of VNTR methods together 
confirmed the presence of a cluster of strains in 78.6% of 
patients, whereas 84.1% clustering was found on the basis of 
spoligotyping alone and 89.4% clustering was found on the 
basis of analysis of VNTRs alone. This high level of agreement 
between unlinked genetic markers is consistent with a clonal 
population structure of circulating M. tuberculosis strains (26). 
Analysis of VNTRs was less discriminatory as a first-line fin- 
gerprinting method: 11 of the 12 clusters identified by analysis 
of VNTRs could be further subdivided into distinct subtypes by 
spoligotyping, whereas only 8 of the 20 clusters identified by 
spoligotyping could be further subdivided by analysis of 
VNTRs. However, five spoligotypes did not have a correspond- 
ing VNTR fingerprint, so the discriminatory power of analysis 
of VNTRs may have been underestimated. Overall, the use of 
spoligotyping in tandem with analysis of VNTRs provided ad- 
ditional cluster discrimination and is comparable to that 
achieved by IS6110 RFLP typing (13,26). More recently, a 
promising new molecular typing method based on 12 minsat- 
ellite-like loci containing VNTRs of genetic elements, called 
mycobacterial interspersed repetitive units (MIRUs), has been 
developed (35). The resolution obtained by analysis of 
MIRUs-VNTRs is close to that of typing by RFLP analysis, 
and it is more discriminatory than spoligotyping or analysis of 
VNTRs alone (34). The level of clustering in our study may 
therefore have been less if the isolates had been typed by either 
the RFLP method or a two-PCR-based genotyping strategy of 
spoligotyping with MIRUs. 
Our study has three main limitations affecting the general- 
izability of the data. First, we obtained DNA from only half of 
the patients enrolled in the study. However, the characteristics 
of the patients from whom isolates were and were not used for 
spoligotyping were similar, so this is unlikely to have biased our 
results. Similarly, although our study population was enrolled 
from only one hospital in Harare, the majority of TB patients 
in the city are seen at this hospital, and we therefore believe 
that the patients that we enrolled are representative of the TB 
patients in Harare. We also enrolled only smear-positive pa- 
tients, and given that smear-negative but culture-positive cases 
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can account for considerable TB transmission, our study may 
provide an incomplete assessment of transmission within the 
community (5). However, by confining our analysis to smear- 
positive patients, we could identify the most efficient sources of 
TB transmission. Finally, we excluded laboratory cross-con- 
tamination as a likely reason for the clustering, as none of the 
samples with identical patterns were processed on the same 
day. 
The study has several major implications for TB control. 
First, if chemoprophylaxis is to be used, it must be lifelong to 
cover the constant risk of exposure and not just short term to 
cover reactivation. Similarly, there may be little value in pro- 
longing standard treatment to reduce the likelihood of relapse 
if the majority of cases are due to reinfection. Second, we 
assume that clustering occurs either because the contact is 
immunocompromised and progresses rapidly to disease after 
exposure or because the index case patient delays seeking 
medical attention, resulting in the potential for many second- 
ary cases. If this is the case, then an increased emphasis should 
be placed on the early identification of cases through enhanced 
public health education campaigns, together with stricter im- 
plementation of the traditional methods of TB control, includ- 
ing treatment until cure. 
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Mycobacterium bovis is the causative agent of bovine tuberculosis, with a wide host range. Fifty human M. 
bovis isolates were typed using spoligotyping and variable number tandem repeats (VNTR). Fifteen of these 
spoligotypes have not yet been recorded in cattle. The predominant spoligotype in humans and cattle was 
subdivided by VNTR. 
Mycobacterium bovis has a wide host range, infecting many 
domestic and wild animals. Although occurring relatively 
rarely, M. bovis can also infect humans. In the United King- 
dom, only about 1% of clinically diagnosed cases of tubercu- 
losis (TB) that are subsequently proven bacteriologically are 
attributed to M. bovis, but in the developing world, M. bovis is 
still a cause for concern (6). The resurgence of bovine TB in 
cattle in the United Kingdom is raising concerns that trans- 
mission from cattle to humans might be a serious public health 
issue. It is therefore important to be able to quickly identify 
where rates of M. bovis in cattle are high and pose a potential 
risk of transmission to humans. M. bovis was once a major 
source of TB in humans in the United Kingdom but was almost 
eradicated after the introduction of control measures to reduce 
bovine tuberculosis in cattle together with the pasteurization of 
milk for human consumption. The majority of bovine TB cases 
in the 1980s and early 1990s presented either in the elderly or 
in those who had been infected abroad and returned or mi- 
grated to the United Kingdom (13). Many animals, such as 
badgers, foxes, ferrets, and deer (1,3,9), are believed to act as 
vectors for transmission to livestock, and some have also been 
associated with transmission to humans (8,16,18). Enhanced 
surveillance of M. bovis infections in humans was initiated in 1998. However, in 2001 a revised system which allows more 
timely collection of data was introduced (4,5). Advances in 
molecular typing have provided tools to enhance our knowl- 
edge of M. bovis dissemination. Restriction fragment length 
polymorphism using the insertion sequence IS6110 is consid- 
ered to provide the best discrimination of M. tuberculosis iso- lates. However, M. bovis isolates from cattle usually have a 
single copy of IS6110 (7); therefore, alternative techniques 
such as spacer oligonucleotide typing (spoligotyping) and vari- 
* Corresponding author. Mailing address: Mycobacterium Refer- 
ence Unit, Health Protection Agency, Dulwich Hospital, East Dulwich 
Grove, London SE22 8QF, United Kingdom. Phone: 0208 693 1312. Fax: 0207 346 6477. E-mail: andreagibson78@hotmail. com. t Present address: Silverburn House, by Penicuik, Midlothian, EH26 9LF, United Kingdom. 
able number tandem repeats (VNTR) have been used success- 
fully in discriminating between strains of M. bovis (1,7,11,12, 
15,17). 
This study examines the molecular epidemiology of M. bovis 
cases within the United Kingdom using two molecular typing 
techniques and compares the typing patterns obtained to those 
prevalent in United Kingdom cattle today. 
All available viable M. bovis isolates (50 isolates) from hu- 
mans diagnosed in the United Kingdom between 1997 and 
2000 were identified; 40 were recovered at the Mycobacterium 
Reference Unit, London, and 10 were recovered at the Scot- 
tish Mycobacteria Reference Laboratory, Edinburgh. DNA 
was extracted by using a quick extraction method (19). Briefly, 
one colony was removed using a 1-µl loop and placed in 150 ml 
of water. An equal volume (150 ml) of chloroform was added, 
and the mixture was vortexed and then boiled at 80°C for 20 
min to kill the cultures. 
Spoligotyping was performed using the method described by 
Kamerbeek et al. (15), and VNTR was performed using the 
method described by Frothingham and Meeker-O'Connell 
(11). The size of each exact tandem repeat at each locus (A to 
E) was determined by running the PCR product on an agarose 
gel containing size markers (100-bp ladder; Promega, 
Southampton, United Kingdom) (20-bp ladder; Sigma-Al- 
drich, Dorset, United Kingdom). Deletion typing was carried 
out on a strain with a spoligotype not typical of M. bovis, using 
the method described by Brosch et al. (2). Seven regions of 
difference (RD) were examined: RD 4,7,8,9,10,12, and 13. 
The Hunter-Gaston index (HGI), which is based on the prob- 
ability of two unrelated strains from a test population being 
placed into different typing groups, was calculated to deter- 
mine the discriminatory power of each typing method alone 
and in combination (14). 
Epidemiological information was obtained from internal 
laboratory records at the Mycobacterium Reference Unit and 
Scottish Mycobacteria Reference Laboratory and from existing 
surveillance data held at the Health Protection Agency Com- 
municable Disease Surveillance Centre. 
Spoligotyping of the 50 human M. bovis isolates produced 25 
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FIG. 1. Spoligotyping patterns for human M. bovis isolates in the United Kingdom. Symbols: ", comparison of human M. bovis spoligotypes with 
a bank of M. bovis spoligotypes seen in United Kingdom cattle; **, international spoligotype website is http: //www. Mbovis. org; -T arbitrarily labeled clusters. Superscript numbers: a, most predominant spoligotype (type 9); b, spoligotype not seen in United Kingdom cattle before; c, identical to type 9 except for absence of spacer 15. 
individual spoligotypes (Fig. 1) and had an HGI of 0.90. Thirty- 
two isolates were divided into seven clusters, A to G (Fig. 1). 
The spoligotypes were compared with M. bovis spoligotypes 
from a bank of over 15,000 cattle isolates collected from all 
over the United Kingdom held at the Veterinary Laboratory 
Agency (VI. A) and dating between 1987 and 2002. The largest 
cluster of human M. bovis isolates (15 isolates, 30%) had been 
seen in cattle before and was sequentially numbered type 9 
(international type SB140; http: //www. Mbovis. org) at the 
VLA. Type 9 is the most frequently seen spoligotype of M. 
bovis (over 30% of all isolates have this spoligotype) isolated 
from cattle and has a wide geographical range in the United 
Kingdom (10). 
Human type 9 isolates were seen across the United King- dom, suggesting that transmission between cattle and humans 
might occur. Interestingly, 15 of the human M. bovis spoligo- 
types had not been seen at the VIA in isolates from cattle. When these 15 types were compared to the international spo- ligotype database, only 2 were recognized. The first was iso- lated in Argentina, the second was isolated in Australia, and the remaining 13 spoligotypes were all unique to the United Kingdom. In the majority of these cases, it is likely that disease 
was due to reactivation of a past infection that had been ac- 
quired prior to milk pasteurization rather than to primary infection, because 72.3% of the patients were over the age of 50. (Fig. 2). Therefore, these 13 unique spoligotypes may re- flect M. bovis strains circulating in the United Kingdom over 50 
years ago. 
M. bovis spoligotypes do not usually contain spacers 39 to 43; however, one spoligotype from the panel contained spacers 40 
to 43, which are more commonly seen in M. tuberculosis. Phe- 
notypic and biochemical tests demonstrated that this isolate 
had typical M. bovis characteristics; it was microaerophilic, 
TCH (thiophen-2-carboxylic acid hydrazide) negative, and pyr- 
azinamide resistant, and it grew better on pyruvate than glyc- 
erol Lowenstein-Jensen slopes. 
Deletion analysis was performed to ascertain the identity of 
this strain. The strain contained RD 4,12, and 13 but lacked 
RD 7,8,9, and 10, indicating that this strain is actually M. 
Africanum and not M. bovis. 
VNTR typing alone produced 18 different patterns and had 
an HGI of 0.85. Combining spoligotyping with VNTR vastly 
improved the level of discrimination, producing 34 different 
types and a very high HGI of 0.96. Furthermore, VNTR was 
very useful in subdividing type 9 spoligotypes, separating the 
group into six subtypes (Table 1). 
Epidemiological information showed that the study popula- 
tion was widely distributed across the United Kingdom, had an 
average age of 58.7 years, and had approximately equal pro- 
portions of males and females (21: 17). Where ethnicity was 
known (a total of 15 patients), 14 patients were white and 1 was 
of black-African origin and was originally from Nigeria but had 
lived in the United Kingdom since 1996. This person had a 
unique spoligotype; therefore, it is possible that she was in- 
fected in Nigeria before arriving in the United Kingdom. Of 
interest, 59% (13 of 22) of cases had some contact with a farm, 
ranging from having a Saturday job milking cows, to living on 
a dairy farm as a child, to being a farmer (now retired). One 
spoligotype cluster represents an outbreak on a farm in 









FIG. 2. Number of M. bovis cases by age group. 
female) living on their parents' farm became infected with M. 
bovis. The brother occasionally helped his father on the farm 
by restraining the cattle and would often be sprayed with nasal 
mucus. Cattle infected with M. bovis of the same spoligotype 
had been detected on the farm in previous years. Transmission 
from cattle to human is thought to have occurred by the inha- 
lation of infected aerosols from cattle. The brother is thought 
to have subsequently infected his sister, as she had no contact 
with the cattle but was also diabetic and pregnant, i. e., im- 
muno-compromised. This is thought to be the first case of 
human-to-human transmission since 1990 (R. M. M. Smith, F. 
Drobniewsky, A. L Gibson, J. D. E. Montague, M. N. Logan, 
D. Hunt, R. G. Hewinson, R. L Salmon, and B. O'Neill, 
unpublished data). 
It is important to monitor bovine tuberculosis in humans, 
especially in those who are at high risk of primary infection, 
such as agricultural and abattoir workers, and to identify any 
transmission between animals and humans. A combination of 
spoligotyping and VNTR is an efficient discriminatory tool for 
the molecular surveillance of M. bovis and also addresses the 
problem of analyzing isolates with single copies of IS6110. The 
TABLE 1. Subdivision of spoligotyping clusters by VN1'R 
Spoligo cluster" 
(no. of isolates) 
No. of VNTR 
subtypes VNTR profiles 
A (2) 2 55543 75543 
B (2) 2 55543 75543 
C (2) 1 75553 
D (3) 2 63543 75543 
E (15) 6 56543 63543 65542 
F (6) 2 
65543 75543 75553 
65543 66543 
G (2) 2 54544 55343 
' Arbitarily labeled clusters 
combined VNTR and spoligotyping approach is of value in 
typing M. tuberculosis isolates. Further improvements in these 
techniques might produce a combined system capable of high 
discrimination for all M. tuberculosis complex isolates in hu- 
mans or other mammals. 
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We describe the first documented spillover of bovine 
tuberculosis from animals into the human population of the 
United Kingdom since the resurgence of the disease in cat- 
tle in the country. This finding suggests that there may be a 
small risk for transmission to humans, making continued 
vigilance particularly necessary. 
In the past, Mycobacterium bovis was a major source of tuberculosis in humans through consumption of unpas- 
teurized milk. Currently, tuberculosis as a result of M. 
bovis infection is comparatively rare, but it remains a 
cause for concern in persons at high risk, such as abattoir 
workers (1). M. bovis principally affects cattle, but it can 
cause disease in a range of wild and domesticated animals, 
for example, badgers, ferrets, cats, deer, and llamoids (2). 
In U. K. cattle, M. bovis infection is now primarily a pul- 
monary disease, and the main route of transmission is like- 
ly to be through aerosol dissemination. Currently, 
approximately 1% of human tuberculosis cases can be 
attributed to M. bovis; most of those are likely to follow 
reactivation (3) or to be recent infections contracted 
abroad. Tuberculosis caused by M. bovis in the young is 
usually a primary infection. We report two human cases in 
Gloucestershire. One of the cases may have resulted from 
intrafamilial spread. 
Case Studies 
Bovine tuberculosis was diagnosed in two siblings- 
one currently residing, the other residing until recently, on 
their parents' farm in Gloucestershire- in 1999. A broth- 
er and sister ages 20 and 17 years, respectively, they are 
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thought to have the first cases of indigenously acquired 
bovine tuberculosis caused by M. bovfs in persons <25 
years of age, with no documented history of travel abroad, 
reported to the Public Health Laboratory Service 
Communicable Disease Surveillance Centre (CDSC) since 
1990. 
When seen by her physician in 1999, the 17-year-old 
girl had a 6-month history of cough, weight loss, and 
lethargy. Infection with acid- and alcohol-fast bacilli 
(AAFB) was confirmed by culture of bronchial washings. 
Her brother had an 18-month history of cough. He was 
subsequently found to be AAFB-smear positive with pul- 
monary cavitation (i. e., he had an infectious case). 
Sputum samples from both case-patients were cultured by 
the Gloucester Public Health Laboratory, and the cultures 
were identified as M. bovis by the Regional Centre for 
Mycobacteriology in Cardiff. All human M. tuberculosis 
isolates are subjected to biochemical analysis and pyrazi- 
namide drug susceptibility testing for differentiation of M. 
bovis. M. bovis is therefore detected as part of the routine 
reference service. 
Both siblings had lived on the same farm most of their 
lives. However, the sister had recently moved into her own 
place at the time of her diagnosis. Both patients had 
received Mycobacterium bovis BCG in secondary school. 
Both smoked. Neither had knowingly drunk unpasteurized 
milk. The girl had no cattle contact. Her brother had occa- 
sional cattle exposure: he would assist when stock were 
confined in a cattle crush' for veterinary examination and 
restrained them by holding their nostrils. During this 
process, he could become covered in bovine mucus and 
saliva. He also reported contact with feral ferrets. 
No disease has been reported in other family members 
or in social contacts. Results of screening of other family 
members (mother, father, and another sibling) were unre- 
markable. Their father had a grade 2 Heaf test result (and a 
previous history of BCG) (this is equivalent to a Mantoux 
response of induration of diameter 5 to 14 mm). Their 
mother had two grade 1 Heaf test results (Mantoux 
response of 0 to 4-mm induration) and no history of BCG. 
The other sibling (age 8) had a grade 1 and a grade 2 Heaf 
test result and no history of BCG. Heaf grades 0 and 1 or a 
Mantoux response of 0 to 4 mm induration are regarded as 
negative; those with a grade 2 reaction (or a Mantoux 
response of induration of diameter 5 to 14 mm following 
injection of 0.1 mL purified protein derivative 100 U/mL) 
are positive. Persons with a grade 2 response are hypersen- 
sitive to tuberculin protein and are not given BCG vaccina- 
tion. A strongly positive reaction to tuberculin is 
'A cattle crush is a small, often portable, cage used to restrain Indi- 
vidual animals. Crushes are often used In the United Kingdom to 




demonstrated by a Heaf grade 3 or 4 or a Mantoux response 
with induration of at least 15-mm diameter. 
The farm had previously held a maximum of 25 beef 
cattle, introduced around 1981. Tuberculosis (M. bovis) 
herd breakdowns2 had been recorded by the former 
Ministry of Agriculture, Fisheries and Food. Five cattle (of 
7 slaughtered in a herd of 15) had bovine tuberculosis in 
1993; they had caseous lymph node lesions and were cul- 
ture positive. Another three (out of the herd of eight, which 
were all slaughtered) had similar lesions in 1997. All 
infected cattle showed lesions typical of M. bovis with 
confirmatory culture obtained; one had prescapular lymph 
nodes enlarged with caseous changes. The remaining ani- 
mals were slaughtered as "direct contacts. " Tuberculosis 
breakdowns have been reported in neighboring herds, and 
the area supports a substantial badger population. After the 
1993 cattle breakdowns, five badgers were trapped; four 
were positive for M. bovis on culture. Similarly, in 1997, a 
single trapped badger was culture positive. 
Conclusions 
M. bovis from the cases and from cattle on the farm in 
1997 were indistinguishable by a combination of restric- 
tion fragment length polymorphism (RFLP) analysis using 
the IS6110 element, spacer oligonucleotide ("spoligotyp- 
ing"), and variable number tandem repeat (VNTR) analy- 
sis (4-6). RFLP analysis using the IS6110 insertion 
sequence represents the standard criterion for differentiat- 
ing M. tuberculosis, but it is insufficiently discriminating 
for M bovis due to the paucity of IS6110 elements in the 
genome of this bacterium. Spoligotyping is based on the 
polymerase chain reaction (PCR) amplification of a poly- 
morphic direct repeat (DR) locus in which the DR ele- 
ments are interspersed with up to 43 spacer regions 
(Figure). The typing process relies on the presence or 
absence of spacers in the amplified DNA, which are 
detected by hybridization to a series of synthetic spacer 
oligonucleotides covalently linked to a filter. The presence 
of hybridized areas is shown by using a chemiluminescent 
reaction detected on film as a dark band; absence of spac- 
ers shows no binding. The sequence is then displayed as a binary bar code, which can be manipulated digitally. 
Similarly, VNTR analysis uses PCR to amplify a region in 
which there are tandem repeats at multiple loci. The result is a digital code describing the number of repeat units at 
each locus (Figure). The spoligotype profile obtained in 
these cases is one of the most common seen in bovine 
tuberculosis in the United Kingdom, and caution is needed before one can say unambiguously that strains have been 
transmitted. Nevertheless, the combination of typing meth- 
ods, together with supportive epidemiology, provides evi- 
dence of exposure to a common source of infection. 
M. bovis was characteristically transmitted to humans 
H3! RV  //////////////////ýý///////////ýýýý//////  
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Figure. Spoligotyping profiles for human and cattle cases of bovine 
tuberculosis. H37Rv and BCG are control strains. 99/6702 and 
99/6703 are from the sister and brother, respectively; 
99/8147-99/8152 are cattle isolates. 
by ingestion of infected milk. Thus, historically, human M. 
bovis lesions were primarily extrapulmonary or intestinal. 
Cattle infected with M. bovis, by contrast, usually have 
pulmonary infection, and shedding of M. bovis in respira- 
tory secretions has been reported by several workers (7-9). 
It is suggested that a possible route of badger to cattle 
transmission is by inhalation of bacilli from grass contam- 
inated with infected badger urine, feces, or sputum (10). 
Cattle preferentially graze edges of fields, and they may 
sometimes be forced to graze close to badger latrines and 
scent-marking areas at the edge of fields. Cattle-to-cattle 
transmission of M. bovis is also likely to be important. 
Work to date (11) indicates that particular tuberculosis 
spoligotypes are usually clustered in specific areas, imply- 
ing that herd breakdowns are localized events originating 
from a relatively static reservoir. In many instances, cattle 
and badgers have been found to share similar spoligotypes 
(11), but further sampling of badgers, cattle, and other 
wildlife is required to identify which species can share the 
infection. Current Department for Environment Food and 
Rural Affairs research is aimed at establishing the epidemi- 
ology and pathogenesis of M. bovis and the possible path- 
ways of interspecies transmission. 
Agricultural workers may acquire the disease by inhal- 
ing cough spray from infected cattle. Typical pulmonary 
tuberculosis then develops, which is what we believe 
occurred here. 
Despite a long history of cattle herd breakdowns on this 
farm, the family members were not screened until the 
human cases occurred. Early detection of the disease in the 
young man before it became infectious might have pre- 
vented transmission to his sister and avoided the need for 
chemoprophylaxis for her infant son. No guidelines were 
in force at the time. Those subsequently issued (12) advo- 
cate screening of human contacts of disease only where 
pulmonary or udder lesions are detected in cattle. Since the 
early 1980s, reports of cattle herd breakdowns have steadi- 
2A tuberculosis breakdown is confirmed when a visible lesion, typ- 
ical of tuberculosis, is seen by an official veterinary officer in the 
carcass of a tuberculosis reactor at postmortem or, If 
Mycobacterium bovis is cultured from the set of lymph glands that 
are routinely collected at postmortem and sent to a state veterinary 
laboratory for culture. 
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ly risen, with a more dramatic increase since 1990. The 
Southwest of England, the West Midlands, and South and 
West Wales have had recent increases in disease in cattle, 
and this trend is extending northward to include 
Derbyshire, Staffordshire, and Shropshire. This incident 
represents the first documented probable spillover into the 
human population from animals since the disease's resur- 
gence in cattle, and it suggests there may be a small risk for 
transmission to humans, even when the bovine case is 
reported as closed, 3 because of the presence of M. bovis in 
the cattle's respiratory tract (7). 
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Can 15-Locus Mycobacterial Interspersed Repetitive 
Unit-Variable-Number Tandem Repeat Analysis 
Provide Insight into the Evolution of 
AQ: A Mycobacterium tuberculosis? 
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The phylogeny and evolution of the bacterium Mycobacterium tuberculosis Is still poorly understood despite 
AQ: C the application of a variety of molecular techniques. We analyzed 469 M. tuberculosis and 49 Mycobacterium 
bovis isolates to evaluate if the mycobacterial interspersed repetitive units-variable-number tandem repeats 
(MIRU-VNTR) commonly used for epidemiological studies can define the phylogeny of the M. tuberculosis 
complex. This population was characterized by previously Identified silent single-nucleotide polymorphisms 
(sSNPs) or by a macroarray based on these sSNPs that was developed In this study. MIRU-VNTR phylogenetic 
AQ: n codes capable of differentiating between phylogenetic lineages were identified. Overall, there was 90.9% 
concordance between the lineages of Isolates as defined by the MIRU-VNTR and sSNP analyses. The MIRU- 
VNTR phylogenetic code was unique to M. bovis and was not observed In any M. tuberculosis Isolates. The codes 
were able to differentiate between different M. tuberculosis strain families such as Beijing, Delhi, and East 
AQ: E African-Indian. Discrepant Isolates with similar but not exactly Identical MIRU-VNTR codes often displayed 
a stepwise trend suggestive of bidirectional evolution. A lineage-specific panel of MIRU-VNTR can be used to 
subdivide each lineage for epidemiological purposes. MIRU-VNTR is a valuable tool for phylogenetic studies 
and could define an evolutionarily uncharacterized population of M. tuberculosis complex organisms. 
Fnl Despite the application of several molecular markers, rela- 12-locus MIRU has been used in combination with other tech- 
tively little is known about the evolution of Mycobacterium niques such as spoligotyping to investigate the evolution of M. 
tuberculosis (3,5,10,27), the bacterial species which causes 2 tuberculosis complex (11,17,27), but to our knowledge, no 
million deaths and 8 million new cases annually (8,25). studies have utilized 15-locus MIRU-VNTR to define evolu- 
Genotyping techniques based on neutral genetic, variation tionary pathways characterized by silent single-nucleotide 
such as multilocus sequence typing (MIST) have been used " ""'polymorphism (sSNP) analysis. 
successfully to characterize bacterial populations (6,9,15, =20). ; - .-, 
Based on the SNP-defined phylogenetic tree (1), we evaluate 
Although the M. tuberculosis genome is thought to be highly the use of MIRU-VNTR, commonly used in epidemiological 
conserved (23,28), sufficient neutral variation was found investigations, as a rapid tool for the phylogenetic classification 
within genes associated with drug resistance in M. tuberculosis of M. tuberculosis and M. bovis. To validate the MIRU-VNTR 
AQ- F complex isolates for construction of a robust phylogenetic tree, phylogenetic classification, an additional panel of M. tubercu- demonstrating that M. tuberculosis is clonal and is subdivided losis and M. bovis strains was characterized with an sSNP mac- into four distinct lineages while Mycobacterium bovis is closely roarray tool (the development of which is described here) and 
related but is found on a separate branch (1). concordance with MIRU-VNTR was examined. MIRU-VNTR (mycobacterial interspersed repetitive units- 
variable-number tandem repeats) is a high-throughput tech- MATERIALS AND METHODS nique that analyzes the number of tandem repeats at loci distributed around the M. tuberculosis enome Studies (30). have explored MIRU-VNTR as a tool for discriminatin be- 
Mycobacterial strains. A panel (panel 1. test population) of 312 M. tubercu- 
losis clinical isolates collected in England and Wales between 1 January and 31 
r both of the D b 1998 hi hi l d d ll i l i g tween strains and in comparison with other molecular tech- 
ecem ,w nc u e a so er c ates res stant to one o 
first-line antituberculous drugs (isoniazid and rifampin) and 100 randomly cho- 
niques (4,16,19,21,26,30), but there are few published sen fully susceptible isolates, as well as 4 M. boar isolates (1), was typed using 
, 4Q- G reports on the use of MIRU-VNTR to study the evolution of 
MIRU-VNTR (12 MIRU plus exact tandem repeats [ETRI A. B, and C the two 
the M. tuberculosis com lex. VNTR anal sis usin 5-locus and pYg 
remaining ETR, D and E, are included within the 12 MIRU and correspond to 
MIRU 4 and IIV All members of this nand had nrwiAýisly been classified into 
Corresponding author. Mailing address: HPA-MRU, Clinical Re- 
search Centre, Barts & The London, Queen Mary's School of Medi- cine and Dentistry, 2 Newark St., Whitechapel, London, El 2AT, United Kingdom. Phone: 44 207 377 5895. Fax: 44 207 5393 459. E-mail: francis. drobniewski@qmul. ac. uk. t Present address: University Hospital Lewisham, Lewisham High Street, London, United Kingdom. 
one of five lineages according to the presence of four characteristic sSNPs (1). 
The laboratory reference strain M. tuberculosis H37Rv (which had been charac- 
terized by sSNP) was also MIRU-VNTR typed. 
A second panel (panel 2, validating population) of 205 isolates containing an 
additional 80 M. tuberculosis isolates from 1998 and 80 isolates from 2004, both 
collected in England and Wales (two different time windows were chosen to 
ensure that the results seen were reproducible and not unique to 1998, the year 
in which the panel 1 strains were isolated), and 45 M. bovis isolates from a panel 
previously described (14), were analyzed using MIRU-VNTR loci. The M. tu" 
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TABLE I. Primer sequences for the macroarray development solution (75-mg/ml nitroblue tctrazolium [U. S. Biochemicals, 
AQ: L Gene Primers (5'-3') Product size (bp) 
Cleveland, Ohio] in 70% dimethylformamide and 50-mg/ml 5-bromo-4-chloro- 
3-indolylphosphate [U. S. Biochemicals] in 100% dimethylformamide) for 1 h. 
oxyR ATCGCCGCCAAGAGGTGCTA 311 
AQ: M TCACGCACTGCACGACGGT 
katG TGTCCCGTCGTGGGTCATAT 370 RESULTS 
TTGTCCAAGCTGGCGTTGT 
rpoB TGCGTGTGTATGTGGCTCAGAAA 159 MIRU-VNTR analysis of panel 1. A test population of 312 CGCCGTGGGTGTTCAAAATAAT 
rpoB GTAAGGCGCAGTTCGGTGG 203 
M. tuberculosis isolates classified by sSNP analysis into four M. 
TITGAGCAGCACCTTGAACGA tuberculosis lineages plus M. bovis (1) was typed using 15-locus 
MIRU-VNTR profiling. MIRU-VNTR profiles were obtained 
from 309/312 (99.0%) M. tuberculosis isolates (the remaining 3 
were removed from further analysis) and 4/4 (100%) M. bovis 
berculosis isolates were all randomly chosen from 1998 and M. The M. bovis 
isolates. These isolates were examined to determine whether 
strains included all available isolates between 1997 and 2001 collected at the any single MIRU-VNTR polymorphism or combination of Health Protection Agency National Mycobacterium Reference Unit (HPA- polymorphisms was common to each lineage and could poten- MRU). Panel 2 was characterized with a macroarray developed in this study to define sSNPs seen in each of the five lineages. The validation was performed 
tially be used to define each lineage. 
blinded. Results were compared only once a lineage based on each technique had 
Analysis of MIRU-VNTR profiles showed that the allelic 
been determined. diversity at certain loci was conserved while others varied con- 
Validation of the macroarray. The macroarray was validated on a subpancl of siderably. No single MIRU-VNTR polymorphism was exclu- 46 previously genotyped isolates from panel 1(1). sive to a lineage. By using a combination of polymorphisms, MIRU-VNTR analysis. 'Iwelve-MIRU fragment analysis was carried out on a CEQ2000 DNA capillary sequencer (Beckman Coulter Fullerton Calif ) as each of 
the five main phylogenetic branches of the tree could 
, , . described previously (19) and was supplemented with three loci: ETR-A, ETR-B, be defined. For example, in lineage I the majority of isolates 
and ETR-C (13). Three capillaries were used per isolate. Capillary 1 was used for (95%) contained 3 copies of MIRU-39 and 4 copies of ETR-A, AQ: H MIRU-4 and -16 (dye2), MIRU-2 and . 24 (dye3), and MIRU-10 and . 23 (dye4). and all isolates contained 4 copies of ETR-C (Table 3). Taken Capillary 2 was used for MIRU-39 and ETR-A (dye2), MIRU-27 and ETR-B ^ together, 90% of the isolates in lineage I contained all three (dye3), and MIRU-31 and -40 (dye4). Capillary 3 was used for MIRU-20 (dye2), MIRU ETR-C (dye3), and MIRU-26 (dye4). MIRU-VNTR profiles were ana- polymorphisms, 
i. e., they defined lineage I. The same analysis 
lyzed using a categorical similarity coefficient (which scores all characters equally was performed on the other lineages. 
AQ: I and considers any different state as no match and any identical state as a full lineage III was highly conserved, with 98.4% of isolates 
match) and were displayed using the unweightcd-pair group method using av- containing the two polymorphisms defining their group, i. e., 5 erage linkages. 
DNA macroarray. Biotin-labeled primers, based on the published sequences of 
copies of MIRU-23 and 2 copies of ETR-C. Lineage IV also 
tuberculosis osis H37Rv and CDC1551, were designed to flank the four aSNPs of Al. displayed a high level of conservation, with 96.7% of isolates 
TI interest (in oayR, ka1G, and rpoB) (Table 1). PCR was carried out in a final containing 2 copies each of MIRU-24 and MIRU-26. The code 
AQ: J volume of 20 ILI, containing 5 Id sterile distilled water, 10 µl 2x reaction buffer for lineage II was more variable; therefore, identifying a single (3 mM MgCl2,3.2 mM deoxynucleoside triphosphatcs, 2x NH4 buffer), 5 µl of defining allele at any locus was difficult. Instead, a combination primer mix (2 µM each primer), 0.2 µl Taq polymerase (5 U/µl; Bioline, London, 
United Kingdom), and 1 pl template DNA. Amplification was performed in of alleles at each locus was used-1,2, or 3 copies of MIRU-16, 
0.2-µl thin-walled 96-well plates (Alpha, Eastlcigh, United Kingdom) in a Per-, 2 copies of MIRU-39, and 1 or 2 copies of ETR-B which kin-Elmer Cetus 9600 Thermocycler with the following program: 3 min at 95°C, defined 92.7% of isolates. M. tuberculosis H37Rv, which be- followed by 30 cycles of 15 s at 95°C, 30 s at 60°C, and I min at 72°C, and one longs to lineage 11, also displayed a lineage II code. final cycle of 5 min at 72°C. 
Two probes were designed per region of interest, one with the wild-type 
All M. bovis isolates contained the three polymorphisms 
sequence according to the published sequences for M. tuberculosis H37Rv and 
defining their lineage; however, only four isolates were exam- 
CDC1551, the other containing the sSNP of interest (1). Each probe was 19 to fined originally by Baker et al. (1). We confirmed that this code 
T2/AQ: N 25 nucleotides long and contained a poly(T) tail of 20 bases (Table 2). was robust by characterizing 45 additional M. bovis isolates Each oligonuclcotide (20 µM containing 0.001% bromophenol blue), an ink with the macroarray and MIRU-VNTR (results below). dot (for membrane orientation), and a color detection control (2 µM of aryl? 
primer) were dotted onto a nylon membrane (see Fig. 1) and fixed by UV 
Macroarray analysis. Based on the sSNP analysis described 
cross-linking. The membrane was washed twice in wash solution (0.5x SSC [1 x by Baker et al. (1), a macroarray was developed to identify SSC is 0.15 M NaCl plus 0.015 M sodium citrate}-0.1% sodium dodecyl sulfate lineage-defining sSNPs and was validated using 46 strains be- [SDS]) for 5 min and allowed to air dry. 
Twelve microliters of amplified axyR-37 and rpoB-3243 fr h 
longing to panel 1. The macroarray and original sSNP results 
om eac sample were combined. ka: G. 87 and rpoB-2646 amplified products were first diluted 1: 10 and 
were concordant, i. e., the macroarray correctly identified the 
. then 12 µl was added. The DNA mix was denatured at 100°C for 10 min 
lineage of each isolate based on the detection of probe-defined 
. Hybridization and detection were performed as previously described (24) with sSNPs. The hybridization patterns for each lineage are shown the following modifications. Denatured DNA and 500 µl of hybridization solu. tion (5x SSPE [lx SSPE is 0 18 M NaG 10 mM NaH PO 
in Fig. 1. For example a lineage 1 isolate displays a positive 
, . 2 4, and 1 mM EDTA (PH 7.7)1-0.5% SDS) were incubated with a membrane for 1h at 60°C Mem- 
hybridization signal at the wild-type cuyR-37, katG-87, and 
. branes were washed twice in stringent wash buffer (0.3x SSPE-0.5% SDS) for 1 rpoB-2646 probes, while at rpoB-3243 a positive hybridization min at room temperature and then once in stringent wash buffer at 60°C for 10 min. The followi signal 
is observed for the mutant probe. 
ng washes were all carried out at room temperature. Membranes were washed twi i i 
MIRU-VNTR analysis of panel 2. In order to validate the 
ce nr nse buffer (0.1 M Tris, 0.1. M NaCl, pH 7.5) and then incubated for 1 min in 5 ml rinse buffer containing 0.5% blocking reagent before 
MIRU-VNTR codes defined with the test population, panel 2 
addition of streptavidin-alkaline phosphate (Roche, East Sussex, United 
(205 isolates) was MIRU-VNTR typed and analyzed for sSNPs 
Kingdom) and incubation for 30 min. Membranes were washed twice with rinse buffer (0 1MT 0 i 
with the macroarray. Overall, there was 88.8% concordance 
b . s, r .1M NaCl, pH 7.5) for 1 min and then equilibrated in a second rinse buffer 0 1M etween the lineages of all isolates defined 
by the macroarray 
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dant, demonstrating that in the majority of cases M. bovis can 
easily be differentiated from M. tuberculosis. Within the M. 
tuberculosis lineages alone, the level of concordance ranged 
from 81.3% to 100% (Table 4). 
Analysis of both panels by MIRU-VNTR. Combining panels 
1 and 2 gave 518 isolates (465 M. tuberculosis and 49 M. bovis 
isolates) analyzed by both MIRU-VNTR and sSNP (DNA 
sequencing or the macroarray). Overall, there was 90.9% con- 
cordance between lineage-defined MIRU-VNTR phylogenetic 
codes and sSNP-defined lineages. The percentage of definable 
isolates ranged from 86.1 to 99.0% for M. tuberculosis and was 
89.8% for M. bovis (Table 5). 
Discrepant results. Since sSNPs display neutral variation, 
they are unlikely to be under any selection pressures. The 
sSNPs discussed here are concordant with other genetic and 
phenotypic groupings (including genetic groups 1 to 3, M. 
tuberculosis-specific deletions, spoligotyping, and IS6110 fam- 
ilies) (1), and therefore they are likely to be definitive. Any 
disagreement with the sSNP-defined lineages was considered 
discrepant. Overall, 47 (9.1%) discrepant results were ob- 
served, i. e., the MIRU-VNTR code did not match the lineage 
defined by sSNP analysis (Table 6). Of the M. tuberculosis 
isolates, 27/42 (64.3%) did not match any of the defined 
MIRU-VNTR codes but had a MIRU-VNTR code very sim- 
ilar to that for one of the four lineages, and in each case this 
matched the lineage defined by sSNP analysis. For example, 
five isolates with lineage II discrepancy b had a VNTR code 
1 similar to that of lineage 11. These isolates differed at MIRU- 
39, possessing 1 copy instead of 2 copies. Three isolates with 
lineage II discrepancy g contained 5 copies of MIRU-16 and 3 
a copies of ETR-B as opposed to the predicted profile, 2 or 3 
copies of MIRU-16 and 1 or 2 copies of ETR-B. In all lineages, 
. t, the allelic diversity at the discrepant loci displayed a stepwise 
trend. For example, isolates with discrepancies b to e in lineage 
11 contained either 1 or 3 copies of MIRU-39 instead of 2 
copies, and isolates with discrepancy g or i contained 3 copies 
of ETR-B instead of 1 or 2 copies. These discrepancies support 
the presence of sublineages within lineage II. 
Twelve M. tuberculosis isolates had MIRU-VNTR codes for 
two lineages. Three isolates defined as lineage II by sSNP 
analysis had the MIRU-VNTR codes for both lineages 11 and 
III, and nine isolates defined as lineage IV had the code for 
this lineage plus another M. tuberculosis lineage code. The 
phylogenetic code for lineage IV was exclusive and was not 
observed in any other lineage; therefore, it seems that any 
discrepant isolate containing the MIRU-VNTR code for lin- 
eage 1V should be designated a lineage IV strain. However, the 
MIRU-VNTR code for lineage 11 was not exclusive, making it 
difficult to determine to which lineage these isolates belonged. 
Only 2/245 (1.2%) isolates in lineage 11 had two codes; there- 
fore, the chances of this occurring are probably low. Interest- 
ingly, if the code for lineage II is modified by only counting 2 
copies of ETR-B instead of 1 and 2 copies, then the code 
becomes highly conserved and is not observed in any other 
lineage. However, the increase in specificity is outweighed by 
the loss in sensitivity, reducing the proportion of isolates de- 
fined from 92.7% to 76.3%. 
The remaining three discrepant strains were defined as lin- 
eage I according to sSNP analysis, but all had the lineage II 
code and a partial code for lineage I. All three had a Beijing 
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TABLE 3. MIRU-VNTR phylogenetic codes for each 
lineage based on panel I 
Lineage MIRU-VNTR code" (no. of 
AO: 0 
nea isolates with correct repeat 
nottotal isolates [%]) 
AQ: P 
Combined MIRU-VNTR` 
No. of isolates with 
Code correct combined 
repeat nottotal 
isolates (%) 
APPL. ENVIRON. MICROBIOL 
TABLE 4. Number of isolates in panel 2 belonging to each 
lineage according to the macroarray and concordance 
with MIRU-VNTR results 
Comparison of macroarray 
Lineage with MIRU-VNTR No. of Defined MIRU-VNTR defined 
macros ay 
isolates loci-repeat no. b 
No. (%) of 
Y Concordance discrepant 
1 (20) 39-3 (19/20 [95]) 39-3 18/20(90) 
rcbwLs 
A-4 (19/20 [95]) A-4 I 16 39-3, A4,04 13/16 (81.3) 3 (18.8) 
C. 4 (20/20 [100]) G4 II 79 16-1,2,3,39-2, B-1,2 68/79 (86.1) 11(13.9) 
11 (168) 16-1,2,3 (164/167 [98.2]) 16-1,2,3 153/166 (92.7) III 38 23-5, C-2 38/38 (100) 0 (0.0) 
39-2 (160/167 [95.8]) 39-2 IV 27 24-2,26-2 23/27 (85.2) 4(14.8) 
B-1,2 (1621166 [97.6]) B-1,2 M. bovis 45 10-2,40-2, C-5 40/45 (88.9) 5 (11.1) 
111 (62) 23-5 (61/62 [98.4]) 23-5 61/62 (98.4) 
C-2 (62/62 [100]) C-2 Total 205 182 (88.8) 23 (11.2) 
IV (62) 24-2 (61/61 [100]) 24-2 59/61 (96.7) 
26-2 (60/62 [98.8]) 26-2 ° Combination of MIRU-VNTR (with repeat number at each locus) producing 
M. bovis (4) 10-2 (4/411001) 10-2 4/4 (100) the most unambiguous definition of each lineage. Numbers stand for MIRU (e. g., 39-3 indicates 3 copies of MIRU-39); letters stand for ETR (e. g., A-4 40-2 (4/4 [100]) 40-2 
G5 (4/4 [100]) G5 
indicates 4 copies of ETR-A). 
° Expressed as the number of isolates with concordant results/total number of 
° Some loci would not amplify; therefore, two isolates from lineage II and one 
isolates (percent). 
isolate from lineage IV were excluded from the analyses, leaving a total of 309 M. 
tuberculosis isolates in panel 1. b Each code consists of the MIRU (numbers) or ETR (letters) designation followed by a dash and the number of copies. For example, 16-1,2,3 indicates 1, MIRU-VNTR discrimination. Once a population of strains 2, or 3 copies of MIRU-16; A-4 indicates 4 copies of ETR-A. ` Combination of MIRU-VNTR producing the most unambiguous definition 
has been assigned to a lineage, it would be useful for epide- 
of each lineage. The number and percentage of isolates tested that were correctly miological studies to be able to subdivide lineages into epide- identified using this combination are given. "" " "miologically linked and unique isolates. The discriminatory 
power of each MIRU-VNTR locus was examined, and a spe- 
cific set of MIRU-VNTR capable of subdividing each lineage 
spoligotype (spacers 1 to 34 absent, spacers 35 to 43 present) was determined (Table 7). Because the MIRU-VNTR used to Ti 
and may represent evolutionary intermediates. define each lineage were conserved, they would not be useful 
Of the discrepant M. bovis isolates, all five had different for epidemiological studies, where the ability to detect maxi- 
codes. Again, a stepwise trend was seen among the discrepant mum diversity is required. A combination of six loci (MIRU- 
isolates. For example, 2,3,4, and 5 copies of ETR-C were 16, -26, -27, -31, and -20 and ETR-A), when applied to lineage 
observed. I isolates, was able to generate the same degree of discrimina- 
Indeterminate isolates. Four isolates not assigned a lineage 'tion as the 15-locus MIRU-VNTR overall. The number of 
in the Baker et al. panel (1) because of incomplete MIST data"'-- -ý MIRU-VNTR loci could not be reduced for lineage II without 
were analyzed by MIRU-VNTR to determine whether they. _ _, reducing the 
discrimination. Nine loci in lineage III (MIRU- 
_ could be classified using these codes. Three isolates had the 10, -16, -20, -26, -27, -31, -39, and -40 and ETR-B) and eight in MIRU-VNTR code for lineage II and none of the other codes. lineage IV (MIRU-4, -10, -31, -39, -40, and -23, ETR-A, and 
The remaining isolate had a code similar to that for lineage I ETR-B) differentiated all isolates. The greatest discrimination 
except that it had 5 copies of ETR-A instead of 4. sSNP within the M. bovis lineage was achieved with eight 
loci: 
macroarray analysis confirmed that three of the isolates were MIRU-23, -24, -26, and -27, ETR-A, ETR-B, and a combina- indeed from lineage II and the remaining isolate was from tion of two MIRU-VNTR from MIRU-4, -31, and -39. 
How- 
lineage I. ever, if a lower level of discrimination is acceptable, then an 
even smaller number of MIRU-VNTR can be used, which may 
be of value for laboratories with resource constraints. For 
Una`° 1 2 3 4 M. bovis 
.. r 
-. t It .. ý, I 1 
ir 
'e "- q 14" 's 
, . 
FIG. 1. Hybridization patterns corresponding to the sSNP defining each lineage. Orientation of probes from left to right and top to bottom: ink spot, color development control, four blanks, wild-type axyR-37, mutant oxyR-37, wild-type katG-87, mutant katG-87, four blanks, wild-type rpoB-2646, mutant rpoB-2646, wild-type rpoB-3243, and mutant rpoB-3243. Blanks were included to extend the length of the macroarray for ease of handling. 
TABLE 5. Number of isolates belonging to each lineage according 
to sSNP analysis and concordance with MIRU. VNTR results 
for all M. tuberculosis and M. bovis isolates tested 
Lineage defined 
by sSNP 
Total no. of 
isolates tested' 
Concordance with 
MIRU"VNTR results (%) 
I 36 31(86.1) 
II 245 220 (89.8) 
III 100 99 (99.0) 
IV 88 77(87.5) 
M. bovis 49 44 (89.8) 
Total 518 471(90.9) 
I Excludes three isolates from panel I that did not amplify. 
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TABLE 6. Discrepancies observed in each lineage from a total population of 518 isolates 
Lineage Defined MIRU-VNTR No. of times loci-repeat no. Discrepancy Discrepant MIRU-VNTR code(s)" observed 
1 39-3, A-4, C-4 a 39-2, A-3,04 + code for lineage II 1 
b 39-2, A-4, G4 + code for lineage II 2 
c 39-3, A-3, C-4 I 
e 39-4, A-4, C-4 I 
II 16-1,2,3,39-2, B-1,2 a Codes for lineages II and III present 3 
b 16-3,39-1, B-2 5 
c 16-3,39-1, B-1 2 
d 16-1,39-3, B-1 I 
e 16-3,39-3, B-2 4 
f 16-4,39-2, B-2 4 
g 16-5,39-2, B-3 3 
h 16-1,39-2, B-3 2 
i 16-3,39-2, B-3 1 
III 23-5, C-2 a 23-3, C-2 I 
IV 24-2,26-2 a Codes for lineages I and IV present 6 
b Codes for lineages II and IV present 2 
c Codes for lineages III and IV present 1 
d 24-2,26-1 2 
M. bovis 10-2,40-2, C-5 a 10-2,40-2, C-2 1 
b 10-2,40-2, G3 1 
c 10-2,40-2, C-4 1 
d ý., aýt, ýýý«",., 7 10-6,40-2, C-4 1 
e., 10-2,40-3, G5 1 
I Numbers stand for MIRU (e. g., 16-1, Z3 indicates that there are 1,2, or 3 copies of MIRU-16); letters stand for ETR (e. g., A-4 indicates that there are 4 copies 
of ETR-A). 
Discrepant loci are boldfaced. 
example, by allowing 4 or fewer discrepancies per lineage (i. e., DISCUSSION 
those isolates that are clustered by using a smaller panel of '". 
MIRU-VNTR compared to the clustering seen with all 15 The identification of key phylogenetic markers within pop- 
MIRU-VNTR), 4,12,7,7, or 6 MIRU-VNTR would be suf-` l'ulations of isolates is important in order to aid in our under- 
ficient to produce the same level of intralineage discrimination `"` standing of M. tuberculosis complex evolution and pathogene- 
as the whole panel when applied to lineage I, II, III, or IV or sis. A series of such markers in M. tuberculosis and M. bovis 
M. bovis, respectively (Table 7). have been described previously by Baker et al. (1), who defined 
TABLE 7. MIRU-VNTR loci used to subdivide each lineage into true clustered and true unique isolates 
lineage No. of No. of No. of Additional MIRU-VNTR for 
clusters MIRU-VNTR total discrimination AO: 0 (n) clustered unique (no. of discrepancies)' (range) isolates isolates (no. of discrepancies' 
1(36) 6(2-9) 27 9 16,26,27,31 (4) A (1) 
A, 20 11 (245) 30(2-13) 120 125 4,10,16,20,23,26,27,31, B (2) 
(0) 
39,40, A, C (4) 
B, 2 (1) 
B, 2,24 (0) 111 (100) 15 (2-13) 63 37 10,16,26,31,39,40, B (2) 20 (1) 
20,27(0) IV (88) 7(2-4) 19 69 4,10,31,39, A, B, 40 (2) 23 (0) M. bow (49) 5 (2 only) 10 39 23,24,26,27, A, B (3) Combination of two MIRU 
from 4,31, and 39 (0) 
' Numbers indicate MIRU (e. g., 16 stands for MIRU-16); letters indicate ETR (e. g., A stands for ETR-A). Isolates could initially be screened with a smaller panel of MIRU-VNTR in a resource-constrained laboratory wishing to produce a high level of intralineage discrimination for epidemiological purposes at a lower cost. This column shows the maximum number of MIRU-VNTR loci required to produce four or fewer discrepancies (i. e., isolates which are clustered by using a smaller panel of MIRU-VNTRs compared to clustering with all 15 MIRU-VNTR). b Additional MIRU-VNTR loci that would need to be added to the smaller panel to give the same level of intralineage discrimination of clustered isolates as the whole panel. 
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five distinct lineages. MIRU-VNTR is a rapid, high-through- copies either increases or decreases over time. Indeed, certain 
put typing tool that provides useful epidemiological markers loci show more allelic diversity than others, which may be due 
for use in tuberculosis outbreaks and control programs. If the to different selection pressures acting at different loci. The 
numeric codes by which MIRU-VNTR types are expressed can molecular clocks of some loci may be faster than others, and 
also define phylogenetic lineages, very large populations of M. certain loci may tolerate more polymorphisms than others. The 
tuberculosis complex isolates can be used in M. tuberculosis exact function of MIRU is not known, and it is not known 
evolution studies, since this typing system is beginning to be whether individual MIRU have different functions. Their high 
used routinely in some centers both in the United Kingdom variability may be a way for the bacteria to adapt to a new 
and globally. environment. Changes in the copy number of tandem repeats 
In this study MIRU-VNTR was successfully applied to a test may affect gene regulation (29) and have been shown to affect 
population to determine phylogenetic codes capable of defin- the expression of genes involved in adaptive responses (22). In 
ing each of the lineages described previously. To validate these Haemophilus influenzae, variability of repeat number has an 
MIRU-VNTR codes, an additional panel was analyzed. This effect on virulence (22,31). These findings suggest that a sim- 
panel was characterized with a portable sSNP-based macroar- ilar phenomenon could be occurring in the MIRU-VNTR of 
ray. Developing a macroarray to identify known sSNPs in a M. tuberculosis complex. 
population allowed rapid identification to species level and MIRU-VNTR can simultaneously define phylogeny and dif- 
identification of key lineages. The macroarray eliminated the ferentiate strains, as demonstrated in this study. A lineage- 
need for time-consuming, more-costly sequencing and so specific panel of MIRU-VNTR was used subsequently to sub- 
proved useful as a preliminary screening tool for M. tubercu- divide each lineage into clustered and unique strains, thus 
losis and M. bovis populations. eliminating the need to analyze all 15 MIRU for every isolate. 
Overall, the MIRU-VNTR phylogenetic codes were able to The advantage of using a smaller panel of MIRU-VNTR is a 
define 90.9% of sSNP-characterized M. tuberculosis and M. reduction in the cost of the analysis. In molecular epidemio- 
bovis isolates by using a combination of just 10 of the 15 loci logical studies, total discrimination would normally be re- 
examined. quired; therefore, isolates could be screened initially with a 
Lineage I accommodates the Beijing family strains. In this small MIRU-VNTR panel, followed by analysis of clustered 
study, 86.1% of the Beijing isolates were defined using the isolates with additional MIRU-VNTR for total discrimination 
MIRU-VNTR lineage I code. Although MIRU-VNTR codes (with additional typing techniques as required). 
are not as definitive as spoligotyping, dnaA-dnaN (7,12,18), ', ` MIRU-VNTR can characterize a population of M. tubercu- 
and sSNP analysis, the data shown here demonstrate that it is losis and M. bovis isolates for phylogenetic/evolutionary Pur- 
a good additional screening marker for Beijing-type strains. poses. It is also suggested that MIRU-VNTR is able to provide 
Ferdinand et at. (11) genotyped spoligotype-defined families information on sublineages and molecular clocks. MIRU- 
using the 12-MIRU system. They found that all Beijing isolates VNTR analysis is a high-throughput, reproducible method, 
could be characterized using a maximum of six MIRU; since ! 'Producing digital results that are readily portable between lab- 
the focus was to characterize all isolates, the loci and repeat 'oratories, and so is suited to phylogenetic studies as well as 
numbers used were not the same for all Beijing isolates. A, having a high discriminatory value for molecular epidemiolog- 
single code for the identification of Beijing isolates maybe ical investigations. Conversely, although genotyping by index- 
more useful before, or in parallel with, discrimination between ing genetically neutral variation provides a robust phylogeny 
these isolates. for M. tuberculosis, its value is limited for definitive epidemi- 
Lineage III contained the Central Asian family (CAS)/Delhi ological typing. This study demonstrated that MIRU-VNTR 
family of strains (2,12). The MIRU-VNTR code for this fam- profiling can be used for rapid classification of M. tuberculosis 
ily, 5 copies of MIRU-23 and 2 copies of ETR-C, defined 99% and M. bovis isolates. Future studies should investigate the 
of the isolates, making the differentiation of CAS/Delhi strains potential for extending the use of MIRU-VNTR to identify the 
within a population simple and specific. other members of the M. tuberculosis complex: Mycobacterium Locus MIRU-24 has previously been used to classify M. africanum, Mycobacterium microti, and Mycobacterium canetti. 
tuberculosis strains into two groups: those containing 1 copy 
and those containing 2 or 3 copies (11). Our MIRU-VNTR ACKNOWLEDGMENTS 
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